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Erdjan Salih, Ph. D. Associate Professor, Department of Periodontology
ABSTRACT
Egg yolk phosvitin is one o f the most highly phosphorylated extracellular 
matrix proteins known in nature with unique physico-chemical properties 
deemed to be critical during ex-vivo egg embryo development. We have 
utilized our unique live mouse calvarial bone organ culture models under 
conditions which dissociates the two bone remodeling stages, viz., resorption 
by osteoclasts and formation by osteoblasts, to highlight important and to date 
unknown critical biological functions o f egg phosvitin. In our resorption model 
live bone cultures were grown in the absence o f ascorbate and were stimulated 
by parathyroid hormone (PTH) to undergo rapid osteoclast 
formation/differentiation with bone resorption. In this resorption model native 
phosvitin potently inhibited PTH-induced osteoclastic bone resorption with 
simultaneous new osteoid/bone formation in the absence o f ascorbate (vitamin 
C). These surprising and critical observations were extended using the bone 
formation model in the absence o f ascorbate and in the presence o f phosvitin 
which supported the above results. The results were corroborated by analyses 
for calcium release or uptake, tartrate-resistant acid phosphatase activity
v
(marker for osteoclasts), alkaline phosphatase activity (marker for osteoblasts), 
collagen and hydroxyproline composition, and histological and quantitative 
histomorphometric evaluations. The data revealed that the discovered 
bioactivity o f phosvitin mirrors that o f ascorbate during collagen synthesis and 
the formation o f new osteoid/bone. Complementing those studies use o f the 
synthetic collagen peptide analogue and cultured calvarial osteoblasts in 
conjunction with mass spectrometric analysis provided results that augmented 
the bone organ culture work and confirmed the capacity o f phosvitin to 
stimulate differentiation o f osteoblasts, collagen synthesis, hydroxyproline 
formation, and biomineralization. There are striking implications and 
interrelationships o f this affect that relates to the evolutionary inactivation o f 
the gene o f an enzyme L-gulono-y-lactone oxidase, which is involved in the 
final step o f ascorbate biosynthesis, in many vertebrate species including 
passeriform birds, reptiles and teleost fish whose egg yolk contain phosvitin. 
These represent examples o f how developing ex-vivo embryos o f such species 
can achieve connective tissue and skeletal system formation in the absence o f 
ascorbate.
Key words: Phosvitin, calvarial bone organ culture, osteoclasts, osteoblasts, 
collagen synthesis, mass spectrometry, egg yolk embryo organogenesis,
evolution.
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1. INTRODUCTION
In the past two decades there has been an emergence o f conceptual 
developments in the area o f extracellular matrix (ECM) component-mediated 
influence on cellular function and behavior. ECM proteins have the capacity to 
play major roles in general tissue morphogenesis by imposing regulatory 
effects on cell growth and differentiation (1-6). Such biological processes are 
achieved, in general, through ECM-receptor mediated cell signaling, in 
particular the integrins (7-9). One specific field in which the ECM non- 
collagenous phosphoproteins have been extensively studied is normally 
mineralizing tissues such as bone (10-18,76) and dentin (19-22). In addition to 
their involvement in biomineralization and its regulation (2-4,6,15,18,23- 
25,76), bone ECM phosphoproteins are implicated in modulating cellular 
function and behavior o f bone cells (6,18,26-32,76) via promoting cell 
adhesion, motility and transmembrane signaling. The covalently-bound 
phosphate groups on these proteins have been shown to play a direct role in the 
nucleation o f Ca-P crystals during biomineralization (15,33) as well as in the 
cell attachment properties (34-36). Other studies demonstrated the effects on 
cellular activity and behavior such as osteoblast differentiation and bone 
formation both in vitro and in vivo by bone sialoprotein (BSP) (2, 37, 38). The 
biological functions o f ECM phosphoproteins continue to evolve with new 
discoveries such as the influence o f covalently-bound phosphates o f ECM 
phosphoproteins on selective/differential transmembrane protein tyrosine 
phosphorylation and down-stream differentially expressed genes in response to
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added BSP in its different phosphorylation states. These observations were 
augmented with studies using live mouse calvarial bone cultures stimulated by 
parathyroid hormone (PTH) to undergo osteoclastic bone resorption which was 
inhibited by added BSP forms (39). Additional studies using isolated cell 
cultures o f osteoblasts, macrophages and osteoclasts provided confirmation for 
the underlying molecular mechanism o f bone organ culture observations (39).
ECM phosphoproteins are not restricted to only bone and dentin but 
quite distinct from those phosphoproteins, egg yolks o f bird, reptile and fish 
contain abundant highly phosphorylated protein known as phosvitin (40,41). 
Phosvitin, derived from the full length protein o f the vitellogenin II gene has 
been suggested to have an extraordinary level o f covalently-bound phosphates 
with estimated -120 sites o f phosphorylation (40), rendering it one o f the most 
highly phosphorylated protein in nature. A second hypothetical protein based 
on vitellogenin I  gene has been predicted to have a homologous phosvitin 
sequence, however, has not been defined at the protein level. Despite its 
discovery almost half a century ago, the attempts to isolate and characterize 
phosphopeptides o f phosvitin have been very limited and achieved minimal 
success as only a few phosphopeptides have been partially characterized with 
poor localization o f a few P-Ser/P-Thr residues within the primary amino-acid 
sequence (77). We have utilized a number o f different chemical and 
biochemical strategies in combination with mass spectrometry (MS) to define 
and document for the first time on a large-scale phosphopeptides and their sites 
o f phosphorylation within the chicken egg yolk phosvitin. Importantly, during
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these studies we have also discovered a novel phosvitin and provided the first 
de novo amino acid sequence data for the full expression o f the vitellogenin I 
gene product. This led us to re-evaluate the nomenclature o f phosvitin and for 
logical reasons we have named the two phosvitins as phosvitin I and 2. The 
knowledge o f the precise phosphorylation sites and the ability to generate small 
bioactive phosphopeptides has two fold importance. There has been a major 
interest for many decades in generating short bioactive phosphopeptides o f 
phosvitin for use as antioxidants in food industry since such naturally occurring 
products are non-toxic whereas synthetic food additives can have adverse 
public health implications. Furthermore, such peptides have the potential to 
promote enamel re-mineralization agent for carries prevention in dentistry. 
However, the lack o f ability to generate small phosphopeptides and knowledge 
o f the phosphorylation sites restricted such usage o f phosvitin and instead milk 
derived casein phosphopeptides are being utilized commercially (78). In this 
regard our proposed studies in the long term will open the path to such 
investigations to design and synthesize phosvitin phosphopeptide analogues 
that can be used in regenerative medicine, dentistry and food industry.
Phosvitin has been shown to have biological functions common with 
those o f bone phosphoproteins, such as strong divalent metal ion binding 
capacity, particularly iron and calcium (42, 43), as well as calcium phosphate 
crystal nucleation (44). However, there are exceptional properties o f phosvitin 
not shared with bone phosphoproteins. These include powerful antioxidant/- 
reducing activity, and anti-bacterial effects (45-47). Phosvitin binds to ferric
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ion (Fe3+) very strongly, whereas it forms weak complexes with the ferrous ion 
(Fe2+) and capable o f converting one oxidation state to another (48). It has been 
shown that phosvitin can effectively inhibit Fe2+- and Cu2+- mediated oxidation 
o f phospholipids (49) and inhibits Fe2+- catalyzed hydroxyl radical (.OH) 
production in Fenton reaction system (45). The extraordinary degree o f 
phosphorylation o f phosvitins and the above antioxidant/reducing agent 
properties suggest that these phosphoproteins have a unique spectrum o f 
biological functions during egg yolk embryo development. Furthermore, the 
above chemical characteristics o f phosvitin overlap with those o f ascorbate 
(vitamin C) which as an antioxidant/reducing agent has major roles in a 
number o f importance physiological reactions such as collagen 
synthesis/stability, iron metabolism and immunity (50). Based up on the 
significance o f collagen as the most abundant protein and its wide distribution 
throughout the vertebrate tissues, organs and skeletal system, it is surprising 
that many species have lost the capacity to synthesize ascorbate. These include 
primates (51, 52), guinea pigs (53), teleost fish (54), bats (55) and passeriform 
birds (59). In these species the lack o f appropriate ascorbate supplementation in 
their diet adversely impact multiple metabolic biochemical processes with 
eventual development o f scurvy. The inability to synthesize vitamin C is due to 
a deficiency in L-gulono-y-lactone oxidase (GLO) which is the enzyme 
responsible for catalyzing the last step o f ascorbate biosynthesis (51). This 
defect has been estimated to have taken place some 35-55 million years ago in 
humans and guinea pigs as a result o f highly mutated nonfunctional versions o f
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GLO gene (79,80). Ascorbate is essential during the biochemical synthesis o f 
collagen and its ultimate fate as a stable component o f the extracellular matrix 
(ECM) without which it is an excepted dogma that there will be no ECM, no 
tissue, organ or skeletal system development. This stability in part is achieved 
by posttranslational hydroxylation o f some proline residues which make up 
almost every third amino-acid residue within the collagen molecule. 4- and 3- 
hydroxyprolines are essential for the three-dimensional folding o f the newly 
synthesized pro-collagen which facilitate the “intra-cross links” and stability 
(81-83). The hydroxylation o f the prolyl residues is carried out by the prolyl 
hydroxylases in the presence o f ferrous (Fe2+) ion and the lysine residues are
_i_2hydroxylated by lysyl hydroxylase enzyme which also require Fe . The
function o f vitamin C as an antioxidant/reducing agent is to ensure continuity
+2o f the cyclic process through regeneration o f the desired ferrous (Fe ) ion 
which becomes oxidized to ferric (Fe+3) ion during the hydroxylation step.
The observed biological properties and characteristics o f phosvitins which 
closely mirror those o f ascorbate, led us to postulate that phosvitins should 
facilitate synthesis o f stable collagen and new bone formation in the absence o f 
ascorbate. This property o f phosvitin has never been investigated or envisioned. 
However, if true it will have revolutionary implications. To test whether 
phosvitins have functions in connective tissue formation, we have utilized an 
ex -vivo live mouse calvarial bone culture models in the absence and presence 
o f phosvitin to reveal its potential biological activity. We have previously used 
these bone organ culture models in studies o f the effects o f BSP and its
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different phosphorylation states on PTH-induced bone resorption (39). In most 
recent studies we have developed an innovative “novel three-dimensional 
cancer-bone metastasis model” using co-cultures o f ex-vivo live calvarial bone 
organ and cancer cells in a roller tube system (57). In our preliminary studies 
using native phosvitin and live bone culture models led to the discovery o f 
novel biological properties o f phosvitin in facilitating new osteoid 
and bone formation in the absence o f ascorbate. These studies and the 
surprising discoveries thus far suggest that we are in a unique position to 
unravel important biological/chemical processes with major scientific impact.
Unlike primates including humans and some o f the other vertebrates, 
evolutionarily mice have retained the capacity to synthesize ascorbate. 
However, knock-out studies in mice o f  ascorbate biosynthesis through deletion 
o f the GLO gene showed that the collagen synthesis and the ratio o f proline: 4- 
hydroxyproline appeared not to change significantly (84). It was suggested 
that collagen synthesis was independent o f ascorbate and there was perhaps 
another mechanism by which stable collagen synthesis and hydroxyproline 
formation was possible (84). Our studies, however, using ex-vivo live neonatal 
mouse calvarial bone cultures which eliminates natural supply o f ascorbate 
showed clearly that in the absence o f added ascorbate in such cultures there 
was no new osteoid/bone formation and hence stable collagen synthesis(57). 
Inclusion o f ascorbate in such cultures on the other hand proceeded with rapid 
formation o f new osteoid and bone. There is an interesting dilemma that also 
arises when one considers the development o f egg yolk embryos in in vitro
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eggs o f passeriform birds, teleos fish and reptiles whose GLO gene is mutated 
and inactive just as for primates including humans. The developing embryos in 
eggs o f these species have no capacity to synthesize ascorbate. Under these 
conditions the fundamental limitations are obvious but yet egg embryos grow 
with all the vital tissues, organs and skeletal system o f which collagen is a 
major component and eventually hatch. Interestingly, chickens similar to mice 
have retained the capacity to synthesize ascorbic acid and during development 
chicken egg embryos can synthesize ascorbate (85). It is possible that ascorbate 
may be stored in the eggs however it is not clear to what extent this stored 
ascorbate may be biologically active due to its chemical instability. One 
possibility is the presence o f phosvitin as an antioxidant/reducing agent under 
such circumstances can help preserve ascorbate activity. Fish, dinosaurs and 
birds were the early vertebrates to evolve pre-dating modem vertebrates and 
primates more than 200 million years. Ironically all o f these early vertebrates 
were egg laying species for reproduction and while the dinosaurs are extinct 
the fish and birds are still in existence and continue to use the same biological 
process for reproduction. The lack o f capacity to synthesize ascorbate on the 
bases o f inactive gene in passeriform birds and teleost fish indicates that the 
developing embryos o f these species in ex-vivo eggs may utilize alternative 
biomolecules and mechanism(s) for collagen synthesis during embryogenesis. 
The main objectives o f the present proposal are to delineate the cellular and 
molecular mechanisms o f the discovered novel bioactivity o f native phosvitin 
in connective tissue and bone formation with potential application to biological
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sciences and regenerative medicine/dentistry. However, such studies may also 
shed some light indirectly to the evolutionary developments.
A number o f chemical, biochemical, histological and histomorphometric 
analysis were used to define phosvitin bioactivity in two bone organ culture 
models. In order to provide further evidence and augment the results o f new 
osteoid/bone formation induced by phosvitin, we will perform some 
quantitative procedures during the proposed studies, (a) The calvarial bones in 
different treatment groups will be subjected to measurements o f the ratio o f 
quantitative mineral content relative to the organic matrix collagen. The 
mineral content and ECM collagen will be determined after 6N HCL acid 
solubilization/hydrolysis o f the calvarial bones followed by calcium and 
amino-acid analysis as previously described (13,15,86,87). The results o f such 
analysis will allow calculation o f the proline : hydroxyproline ratios. This will 
provide important information with regards to the new osteoid/bone formation 
and its degree o f biomineralization in the presence o f phosvitin versus 
ascorbate. Such data will help in explaining the differences in the amount o f 
calcium uptake in these two groups in relation to the degree o f new osteoid 
formed and ALP activity, (b) The new ECM and collagen synthesis will be 
evaluated by L-[5-3H]proline in bone organ cultures and determine the new 
proline incorporation using scintillation counting o f the acid solubilized bones 
(84). The data from such experiments will compliment and confirm the 
histolomorphometric measurements, calcium uptake, and ALP activity data 
related to new osteoid/bone formation. In the bone resorption model in
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addition to those analysis described above and under preliminary data, we will 
assay for matrix degradation by ELISA approach for quantitative release o f 
collagen fragments as described in our previous studies (39).
Despite its discovery more than half a century ago, phosvitin has not been 
characterized with respect to its biological functions related to connective 
tissue and bone formation. This is most likely due to the lack o f  an appropriate 
experimental model that could be used which can reveal clearly such 
bioactivity with interpretable data and without major uncertainties or 
complications that the observed effects are solely due to the added biomolecule. 
For example common in vivo animal models such as mice would have multiple 
metabolic problems if ascorbate were eliminated from the diet but mice have 
retained the capacity to synthesize ascorbate. It is possible to generate knock­
out mice lacking the capacity to synthesize ascorbate, however, such an 
approach is also associated with the problem that the absence o f ascorbate 
leads to major adverse general physiological problems that could complicate 
the clear interpretation o f the final observed experimental outcome. One o f the 
unique chemical characteristics o f phosvitin is its powerful 
antioxidant/reducing agent capacity which mirrors that o f ascorbate. 
Importantly, ascorbate as an antioxidant/reducing agent is an essential 
biomolecule during collagen biosynthesis and hence, formation and 
maintenance o f connective tissue, organs and skeletal system. This led to our 
postulate that phosvitin should facilitate collagen synthesis and bone formation 
in the absence o f ascorbate. We have utilized our unique and well established
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ex-vivo live neonatal mouse calvarial bone organ culture model systems in the 
absence and presence o f phosvitin to reveal its potential biological activity in 
connective tissue and bone biology. Using conditions that separate the different 
bone remodeling stages, viz., osteoclastic bone resorption or osteoblastic bone 
formation model systems highlighted the unique and to date unknown 
biological properties o f phosvitin with important scientific and evolutionary 
implications. We report on our findings that give rise to critical unknown 
physiological functions o f phosvitin in the synthesis o f stable collagen, 
formation o f new osteoid and general connective tissue and bone 
organogenesis with major scientific and evolutionary impact.
1.1 Phosvitin
Egg yolk is composed o f clear, yellow-colored fluid called plasma and 
suspended particles called granules (90,91,92). After dilution with 0.3 N NaCl 
and centrifugation for at 10000 g for 30 min, the yolk can be divided into 
supernatant which is plasma and pallet o f granules (90,93). The granular 
fraction o f the egg yolk contains lipovitellin and phosvitin (90,94,95). Hen egg 
yolk phosvitin was first isolated by Mecham and Olcotte in 1949 by diluting 
the egg yolk with magnesium sulphate(90). It has been proven that in 
nonmammalian vertebrates, the macromolecular hepatically derived 
lipophosphoprotein vitellogenin serves as the precursor for lipovitellin and 
phosvitin(90). Egg yolk phosphoproteins are composed o f phosvitin and 
phosvettes (90,96).
Phosvitin accounts for 60% o f total egg yolk phosphoproteins and holds
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about 90% o f the egg yolk phosphorous. The meaning o f phosvitin indicates 
that it contains high amount o f phosphorous and its origin o f egg yolk (90,97). 
In 1967, Taborsky and Mok first determined the molecular weights o f minor 
and major phosvitin as 36000 and 40000 Da. Egg yolk phosvitin is a 
heterogeneous protein composed o f 7 components and in which 2 main 
components account for 80% and 15%, respectively (90,98). Wallance and 
Morgan reported that the unfractionated phosvitin is composed o f 5 major 
components known as B, C, El, E2, and F; and their molecular weights are 
40000, 33000, 15000, 18000, and 13000 Da, respectively(90,99). Abe and 
others (1982) reported that molecular weights o f phosvitin components ranged 
from 18500 to 60000 Da(90,100). Also, they identified 2 main components o f 
phosvitin in sodium dodecyl sulfate polyacrylamide-gel electropherogram as a 
and p, which could be the 2 components, referred by Taborsky and Mok(1967) 
as major and minor phosvitin (90,101).
Shainkin and Perlmann(1971) reported that the purified phosvitin with the 
molecular weight o f 40000 Da contains 6.5% o f carbohydrates consisting o f 6 
hexose, 5 glucoseamine, and 2 sialic acids attached to the N-acetyl derivatives 
per molecule, and the carbohydrate components show a triple-branched 
antenna-like structure (90,102,103,104).
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1.2 Mechanism of phosvitin induced new osteoid and bone formation
Characterization o f  ECM phosphoproteins in vertebrate species that are 
evolutionarily pre-dating contemporary vertebrate species link the fundamental 
bases o f mechanism o f biomineralization and connective tissue formation to 
the ancient times (72). Internalization o f the egg yolk ECM phosphoprotein 
phosvitin into the oocyte via specific cell receptor binding and subsequent 
endocytosis (73), suggests several important physiological functions o f 
phosvitins during embryogenesis o f birds, reptiles and fish which are not well 
understood. In particular, for those bird, fish and reptile species whose GLO 
genes are inactive and hence, lack the capacity to synthesize ascorbic acid with 
consequence o f inability to achieve collagen synthesis. The critical scientific 
knowledge as to how in the absence o f ascorbic acid the developing egg yolk 
embryos attain normal connective tissue, organ and skeletal system formation 
o f these distant vertebrates borders between very limited to non-existent. While 
this proposal’s main objectives are not concerned directly with egg embryo 
development, however, the discovery o f the novel bioactivity o f phosvitin and 
the proposed studies will indirectly shed some light to those biological events 
as well.
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1.3 Chemical properties of phosvitin as antioxidant/reducing agent
The present thesis will extend the studies to defining the precise 
biochemical and chemical pathway(s) by which phosvitins impact new 
osteoid/bone formation in our mouse calvarial organ culture model systems. 
Based upon our results we hypothesize that phosvitins can function same as 
ascorbate as an antioxidant/reducing agent during the synthesis o f collagen 
involving Fe+2/Fe+3 and prolyl-hydroxylases, but with potential subtle 
differences, see Scheme 1 below. The possibility o f intracellular phosvitin 
function clearly requires that phosvitin must be internalized. The 
internalization o f  phosvitin by developing egg yolk oocyte is well known (73), 
however, whether this occurs with mammalian cells or mouse calvarial cells is 
not known. There will be further approaches to clarify the left-hand potential 
intracellular action in the mechanism o f Scheme 1 in the future.
13
Scheme 1. The possible pathways o f phosvitin’s antioxidant function .
Scheme 1. shows the possible pathway o f intracellular phosvitin’s antioxidant
function. Based upon our results we hypothesize that phosvitin can function
same as ascorbate as an antioxidant/reducing agent during the synthesis o f
collagen involving Fe+2/Fe+3 and prolyl-hydroxylases, but with potential subtle
differences. The possibility o f intracellular phosvitin function clearly requires
that phosvitin must be internalized. The internalization o f phosvitin by
developing egg yolk oocyte is well known (89), however, whether this occurs
with mammalian cells or mouse calvarial cells is not known. There will be
further approaches to clarify the left-hand potential intracellular action in the
future.
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2. Specific Aims
Aim I : To test wheather phosvitin can act as asascobate in synthetic peptidein 
in vitro hydroxylation o f type I collagen sequence.
Aim 2: Cell culture primary osteoblast ± phosvitin, alendronate (Forsamax) and 
bisphosphonate.
Aim 3: Gene expression in primary osteoblast ± phosvitin and ascobate.
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2.1 Mechanism of Phosvitin
The right-hand (extracellular) non-classical mechanism o f Scheme 1 will be 
evaluated by using synthetic collagen type I peptide o f length ~20 amino acids 
and containing the potential proline hydroxylation motifs o f repeating (PPG- 
PSG)3, i.e., G-PPG-PSG-PPG-PSG-PPG-PSG-K as a substrate for proly- 
hydroxylases and calvarial bone cell lysate in a test tube conditions. The choice 
o f the synthetic peptide with above repeat tri-peptides is to evaluate both the 4- 
prolyl-hydroxylase (PP*G sequence) and the 3-proly-hydroxylase (P*SG 
sequence) activity where the asterisks indicate the respective potential proline 
hydroxylation sites. The primary rat osteoblast cell lysate will be generated 
from 19 days embryonic rat calvaria. The analysis for hydroxylation o f proline 
residues within the synthetic peptide will be by MS analysis whereby a mass 
addition o f 16 Da and multiples o f this on a peptide o f known mass will define 
proline hydroxylation and their numbers. MS/MS sequence analysis o f such 
peptides will define the precise proline hydroxylation sites. For this latter case 
the synthetic peptide sequence above will be inserted into the database for 
automated search purposes. The results o f such test tube experiments will 
define the capacity o f phosvitin to act in the mechanistic pathways outlined 
above in Scheme 1.
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2.2 Gene Markers of Osteoblast cells 
2.2.1 RUNX 2
RUNX 2(Runt-related transcription factor 2) is a member o f the RUNX 
family o f transcription factors and encodes a nuclear protein with an Runt 
DNA-binding domain. This protein is essential for osteoblastic differentiation 
and skeletal morphogenesis and acts as a scaffold for nucleic acids and 
regulatory factors involved in skeletal gene expression. The protein can bind 
DNA both as a monomer or, with more affinity, as a subunit o f a heterodimeric 
complex. Mutations in this gene have been associated with the bone 
development disorder cleidocranial dysplasia (CCD). Transcript variants that 
encode different protein isoforms result from the use o f alternate promoters as 
well as alternate splicing. (105)
2.2.2 SP7 (Osterix)
SP7 (SP7 transcription factor) encodes a member o f the Sp subfamily o f 
Sp/XKLF transcription factors. Sp family proteins are sequence-specific DNA- 
binding proteins characterized by an amino-terminal trans-activation domain 
and three carboxy-terminal zinc finger motifs. This protein is a bone specific 
transcription factor and is required for osteoblast differentiation and bone
17
formation. (106)
2.2.3 ACTS
ACTB (actin, beta) encodes one o f six different actin proteins. Actins are 
highly conserved proteins that are involved in cell motility, structure, and
integrity. This actin is a major constituent o f the contractile apparatus and one 
o f the two nonmuscle cytoskeletal actins. (107)
2.2.4 IBSP
The protein encoded by this gene is a major structural protein o f the bone 
matrix. It constitutes approximately 12% o f the noncollagenous proteins in 
human bone and is synthesized by skeletal-associated cell types, including 
hypertrophic chondrocytes, osteoblasts, osteocytes, and osteoclasts. The only 
extraskeletal site o f it’s synthesis is the trophoblast. This protein binds to 
calcium and hydroxyapatite via its acidic amino acid clusters, and mediates cell 
attatchment throughan RGD sequence that recognizes the vitronectin receptor. 
(117)
2.2.5 TNF11
This gene encodes a member o f the tumor necrosis factor (TNF) cytokine 
family which is a ligand for osteoprotegerin and functions as a key factor foi 
osteoclast differentiation and activation. This protein was shown to be a 
dentritic cell survival factor and is involved in the regulation of T cell-
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dependent immune response. T cell activation was reported to induce 
expression o f this gene and lead to an increase o f osteoclastogenesis and bone 
loss. This protein was shown to activate antiapoptotic kinase AKT/PKB 
through a signaling complex involving SRC kinase and tumor necrosis factor 
receptor-associated factor (TRAF) 6, which indicated this protein may have a 
role in the regulation o f cell apoptosis. Targeted disruption o f the related gene 
in mice led to severe osteopetrosis and a lack o f osteoclasts. The deficient mice 
exhibited defects in early differentiation o f T and B lymphocyte, and failed to 
form lobulo-alveolar mammary structures during pregnancy. Two alternatively 
spliced transcript variants have been found. (117)
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3 Material and Method
Glycerophosphate, Ascorbate and Phosvitin
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine semm (Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 4 groups for mineralization as followed: (1) Control group 
(2) P-Glycerophosphate group (3) Ascorbate group (4) Phosvitin group.
Each group was cultured with different materials as follow:(l) Control 
group was cultured with Alpha MEM only. (2) P-Glycerophosphate group was 
cultured with Alpha MEM and lOmM/ml p-Glycerophosphate (Santa Cmz 
Biotechnology, Inc.). (3) Ascorbate group was cultured with Alpha MEM, 
lOmM/ml P-Glycerophosphate and 20pg/ml Na ascorbate (Sigma-Aldrich Co.). 
(4) Phosvitin group was cultured with Alpha MEM, lOmM/ml p~ 
Glycerophosphate and 20pg/ml phosvitin(Phosvitin from egg yolk, Sigma- 
Aldrich Co.).
We put 2ml medium in each well with osteoblast cells and change medium 
every 5 days for total period o f 20 days. We used 3 wells for samples according 
to each group and different time set o f every 5 days. In other words, we used 3
3.1 Bio-Mineralization of Primary Osteoblast cells cultured with P-
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well for the very first day o f control group as “Day 0”and used another 3 wells 
for 5 days o f control group as “Day 5” and used another 3 wells for 10 days o f 
control group as “Day 10” ...followed by the same procedure till “Day 20”. It 
applied to (3-Glycerophosphate group, Ascorbate group and Phosvitin group.
According to different time set and groups, we saved the medium o f each 3 
wells to another 2ml Eppendorf tubes (US A Scientific Inc.) every 5 days and 
kept it in a -80 °C freezer for further analysis. After that, we put 0.5 ml 
NaCl+P4o into each well as buffer. Then we scraped the cell layer off and put it 
into another 2ml tubes which were also kept in a -80 °C freezer for further 
analysis.
The whole experiment was done after 20 days. Then we started to do the 
analysis o f each sample we collected. The medium we saved was used for 
calcium assay for the calcium concentration. Regarding to the tubes with cell 
layer, we centrifuged them in 10000 rpm for 5 minutes and saved the 
supernatant in another tubes for BCA and ALP assay. Then we put 0.4 ml 0.1 M 
HC1 in each tube with cell pellet for dissolving calcium and shook them with a 
vortex mixer and shaker (Vortex-Genie 2, Scientific Industries, Inc.). After 30 
minutes later for resting, we centrifuged them in 10000 rpm for 5 minutes and 
then put in 120pl, 2M NaOH for calcium assay.
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Alendronate
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine serum(Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 4 groups for mineralization as followed: (1) Control group 
(2) 0.1 pM Alendronate group (3) 1 pM Alendronate group (4) 5 pM 
Alendronate group.
Each group was cultured with different materials as follow:(l) Control 
group was cultured with alpha MEM, lOmM/ml P-Glycerophosphate and 
20pg/ml Na ascorbate (2) 0.1 pM Alendronate group was cultured with alpha 
MEM, lOmM/ml P-Glycerophosphate, 20pg/ml Na ascorbate and 0.1 pM 
alendronate(Sigma-Aldrich Co.). (3) 1 pM Alendronate group was cultured 
with Alpha MEM, lOmM/ml p-Glycerophosphate , 20pg/ml Na ascorbate and 
1 pM alendronate (4) 5 pM Alendronate group was cultured with alpha MEM, 
lOmM/ml p-Glycerophosphate, 20pg/ml Na ascorbate and 5 pM alendronate.
We put 2ml medium in each well with osteoblast cells and change 
medium every 5 days for total period o f 15 days. We used 3 wells for samples 
according to each group and different time set o f every 5 days. In other words,
3.2 Bio-Mineralization of Primary Osteoblast cells cultured with
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we used 3 well for the very first day o f control group as “Day 0”and used 
another 3 wells for 5 days o f control group as “Day 5” and used another 3 wells 
for 10 days o f control group as “Day 10” ...followed by the same procedure till 
“Day 15”. It applied to 0.1 pM Alendronate group, 1 pM Alendronate group, 5 
pM Alendronate group as well.
According to different time set and groups, we saved the medium o f each 3 
wells to another 2ml tubes every 5 days and kept it in a -80 °C freezer for 
further analysis. After that, we put 0.5 ml NaCl+ Nonidet-P-40 into each well 
as buffer. Then we scraped the cell layer off and put it into another 2ml tubes 
which were also kept in a -80 °C freezer for further analysis.
The whole experiment was done after 15 days. Then we started to do the 
analysis o f each sample we collected. The medium we saved was used for 
calcium assay for the calcium concentration. Regarding to the tubes with cell 
layer, we centrifuged them in 10000 rpm for 5 minutes and saved the 
supernatant in another tubes for BCA and ALP assay. Then we put 0.4 ml 0.1 M 
HC1 in each tube with cell pellet for dissolving calcium and shook them with a 
vortex mixer and shaker (Vortex-Genie 2, Scientific Industries, Inc.). After 30 
minutes later for resting, we centrifuged them in 10000 rpm for 5 minutes and 
then put in 120pl, 2M NaOH for calcium assay.
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Bisphosphonate
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine serum(Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 4 groups for mineralization as followed: (1) Control group 
(2) 0.1 pM New-Bisphosphonate group (3) 1 pM New-Bisphosphonate group 
(4) 5 pM New-Bisphosphonate group.
Each group was cultured with different materials as followed:(l) Control 
group was cultured with alpha MEM, lOmM/ml (3-Glycerophosphate and 
20pg/ml Na ascorbate (2) 0.1 pM New-Bisphosphonate group was cultured 
with alpha MEM, lOmM/ml P-Glycerophosphate, 20pg/ml Na ascorbate and 
0.1 pM new-bisphosphonate. (3) 1 pM New-Bisphosphonate group was 
cultured with Alpha MEM, lOmM/ml p-Glycerophosphate , 20pg/ml Na 
ascorbate and 1 pM new-bisphosphonate (4) 5 pM New-Bisphosphonate group 
was cultured with alpha MEM, lOmM/ml p-Glycerophosphate, 20pg/ml Na 
ascorbate and 5 pM new-bisphosphonate.
3.3 Bio-Mineralization of Primary Osteoblast cells cultured with New-
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We put 2ml medium in each well with osteoblast cells and change 
medium every 5 days for total period o f 15 days. We used 3 wells for samples 
according to each group and different time set o f every 5 days. In other words, 
we used 3 well for the very first day o f control group as “Day 0”and used 
another 3 wells for 5 days o f control group as “Day 5” and used another 3 wells 
for 10 days o f control group as “Day 10” ...followed by the same procedure till 
“Day 15”. It applied to 0.1 pM New-Bisphosphonate group, 1 pM New- 
Bisphosphonate group, 5 pM New-Bisphosphonate group as well.
According to different time set and groups, we saved the medium o f each 3 
wells to another 2ml tubes every 5 days and kept it in a -80 °C freezer for 
further analysis. After that, we put 0.5 ml NaCl+ Nonidet-P-40 into each well 
as buffer. Then we scraped the cell layer o ff and put it into another 2ml tubes 
which were also kept in a -80 °C freezer for further analysis.
The whole experiment was done after 15 days. Then we started to do the 
analysis o f each sample we collected. The medium we saved was used for 
calcium assay for the calcium concentration. Regarding to the tubes with cell 
layer, we centrifuged them in 10000 rpm for 5 minutes and saved the 
supernatant in another tubes for BCA and ALP assay. Then we put 0.4 ml 0.1M 
HC1 in each tube with cell pellet for dissolving calcium and shook them with a 
vortex mixer and shaker (Vortex-Genie 2, Scientific Industries, Inc.). After 30 
minutes later for resting, we centrifuged them in 10000 rpm for 5 minutes and 
then put in 120pl, 2M NaOH for calcium assay.
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Alendronate
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine serum(Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 3 groups for mineralization as followed: (1)1 pM 
Alendronate group (2) 30pM Alendronate group (3) 100 pM Alendronate 
group.
Each group was cultured with different materials as follow:(l) 1 pM 
Alendronate group was cultured with alpha MEM and 1 pM 
alendronate(Sigma-Aldrich Co.). (2) 30 pM Alendronate group was cultured 
with Alpha MEM and 30 pM alendronate (3) 100 pM Alendronate group was 
cultured with alpha MEM and 100 pM alendronate.
We removed medium from wells and washed them with PBS(Phosphate 
Buffered Saline, Ricca Chemical Co.).Then we put 1 ml 0.25% Trypsine- 
EDTA (Gibco, Life Technologies Co.) in each well to trypsinize the cell layers 
from the wells around 30 minutes in an incubator. After that, we took the 
detached cell layers to centrifuge at 1500 r.p.m. for 5 minutes. Then we 
removed the supernatant and put 1 ml alpha-MEM into the tube and pipetted it
3.4 Cell number counting of Primary Osteoblast Cells cultured with
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for mixing. After that, we took 36pl medium from the tube and mixed it with 4 
pi Tripon Blue for dying and put it under a microscope for cell counting.
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Bisphosphonate
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine serum(Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 3 groups for mineralization as followed: (1)1 pM New- 
Bisphosphonate group (2) 30pM New-Bisphosphonate group (3) 100 pM New- 
Bisphosphonate group.
Each group was cultured with different materials as follow:(l) 1 pM New- 
Bisphosphonate group was cultured with alpha MEM and 1 pM new- 
bisphosphonate group (2) 30 pM New-Bisphosphonate group was cultured 
with Alpha MEM and 30 pM new-bisphosphonate (3) 100 pM New- 
Bisphosphonate group was cultured with alpha MEM and 100 pM new- 
bisphosphonate.
We removed medium from wells and washed them with PBS(Phosphate 
Buffered Saline,Ricca Chemical Co.).Then we put 1 ml 0.25% Trypsine- 
EDTA(Gibco, Life Technologies Co.) in each well to trypsinize the cell layers 
from the wells around 30 minutes in an incubator. After that, we took the 
detached cell layers to centrifuge at 1500 rpm for 5 minutes. Then we removed
3.5 Cell number counting of Primary Osteoblast Cells cultured with New-
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the supernatant and put 1 ml alpha-MEM into the tube and pipetted it for 
mixing. After that, we took 36pl medium from the tube and mixed it with 4 pi 
Tripon Blue for dying and put it under a microscope for cell counting.
3.6 RNA Exaction of Primary Osteoblast Cells
We cultured primary osteoblast cells from 16-18 days old embryonic rats 
(CD® IGS 001 rats, Charles River Laboratory, MA) in six-well plates 
(Coming* Costar* Cell Culture Plates, Fisher Scientific Co.) with Alpha MEM 
(Sigma-Aldrich Co.) which included 10% fetal bovine semm (Sigma-Aldrich 
Co.),l% Pen Strep (Gibco, Life Technologies Co.) and 1% MEM Non- 
Essential Amino Acids Solution(100X , Gibco, Life Technologies Co.) in each 
well. After the osteoblast cells were confluent in these six-well plates, we set 
up an experiment o f 3 groups for RNA extraction as followed: (1) Control 
group (2) Ascorbate group (3) Phosvitin group.
Each group was cultured with different materials as follow:(l) Control 
group was cultured with Alpha MEM only. (2) Ascorbate group was cultured 
with Alpha MEM and 20pg/ml Na ascorbate (Sigma-Aldrich Co.). (3) 
Phosvitin group was cultured with Alpha MEM and 20pg/ml Phosvitin 
(Phosvitin from egg yolk, Sigma-Aldrich Co.).
2 Days later, we changed medium (the content is the same but no 10% fetal 
bovine semm). The next day, these 3 groups were ready for RNA extraction.
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3.7 RNA Exaction Procedures
1. Cells: Harvest a maximum o f 1 x 10  ^cells, as a cell pellet or by direct 
lysis in the vessel. Add the appropriate 600 pi o f Buffer RLT because the
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amount o f cells is equal or less than 1 x 10 .
2. Add 1 volume o f 70% ethanol to the lysate, and mix well by pipetting. Do 
not centrifuge. Proceed immediately to step 3.
3. Transfer up to 700 pi o f the sample, including any precipitate, to an 
RNeasy Mini spin column placed in a 2 ml collection tube (supplied). 
Close the lid, and centrifuge for 15 s at >8000 x g. Discard the flow­
through.
4. Add 700 pi Buffer RW1 to the RNeasy spin column. Close the lid, and 
centrifuge for 15 s at >8000 x g. Discard the flow-through.
5. Add 500 pi Buffer RPE to the RNeasy spin column. Close the lid, and 
centrifuge for 15 s at >8000 x g. Discard the flow-through.
6 . Add 500 pi Buffer RPE to the RNeasy spin column. Close the lid, and 
centrifuge for 2 min at >8000 x g. Optional: Place the RNeasy spin 
column in a new 2 ml collection tube (supplied). Centrifuge at full speed 
for 1 min to dry the membrane.
7. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). 
Add 30-50 pi RNase-free water directly to the spin column membrane.
31
Close the lid, and centrifuge for 1 min at >8000 x g to elute the RNA.
8 . If the expected RNA yield is >30 pg, repeat step 7 using another 30-50 pi
o f RNase-free water, or using the eluate from step 7 (if high RNA 
concentration is required). Reuse the collection tube from step 7. (108)
3.8 Real-Time PCR Quantification of Gene Expression
Total RNA was extracted from osteoblast cells using RNeasy Mini Kit 
(QIAGEN). Single strand cDNA was synthesized from 0.75 pg total RNA with 
GeneAmp®  RNA PCR Core Kit (Applied Biosystems® ). Real-time PCR was 
performed using 4.5 pi cDNA(5ng/pl) in a 10-pl reaction volume with with 
Real-time PCR system TaqMan®  Universal PCR Master Mix(Applied 
Biosystems® ).Specific primers ,Osterix and Runx 2, (TaqMan®  Gene 
Expression Assay, Applied Biosystems® ) and 4.5 pi o f cDNA(5ng/pl) were 
used in each PCR reaction(25°C for 10 minutes, 42°C for 15 minutes, 99°C for 
5 minutes and 4°C for 5 minutes, MyCycler Thermal Cycler, BIO-RAD). The 
sense and antisense primers were designed based on published rat cDNA 
sequences. Primer sequences were as follows: Osterix, 5’- 
GCCTACTTACCCGTCTGACTTT-3’ and 5’-
GCCCACTATTGCCAACTGC-3’; Runx 2, 5’-GCACCCAGCCCATAA- 
TAGA-3’ and 5 ’-TTGGAGCAAGGAGAACCC-3 ’. All real-time PCR 
reactions were performed in triplicate and the result after calibration were
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presented as fold increase relative to the control group (113).
3.9 Observation of global OC activity by Neutral Red Staining and global 
assessment of bone resorption by Silver Nitrate Staining
Neutral red staining has been known to provide quantitative estimation 
o f OC activity. In the live bone organ culture that we have utilized, OC cells 
are capable o f rapid uptake o f NR. Due to its multinucleated nature, the 
staining allows clear contrast to be made between OCs and other bone cells 
(109). At the end o f the experiment, the bisected half calvaria were stained with 
70 pg/ml NR (Sigma-Co) then incubated under 37 °C for 45 min. Microscopic 
observations were made and digital images were taken. The calvaria were then 
washed with Phosphate buffered saline (PBS) before fixation in 10% formalin 
overnight. The calvaria were then washed once more with PBS before counter 
stained with 2% silver nitrate (Sigma-Aldrich) for 20 minutes. Under 
microscope, the stain provides visualization o f the apparent regions where 
resorption had occurred. All digital images were captured under magnification 
o f 20X, 100X, and 200X, with compound microscope (Nikon), by Retiga 1300 
digital camera (Qimaging, Canada) then processed with Procapture 5 digital 
imaging software on a Dell dimension desktop.
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3.10 Assessment of Media Calcium Release and Uptake in bone resorption 
and formation model
In the bone resorption and formation mouse calvaria cultures, calcium 
release and uptake was reflected in the media respectively. Calcium assays are 
based on the chemical reaction between calcium chelating chromophoric 
reagent and calcium ion available in the media (110). The reaction forms an 
intense purple complex, which is reflected by the absorbance. The absorbance 
is directly proportional to the calcium concentration o f the media. Media 
calcium concentration was first determined by performing calcium assays 
utilizing Arsenozo III (Sigma-Co) calcium reagent. However, due to the high 
background absorbance values obtained with Arsenozo III calcium assay, the 
data were later re-confirmed with O-Cresolphthalein Complexone (Sigma-Co) 
calcium assay. The results from both calcium assays were similar and show no 
significant difference between the two calcium assay methods.
3.11 Determination of Standard Curve for Calcium Assay
The determination o f media calcium concentration was calculated by 
using a standard curve. Calcium Chloride standards with concentrations 
ranging from 0-50 nmol/10 pL were prepared. Linearity o f the assay and 
correlation coefficient greater than 0.98 were achieved with calcium reagent 
concentration o f 3 mg/10 ml after experimenting with concentrations o f 3 
mg/10 ml, 1 mg/10 ml, and 0.5 mg/10 ml. For Arsenozo III calcium assay, 
calcium reagent was prepared with Sodium Acetate buffer at pH 4.8. Linearity
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o f assay and correlation value greater than 0.98 were also achieved with o- 
Cresolphthalein Complexone calcium reagent at a concentration o f 1.8 mg/10 
ml. In this latter assay, the calcium reagent was prepared with Sodium 
Bicarbonate buffer at pH o f 10.8.
3.12 Arsenozo III and O-Cresolphthalein Complexone Calcium Assay
Identical experimental procedures were applied to both calcium assays. 
Addition o f 190 pL o f calcium reagents were pipetted into a 96 wells plate. 
Followed by the addition o f 10 pL o f each standard and sample into its 
respective well. The assay was carried out in duplicates o f  the standards and 
samples. Proper reaction was ensured by gentle agitation 
o f the 96 wells plate for duration o f 20-30 seconds. The absorbance values 
were obtained with Ultraviolet and visible light Spectrophotometer (Genius) at 
wavelength o f 620 nm and 560 nm for Arsenozo III and O-Cresolphthalein 
Complexone calcium assay respectively.
Average absorbance values were calculated for each standard and 
sample. Background reading was adjusted by subtracting averaged blank 
standard absorbance value from the averaged sample absorbance values. 
Averaged standard absorbance values were then plotted as a function o f final 
calcium concentration to obtain the standard curve equation o f y=mx+b. 
Correlation coefficient for standard curve were above 0.99. Corrected sample 
absorbance values were plotted to calculate the final calcium concentration. 
Sample dilution factor was taken into account by multiplying the final calcium 
concentration with 0.1 to obtain units o f pM/ml. Then normalized with calvaria
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dry weight obtained, described later, to obtain final units pM/ml/mg. The data 
produced reflects the calcium released or uptake at each collection time point 
o f 1, 2, 4, 6 , 8, and 10 days. Using Microsoft Excel the data were plotted as a 
function o f time and cumulative calcium release or uptake graphs.
3.13 Normalization of Calcium Concentration by calvaria weight
In order to obtain the calvaria dry weights and perform TRAP and ALP 
assay, at the end o f each experiment, calvaria designated for TRAP/ALP assay 
from each group were placed in eppendorf tube, covered by perforated 
parafilm, placed in a lyophilization flask, and stored at -80 °C overnight. The 
conversion o f the liquid in calvaria to a solid state is critical in facilitating 
sublimation process o f lyophilization. Lyophilization was performed with 
lyophilizer (Virtis Sentry 2.0) until complete dehydration o f the calvaria. The 
dry weights o f the calvaria were measured and used to normalize the calcium 
concentration.
3.14 Assessment of OC with TRAP activity
In the resorption model, TRAP is highly expressed by OC making it an 
ideal marker for OC activity. TRAP assay utilizes the inhibiting effect o f 
tartrate on non-TRAP to isolate the TRAP activity. The OC activity is 
determined based on reactions utilizing p-nitrophenyphospate as a 
chromogenic substrate in the assay. TRAP dephosphorylates p- 
nitrophenyphospate (p-NPP) producing p-nitrophenol (p-nP) which under
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alkaline condition deprotonates the phenolic -OH group producing a bright 
yellow color that can be measured by Ultraviolet and visible light 
Spectrophotometer. The calvaria used for the normalization o f the calcium 
concentration were prepared and used for TRAP activity assay after. Releasing 
o f cellular enzymes from the calvaria was accomplished by addition o f 250 pL 
lysis buffer, consisted o f 150 mM NaCl, 30 mM o f sodium bicarbonate at pH 
7.8, and 0.5% Nonidet P-40. Calvaria were agitated every 15 min for 1 hour to 
assist lysing o f the cell and kept on ice to maintain enzyme activities. After 
incubation, the calvaria were centrifuged at 100,000 g for 30 min at -4 °C to 
separate cellular enzyme extract and cellular debris supernatant. TRAP activity 
was measured by incubating 50 pL o f cellular extract with 250 pL o f 0.1 M 
sodium acetate buffer at pH 4.8, containing 50 mM tartaric acid, and 16 mM p- 
NPP (Sigma-Aldrich) for 30 min at 37 °C in a 96 well plate. At the end o f the 
30 min incubation time, 10 uL o f 1 M NaOH was added to each sample to stop 
the reaction, and read at absorbance wavelength o f 410 nm with Genius 
detector as described in (109). Samples were assayed in duplicates.
3.15 Assessment of OB with ALP activity
In the formation model, ALP activity was used as a marker for OB 
activity. Similar to TRAP assay, ALP assay utilizes p-NPP as a chromogenic 
substrate in the assay. Alkaline phosphatases from OB were released with 
procedure as previously described in TRAP assay. Addition o f 50 pL o f 
cellular extract with 0.15 M NaCl, 30 mM sodium bicarbonate buffer, pH 7.8,
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and p-NPP to a final volume o f 300 uL for 30 min at 37 °C in a 96 well plate. 
Samples were duplicated in the assay. After incubation, samples were read at 
absorbance wavelength o f 405 nm with Genius detector as described in (111).
3.16 TRAP and ALP Calculation
The absorbance measurements for both TRAP and ALP assays were 
first calibrated by subtracting the average background absorbance. 
Concentration o f p-NP were calculated with adjusted measured absorbance 
using Beer-Lambert law equation, c= AA. /(eAx 1). Using molar absorptivity 
constant (s405) o f 12,500 (mol/L)',cm ' 1 and a path length (1) o f 1cm. Incubation 
time o f 30 minutes was used to calculate the rate o f substrate hydrolysis in 
units o f mol/L*min. The rate o f substrate hydrolysis is then normalized for the 
protein content (per mg protein) determined by modified method o f Lowry’s 
micro-protein assay using bicinchoninic acid assay (BCA, 112). The final 
enzyme activity is expressed in units o f pmol/L*min/mg protein.
38
3.17 Histological observation of OC formation and bone formation
Histological observations o f each treatment groups were obtained from 
4 calvaria from each group with three different regions and two serial sections 
for each calvarium. A total 20 sections obtained from each experiment. All 
digital images o f H & E stained sections were captured under magnification o f 
200X and 400X, with compound microscope (Nikon), by Retiga 1300 digital 
camera (Qimaging, Canada) then processed with Procapture 5 digital imaging 
software on a Dell dimension desktop.
39
3.18 Primary osteoblasts as prolyl-hydroxylase enzyme source and 
hydroxylation of synthetic collagen peptide analogue
We have designed and utilized a synthetic collagen peptide analogue 
containing 20 amino-acids and consensus sequences with multiple potential 
proline hydroxylation sites, GPPGPSGPPGPSGPPGPSGK, (synthesized by 
Peptide 2 Inc., Chantilly, VA USA).
(1) Cultured primary calvarial osteoblasts as enzyme source: The primary 
19 day embryonic rat calvarial osteoblasts were generated as described 
previously [62]. We have cultured the primary osteoblasts in 10 ml o f a-MEM 
supplemented with non-essential amino-acids, 10% fetal calf serum and
penicillin/streptomycin antibiotic in 10 cm culture dishes with initial cell
6
density ~1 x 10 cells per dish. At confluency (~10 day culture) the cells were 
cultured overnight with a-MEM media containing “no fetal calf serum” and the
cell layers o f four 10 cm culture dishes were collected, (i) Total cell lysate
6
preparation: The cell layers from two culture dishes (total -15x10 cells) were 
collected using sterile cell scraper in the presence o f 1 ml lyses buffer, 50 mM 
NH4HCO3, pH 7.8,containing 0.5% Nonidet-P-40, and kept on ice for 1 hr. 
The sample was then centrifuged at 10,000 r.p.m. using Eppendorf bench top 
centrifuge to remove cell debris and the supernatant was kept as an enzyme 
source, (ii) Microsomal fraction containing endoplasmic reticulum (ER)+Golgi
preparation: The cell layers from two culture dishes (total -10x10^ cells) were
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collected using sterile cell scraper in the presence o f 1 ml o f 50 mM 
NH4HCO3, pH 7.8, buffer with “no” Nonidet-P-40. The sample was then 
centrifuged at 10,000 r.p.m. using Eppendorf bench top centrifuge to remove 
nucleus and cell membrane. The supernatant containing microsomal fractions 
was then subjected high speed centrifugation at 100,000 g to collect the 
ER+Golgi fraction. The pellet was then suspended in 200 pi o f 50 mM 
NH4HC03, pH 7.8 containing 0.5% Nonidet-P-40 and kept as an ER+Golgi 
enzyme source as described previously, [12]. The two osteoblast enzyme 
sources, (i) and (ii), were then used to evaluate the prolyl-hydroxylation o f  the
synthetic collagen peptide analogue in the absence and presence o f ascorbate,
+2 +3
phosvitin, Fe and Fe and 2-ketoglutarate. Reaction conditions with total
volume o f 100 pi containing 50 pi o f total cell lysate or 20 pi o f microsomal
+2 +3
fraction enzyme source: (a) negative control-1 containing no Fe and Fe , 50 
pg peptide + 0.3 mM 2-ketoglutarate + enzyme source (i) or (ii) + 50 mM
NH4HCO3, pH 7.8; (b) negative control-2 containing no enzyme source, 50 pg
+2
peptide + 0.3 mM 2-ketoglutarate + 100 pM ferrous chloride (Fe ) + 50 mM
+3
NH4HCO3, pH 7.8; (c) negative control-3 with Fe , 50 pg peptide + 0.3 mM
+3
2-ketoglutarate + 100 pM ferric chloride (Fe ) + enzyme source (i) or (ii) + 50
+2
mM NH4HCO3, pH 7.8 ; (d) positive control with ferrous chloride (Fe ), 50
+2
pg peptide + 0.3 mM 2-ketoglutarate + 100 pM ferrous chloride (Fe ) + 
enzyme source (i) or (ii) + 50 mM NH4HCO3 , pH 7.8 ; (e) test reaction with 
ascorbate, 50 pg peptide + 0.3 mM 2-ketoglutarate + 100 pM ferric chloride
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(Fe ) + enzyme source (i) or (ii) + 1 mM Na ascorbate + 50 mM NH4HCO3,
pH 7.8 ; (f) test reaction with phosvitin, 50 fig peptide + 0.3 mM 2-
+3
ketoglutarate + 100 pM ferric chloride (Fe ) + enzyme source (i) or (ii) + ~0.4 
pM Phosvitin + 50 mM NH4HCO3, pH 7.8. The reactions were allowed to
o
proceed for 1 hr at 37 C, followed by aliquots o f 10 pi from each reaction 
condition (a) -  (f) subjected to LC-MS/MS analysis to define proline 
hydroxylation and the precise site(s) o f hydroxylation within the peptide.
(2) Mass spectrometric analysis for the prolyl-hydroxylation o f the synthetic 
collagen peptide analogue: Nano-flow liquid-chromatography-electrospray- 
ionization tandem mass spectrometric (LC- ESI-MS/MS) analyses were carried 
out using an LTQ-linear ion trap mass spectrometer (Thermo Electron, San 
Jose, CA). The reaction samples o f 10 pi each from (a) - (f) above were 
suspended in 20 pi o f 97.4% H2O: 2.5%CH3CN:0.1% HCO2H followed by 
LC-ESI-MS/MS analyses using an on- line auto-sampler (Micro AS, Thermo- 
Finnigan, CA) with auto-injections o f 3 pi onto an in-line fused silica micro­
capillary column, (75 pm X 10 cm), packed in-house with C 18 resin (Micron 
Bio-resource, Inc. Auburn, CA) and developed at a flow rate o f 250 nl/min. 
Peptides were separated by a 55 min elution comprising o f multi-step-linear 
gradient using solvent A, H20/2.5 % CH3CN/O.I %  HC02H, and solvent B, 
CH3CN/0.1 %  HCO2H. The gradient steps were from 100 %  solvent A to 8% 
solvent B in 5 min, to 15 % solvent B in 10 min, to 25 % solvent B in 10 min, 
to 50 %  solvent B in 20 min, and to 95 % solvent B in 10 min using a Surveyor
+3
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MS Pump Plus (ThermoFinnigan, CA). The eluted peptides were directly nano- 
electrosprayed and the MS/MS data were generated using data- dependent 
acquisition with a MS survey scan range between 390 and 2000 m/z. This data- 
dependent acquisition begins with the LC separation which generates a total 
ion chromatogram in a survey scan followed by selection o f specific ions for 
collision induced dissociation (CID, MS/MS) in descending order o f signal 
intensity. Each survey scan (MS) was followed by automated sequential 
selection o f five peptides for CID, at 35% normalized collision energy, with 
dynamic exclusion parameters, repeat count 1, repeat duration 30s and 
exclusion duration 20s. This process was continuously alternated between MS 
survey scan and five tandem MS throughout the nano-LC chromatography.
(3) MS/MS data search for identification o f prolyl-hydroxylation and location 
o f the hydroxylated proline residue within the synthetic collagen peptide 
analogue. Since our designed synthetic collagen peptide has unique sequence 
with repeats o f GPP, PPG, GPS, and PSG we have generated a custom 
database containing multiple unrelated proteins and inserted the synthetic 
peptide sequence, GPPGPSGPPGPSGPPGPSGK, into that database. This 
permitted rapid search o f the MS/MS data generated from the analysis o f above 
reaction aliquots by usual Bioworks 3.3.1 software and SEQUEST search 
engine [63]. The DTA files were generated with the following settings: 
precursor-ion tolerance o f 1.5 amu, fragment ion tolerance o f 1.0 amu, and 
automated calculated charged states +1, +2, and +3. The searches were 
performed with parameters: half trypsin since we have only one trypsin
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recognized residue within the peptide, and +16 Da (mass addition) 
modifications o f proline residues which are expected to occur if proline 
hydroxylation occurred. We have also specified up to 5 potential 
hydroxylations on the peptide because there are multiple potential proline 
residues within the peptide that may possibly become hydroxylated.
The database search results were filtered using the criteria: ACn >0.1; 
probability <0.1; for and XCorr >  1.8, 2.2, 3.75 for Z= +1, +2, and +3. In 
addition to the search parameters and criteria used, the identified peptide 
sequences assessed manually by examining each o f the identified peptide 
MS/MS spectra for the quality and the confidence through the y and b ion 
fragment series. In such evaluation the number o f y and b ion fragments, their 
consecutive occurrence in a series and representation o f “high-intensity” ion- 
fragments were used as bases for acceptance.
Biomineralization o f cultured primary osteoblasts in the absence and presence 
o f ascorbate and phosvitin: The primary rat osteoblasts were cultured in six
well (3.5 cm each well) culture plates until confluent as described above. One
6
culture plate (six wells, 2x10 cells/well) o f confluent osteoblasts was used for 
each o f the following treatments, (a) Media alone; (b) media + 10 mM p- 
glycerophosphate; (c) media + 10 mM p-glycerophosphate + 20 pg/ml (100 
pM) Na ascorbate; and (d) media + 10 mM p-glycerophosphate + 20 pg/ml 
(0.7 pM ) phosvitin. These cultures were incubated for 5 days followed by (i) 
triplicate wells o f each treatment were used for fixing with 10 %  formalin
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overnight followed by exposure to 2%  silver nitrate for 30-60 min to visualize 
Ca-P deposition microscopically, and (ii) triplicate wells o f each treatment 
were processed for quantitative calcium analysis to determine extent o f mineral 
deposition in the cell layer. For quantitative calcium analysis in (ii the media 
was removed and the cell layer was collected in the presence o f 0.5 ml o f 50 
mM NH4HCO3 using sterile cell scraper and placed in Eppendorf tubes and 
left on ice for lhr for cells to burst in this “hypotonic” buffer. The insoluble 
cell debris, nucleus and the mineralized ECM was then collected by bench top 
centrifugation at 10,000 r.p.m.. The pellet containing the ECM and insoluble
cellular components was then suspended in 0.5 ml o f 0.1 M HC1 and left at 4°C 
overnight for dissolution o f the Ca-P mineral. The HC1 extracts were then 
partially neutralized by addition o f sub-molar equivalent o f 1.0 M NaOH (40 pi, 
keeping still the pH < 4) and centrifuged as above to pellet the insoluble ECM 
and cellular components. 10 pi o f supernatant from each triplicate sample 
treatments (a)-(d) were assayed for calcium levels in duplicates as described 
above using Arsenazo III reagent calcium assay. The media calcium levels o f 
these mineralizing primary osteoblasts treated as in (a)-(d) above was also 
determined in order to correlate with calcium deposition levels.
Synthesis o f hydroxyproline containing collagens and critical proteins involved 
in osteoblast differentiation by cultured osteoblasts in the absence and presence 
of, (3-glycerolphosphate, ascorbate and phosvitin:- The insoluble ECM and 
cellular components (the pellet after HCL extraction o f the mineralized cell 
layers above) was re-suspended in 0.1 ml o f 50 mM NH4HCO3, pH 7.8, and
45
10 pi o f the HCL soluble extract (partially neutralized) was included in this
o
suspension and subjected to trypsin (5 pg) digestion overnight at 37 C. 10 pi o f 
such trypsin digested samples derived from each o f the culture conditions (a) - 
(d) above were suspended in 20 pi o f 97.4% H2O: 2.5%CH3CN:0.1% HCO2H 
followed by LC-ESI-MS/MS analyses using an on-line auto-sampler (Micro 
AS, Thermo-Finnigan, CA) with auto-injections o f 3 pi onto an in-line fused 
silica micro- capillary column, (75 pm X 10 cm) as detailed above. The 
MS/MS data generated from the analysis o f aliquots from the above samples 
were searched against the rat-specific database, Uniprot (Universal Protein 
Resources, Version 9.0), which combines the data from Swiss-Prot (version 51) 
TreMBL (Version 34) and PIR using the Bioworks 3.3.1 software and 
SEQUEST search engine [63]. The data were searched with specified dynamic 
modification o f 16 Da mass additions for hydroxylation o f the proline residues 
and the results documented as described above.
Statistics: Data are presented as means ± S.D. The paired Student's t-Test was 
used to compare groups. The differences between groups were considered 
statistically significant for p < 0.05. It should be noted that although there are 
multiple treatment sets the important comparisons are between PTH treatment 
versus control (media alone) showing PTH induced bone resorption, or PTH 
treatment versus ascorbate or phosvitin to indicate effects o f these added 
factors on PTH-induced bone resorption. Similarly in the bone formation 
model the comparison needed is negative controls versus ascorbate or phosvitin 
treatment, or positive control (+ascorbate) versus +phosvitin. Such analysis
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require paired Student's t-Test and not an Anova type analysis. Chemical, 
biochemical, and quantitative histomorphometric data are presented as means 
± S.D. The original data sets were evaluated for group variance using Shapiro- 
Wilks test and were found to have normal distribution and hence parametric 
statistical analysis was applied. The statistical significance o f the differences 
between controls versus treatment groups, and between different treatment 
groups were evaluated using two-tailed paired t-Test with unequal variance. 
The differences between groups were considered statistically significant for p <
0.05.
47
4. RESULTS
4.1 Calcium assay of Cell Layer of Bio-Mineralization of Primary
Osteoblast cells cultured by P-Glycerophosphate, Ascorbate and
Phosvitin
The calcium concentration o f cell layer o f each group over the 20 day 
culture period were determined for :(1) Control group was cultured with Alpha 
MEM only. (2) p-Glycerophosphate group was cultured with Alpha MEM and 
lOmM/ml p-Glycerophosphate (Santa Cruz Biotechnology, Inc.). (3) Ascorbate 
group was cultured with Alpha MEM, lOmM/ml P-Glycerophosphate and 20pg/ml 
Na ascorbate (Sigma-Aldrich Co.). (4) Phosvitin group was cultured with Alpha 
MEM, lOmM/ml P-Glycerophosphate and 20pg/ml Phosvitin(Phosvitin from 
egg yolk, Sigma-Aldrich Co.).
Cell layers were collected on 0, 5, 10, 15 and 20 day during culture period. 
The data were expressed as pmol calcium per ml media. Figure 1. shows each 
group has more calcium concentration accumulation when culture period is 
longer.
As what we expect, Figure 1. shows there are significant differences 
between all these groups when compared, especially for ascobate group and 
phosvitin group when compare to control group. But there are some 
comparisons having no significant differences depending on different groups 
and time set, especially between control group and p-Glycerophosphate group. 
Elowever, the comparisons o f all data between control group and phosvitin
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group are statistic significant except Day 0. Also, the comparisons o f all data 
between p-Glycerophosphate group and phosvitin group are statistic significant 
except Day 0. In addition, all comparisons between control group and ascobate 
group are statistic significant except Day 0. And most o f comparisons are 
statistic significant between P-Glycerophosphate group and ascobate group.
49
Figure 1. Ca: Concentration ot Osteoblast Cell Layers((imolc/ml)
Figure 1. shows there are significant differences between all these groups when 
compared, especially for ascobate group and phosvitin group when compare to 
control group. But there are some comparisons having no significant 
differences depending on different groups and time set, especially between 
control group and (3-Glycerophosphate group. However, the comparisons o f all 
data between control group and phosvitin group are statistic significant except 
Day 0. Also, the comparisons o f all data between |3-Glycerophosphate group 
and phosvitin group are statistic significant except Day 0. In addition, all 
comparisons between control group and ascobate group are statistic significant 
except Day 0. And most o f comparisons are statistic significant between 13- 
Glycerophosphate group and ascobate group.
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4.2 Calcium assay of Media of Bio-Mineralization of Primary Osteoblast 
cells cultured by P-Glycerophosphate, Ascorbate and Phosvitin
The calcium uptake o f media in each group over the 20 day culture period 
were determined for :(1) Control group was cultured with Alpha MEM only. (2) 
p-Glycerophosphate group was cultured with Alpha MEM and lOmM/ml 13- 
Glycerophosphate (Santa Cruz Biotechnology, Inc.). (3) Ascorbate group was 
cultured with Alpha MEM, lOmM/ml P-Glycerophosphate and 20pg/ml Na 
ascorbate (Sigma-Aldrich Co.). (4) Phosvitin group was cultured with Alpha 
MEM, lOmM/ml p-Glycerophosphate and 20pg/ml Phosvitin(Phosvitin from
egg yolk, Sigma-Aldrich Co.).
The media were collected on 0, 5, 10, 15 and 20 day during culture period. 
The data represented were corrected with media only calcium concentration to 
obtain net calcium uptake and expressed as pmol calcium per ml media.
Figure 2. shows each group has more calcium uptake when culture period is
longer, except control group.
As what we expect, Figure 2. shows there are significant differences 
between all these groups when compared, especially for ascobate group and 
phosvitin group when compare to control group. But there are some 
comparisons having no significant differences depending on different groups 
and time set, especially between ascobate group and phosvitin group. However, 
the comparisons o f all data between control group and phosvitin group are 
statistic significant except Day 0. Also, the comparisons o f all data between P- 
Glycerophosphate group and phosvitin group are statistic significant except
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Day 0. In addition, all comparisons between control group and ascobate group 
are statistic significant except Day 0.
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Figure 2. Culmulativc Uptaking Ca- Concentration from Media by Osteoblast Cells
Figure 2. shows each group has more calcium uptake when culture period is 
longer, except control group. There are significant differences between all 
these groups when compared, especially for ascobate group and phosvitin 
group when compare to control group. But there are some comparisons having 
no significant differences depending on different groups and time set, 
especially between ascobate group and phosvitin group. However, the 
comparisons o f all data between control group and phosvitin group are statistic 
significant except Day 0. Also, the comparisons o f all data between 13- 
Glycerophosphate group and phosvitin group are statistic significant except 
Day 0. In addition, all comparisons between control group and ascobate group 
are statistic significant except Day 0.
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4.3 ALP Activity of Bio-Mineralization of Primary Osteoblast cells 
cultured by P-Glycerophosphate, Ascorbate and Phosvitin
Figure 3. shows all ALP activities go lower in each group when culture 
period is longer. However, control group is the only group which maintained a 
constant ALP activity.
Figure 3. shows there are significant differences between control group and 
(3-Glycerophosphate group except Day 0 and Day 5. There are significant 
differences between control group and ascorbate group except Day O.And it is 
the same with control group and phosvitin group as well. Also, there are 
significant differences between p-Glycerophosphate group and ascorbate group 
except Day 0 and Day 20.And it is the same with p-Glycerophosphate group 
and phosvitin group as well. In addition, there are significant differences 
between ascorbate group and phosvitin group except Day 0 and Day 20.
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Figure 3. ALP Activity o f  Osteoblast C'ells(gmol L*min mg protein)
Figure 3. shows all ALP activities go lower in each group when culture 
period is longer. However, control group is the only group which maintained a 
constant ALP activity. There are significant differences between control group 
and p-Glycerophosphate group except Day 0 and Day 5. There are significant 
differences between control group and ascorbate group except Day O.And it is 
the same with control group and phosvitin group as well. Also, there are 
significant differences between P-Glycerophosphate group and ascorbate group 
except Day 0 and Day 20.And it is the same with P-Glycerophosphate group 
and phosvitin group as well. In addition, there are significant differences 
between ascorbate group and phosvitin group except Day 0 and Day 20.
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4.4 Calcium assay of Cell Layer of Bio-Mineralization of Primary
Osteoblast cells cultured by Alendronate
The calcium concentration o f cell layer o f each group over the 15 day 
culture period were determined for :(1) Control group was cultured with alpha 
MEM, lOmM/ml p-Glycerophosphate and 20pg/ml Na ascorbate (2)0.1 pM 
Alendronate group was cultured with alpha MEM, lOmM/ml [3- 
Glycerophosphate, 20pg/ml Na ascorbate and 0.1 pM alendronate(Sigma- 
Aldrich Co.). (3) 1 pM Alendronate group was cultured with Alpha MEM, 
lOmM/ml P-Glycerophosphate , 20pg/ml Na ascorbate and 1 pM alendronate 
(4) 5 pM Alendronate group was cultured with alpha MEM, lOmM/ml p- 
Glycerophosphate, 20pg/ml Na ascorbate and 5 pM alendronate.
Cell layers were collected on 0, 5, 10 and 15 day during culture period. The 
data were expressed as pmol calcium per ml media. Figure 4. shows each 
group has more calcium concentration accumulation when culture period is 
longer but it drops down at Day 15,except control group. However, control 
group shows a constant calcium concentration accumulation when culture 
period is longer.
Figure 4. shows there are significant differences between control group and 
0.1 pM Alendronate group except Day 0. And it’s the same between control 
group and 5 pM Alendronate group. However, most o f comparisons within 
these three alendronate group (0.1 pM alendronate group, 1 pM alendronate 
group and 5 pM alendronate group) are not statistic significant.
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Figure 4. C’a: Concentration o f Osteoblast Cell Layers in Alendronate! jamolc ml)
b
Centre; 0.1 uM 1 -*M 5 aM
» DavQ 
»Dav5 
Day 10 
•Day lb
Day 0 Day 5 Day 10 Day 15
'♦"Central 
mV 
I M 
«*«““b uM
Figure 4. shows each group has more calcium concentration accumulation 
when culture period is longer but it drops down at Day 15,except control group. 
However, control group shows a constant calcium concentration accumulation 
when culture period is longer. There are significant differences between control 
group and 0.1 pM Alendronate group except Day 0. And it’s the same between 
control group and 5 pM Alendronate group. However, most o f comparisons 
within these three alendronate group (0.1 pM alendronate group, 1 pM 
alendronate group and 5 pM alendronate group) are not statistic significant.
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4.5 Calcium assay of Media of Bio-Mineralization of Primary Osteoblast 
Cells cultured with Alendronate
The calcium uptake o f media in each group over the 15 day culture period 
were determined for :(1) Control group was cultured with alpha MEM, 
lOmM/ml (3-Glycerophosphate and 20pg/ml Na ascorbate (2) 0.1 pM 
Alendronate group was cultured with alpha MEM, lOmM/ml (3- 
Glycerophosphate, 20pg/ml Na ascorbate and 0.1 pM alendronate(Sigma- 
Aldrich Co.). (3) 1 pM Alendronate group was cultured with Alpha MEM, 
lOmM/ml (3-Glycerophosphate , 20pg/ml Na ascorbate and 1 pM alendronate 
(4) 5 pM Alendronate group was cultured with alpha MEM, lOmM/ml [3- 
Glycerophosphate, 20pg/ml Na ascorbate and 5 pM alendronate.
The media were collected on 0, 5, 10 and 15 day during culture period. The 
data represented were corrected with media only calcium concentration to 
obtain net calcium uptake and expressed as pmol calcium per ml media.
Figure 5. shows each group has more calcium uptake when culture period is 
longer.
Figure 5. shows all the comparisons between control group and these three 
alendronate groups are statistic significant except Day 0. In other words, there 
are significant differences between control group and 0.1 pM alendronate 
group. And there are significant differences between control group and 1 pM 
alendronate group. Also, there are significant differences between control 
group and 5pM alendronate group. However, most o f the comparisons within 
these three alendronate groups are not statistic significant depending on 
different groups and time set, including 0.1 pM alendronate group comparing
58
with 1 |liM alendronate group, 0.1 pM alendronate group comparing with 5 pM 
alendronate group and 1 pM alendronate group comparing with 5 pM 
alendronate group.
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Figure 5. Cumulative Uptaking C'a: Concentration from Media in Alendronate!pmolc ml )
Figure 5. shows each group has more calcium uptake when culture period is 
longer. All the comparisons between control group and these three alendronate 
groups are statistic significant except Day 0. In other words, there are 
significant differences between control group and 0.1 pM alendronate group. 
And there are significant differences between control group and 1 pM 
alendronate group. Also, there are significant differences between control 
group and 5pM alendronate group. However, most o f the comparisons within 
these three alendronate groups are not statistic significant depending on 
different groups and time set, including 0.1 pM alendronate group comparing 
with 1 pM alendronate group, 0.1 pM alendronate group comparing with 5 pM 
alendronate group and 1 pM alendronate group comparing with 5 pM
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alendronate group.
4.6 ALP Activity of Bio-Mineralization of Primary Osteoblast Cells 
cultured with Alendronate
Figure 6 . shows all ALP activities go higher in each group when culture 
period is longer till Day 10 but then ALP activities go lower at Day 15. What is 
noticed, control group is the only group which ALP activities keep going 
higher.
Figure 6 . shows all the comparisons between 0.1 pM alendronate group and 5 
pM alendronate group are not statistic significant except Day 0. Also, most o f 
comparisons between control group and 0.1 pM alendronate group are not 
statistic significant. And it’s the same between control group and 5pM 
alendronate group as well. On the other hand, there are significant differences 
between control group and 1 pM alendronate group except Day 0.
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Figure 6. ALP Activity o f Osteoblast Cells in Alendronate! pmol L*min mg protein)
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Figure 6 . shows all ALP activities go higher in each group when culture period 
is longer till Day 10 but then ALP activities go lower at Day 15. What is 
noticed, control group is the only group which ALP activities keep going 
higher. All the comparisons between 0.1 pM alendronate group and 5 pM 
alendronate group are not statistic significant except Day 0. Also, most o f 
comparisons between control group and 0.1 pM alendronate group are not 
statistic significant. And it’s the same between control group and 5pM 
alendronate group as well. On the other hand, there are significant differences 
between control group and 1 pM alendronate group except Day 0.
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Osteoblast Cells cultured with New-Bisphosphonate
The calcium concentration o f cell layer o f each group over the 15 day 
culture period were determined for :(1) Control group was cultured with alpha 
MEM, lOmM/ml P-Glycerophosphate and 20pg/ml Na ascorbate (2) 0.1 pM 
New-Bisphosphonate group was cultured with alpha MEM, lOmM/ml P- 
Glycerophosphate, 20pg/ml Na ascorbate and 0.1 pM new- 
bisphosphonate(Sigma-Aldrich Co.). (3) 1 pM New-Bisphosphonate group was 
cultured with Alpha MEM, lOmM/ml p-Glycerophosphate , 20pg/ml Na 
ascorbate and 1 pM new-bisphosphonate (4) 5 pM New-Bisphosphonate group 
was cultured with alpha MEM, lOmM/ml p-Glycerophosphate, 20pg/ml Na 
ascorbate and 5 pM new-bisphosphonate.
Cell layers were collected on 0, 5, 10 and 15 day during culture period. The 
data were expressed as pmol calcium per ml media. Figure 7. shows each 
group has more calcium concentration accumulation when culture period is 
longer but it drops down at Day 15,except control group. However, control 
group shows a constant calcium concentration accumulation when culture 
period is longer. What is noticed that the calcium concentration o f 0.1 pM 
New-Bisphosphonate group dropped down much more compared to other 
alendronate groups.
Figure 7. shows there are significant differences between control group and 
0.1 pM new-bisphosphonate except Day 0. And it’s the same between 0.1 pM 
new-bisphosphonate and 5 pM new-bisphosphonate. However, most o f 
comparisons within control group and these three alendronate groups (0.1 pM
4.7 Calcium assay of Cell Layer of Bio-Mineralization of Primary
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alendronate group, 1 pM alendronate group and 5 pM alendronate group) are 
not statistic significant.
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Figure 7. Ca: Concentration o f  Osteoblast Cell Layers in New-Bisphosphonatc((imole ml)
Figure 7. shows each group has more calcium concentration accumulation 
when culture period is longer but it drops down at Day 15,except control group. 
However, control group shows a constant calcium concentration accumulation 
when culture period is longer. What is noticed that the calcium concentration o f 
0.1 pM New-Bisphosphonate group dropped down much more compared to 
other alendronate groups. There are significant differences between control 
group and 0.1 pM new-bisphosphonate except Day 0. And it’s the same 
between 0.1 pM new-bisphosphonate and 5 pM new-bisphosphonate. However, 
most o f comparisons within control group and these three alendronate groups 
(0.1 pM alendronate group, 1 pM alendronate group and 5 pM alendronate 
group) are not statistic significant.
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The calcium uptake o f media in each group over the 15 day culture period 
were determined for :(1) Control group was cultured with alpha MEM, 
lOmM/ml p-Glycerophosphate and 20pg/ml Na ascorbate (2) 0.1 pM New- 
Bisphosphonate group was cultured with alpha MEM, lOmM/ml p- 
Glycerophosphate, 20pg/ml Na ascorbate and 0.1 pM new- 
bisphosphonate(Sigma-Aldrich Co.). (3) 1 pM New-Bisphosphonate group was 
cultured with Alpha MEM, lOmM/ml P-Glycerophosphate , 20pg/ml Na 
ascorbate and 1 pM new-bisphosphonate (4) 5 pM New-Bisphosphonate group 
was cultured with alpha MEM, lOmM/ml P-Glycerophosphate, 20pg/ml Na 
ascorbate and 5 pM new-bisphosphonate.
The media were collected on 0, 5, 10 and 15 day during culture period. The 
data represented were corrected with media only calcium concentration to 
obtain net calcium uptake and expressed as pmol calcium per ml media.
Figure 8 . shows each group has more calcium uptake when culture period is 
longer.
Figure 8 . shows all the comparisons within these four groups are not 
statistic significant at Day 0 and Day 5.And most o f the comparisons within 
these four groups are statistic significant at Day 10 and Day 15.However, all 
the comparisons between 0.1 pM New-Bisphosphonate group and 1 pM New- 
Bisphosphonate group are not statistic significant.
4.8 Calcium assay of Media Calcium Concentration of Bio-Mineralization
of Primary Osteoblast Cells cultured with New-Bisphosphonate
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Figure 8. Culmulativc Uptaking Ca: Concentration from Media in Ncw-Bisphosphonatc
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Figure 8 . shows each group has more calcium uptake when culture period is 
longer. All the comparisons within these four groups are not statistic significant 
at Day 0 and Day 5.And most o f the comparisons within these four groups are 
statistic significant at Day 10 and Day 15.However, all the comparisons 
between 0.1 pM New-Bisphosphonate group and 1 pM New-Bisphosphonate 
group are not statistic significant.
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Figure 9. shows all ALP activities go higher in each group when culture 
period is longer till Day 10 but then ALP activities go lower at Day 15. What is 
noticed, control group is the only group which ALP activities keep going 
higher.
Figure 9. shows all the comparisons between 0.1 pM new-bisphosphonate 
group and 5 pM new-bisphosphonate group are not statistic significant. Also, 
most o f comparisons between 0.1 pM new-bisphosphonate group and 1 pM 
new-bisphosphonate group are not statistic significant. All the comparisons 
between control group and 0.1 pM new-bisphosphonate group are statistic 
significant except Day O.And it’s the same between control group and 5pM 
new-bisphosphonate group as well.
4.9 ALP Activity of Bio-Mineralization of Primary Osteoblast Cells
cultured with New-Bisphosphonate
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Figure 9. ALP Activ ity of Osteoblast Cells in Ncw-Bisphosphonatc ptmol L*mm mg protein)
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Figure 9. shows all ALP activities go higher in each group when culture period 
is longer till Day 10 but then ALP activities go lower at Day 15. What is 
noticed, control group is the only group which ALP activities keep going 
higher. All the comparisons between 0.1 pM new-bisphosphonate group and 5 
pM new-bisphosphonate group are not statistic significant. Also, most o f 
comparisons between 0.1 pM new-bisphosphonate group and lpM  new- 
bisphosphonate group are not statistic significant. All the comparisons between 
control group and 0.1 pM new-bisphosphonate group are statistic significant 
except Day O.And it’s the same between control group and 5pM new- 
bisphosphonate group as well.
69
4.10 Cell number counting of Osteoblast Cells cultured with Alendronate
Fgure 10. shows that most o f osteoblast cell were dead.
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Figure 10. Osteoblast Cell Number Counting after cultured by Alendronate
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Figure 10.
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shows that most o f osteoblast cell were dead.
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4.11 Cell number counting of Osteoblast Cells cultured with New- 
Bisphosphonate
Figure 11. shows that there were more live osteoblast cells than dead 
osteoblast cells.
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Figure 11. Osteoblast Cell Number Counting after cultured by New-Bisphosphonate
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Figure 11. shows that there were more live osteoblast cells than dead 
osteoblast cells.
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Figure 12. shows the relative quantity o f qPCR o f Osterix and Runx 2 in rat 
osteoblast cells. The quantity o f Osterix in ascorbate group is three times 
higher than that in control group but the quantity o f Runx 2 in ascorbate group 
is similar with that in control group. Also, both o f the quantity o f Osterix and 
Runx 2 in control group is twice higher than that in phosvitine group.
There are significant differences o f Osterix gene expression between control 
group and ascorbate group but there are no significant differences o f Runx 2 
gene expression between control group and ascorbate group. And, there are 
significant differences o f both Osterix and Runx 2 gene expression between 
control group and phosvitin group.
4.12 Real-Time PCR Quantification of Gene Expression
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Figure 12. quantitative RT-PCR o f  Osterix and Runx 2
4
Control V(t.C Phosvion
Figure 12. shows the relative quantity o f qPCR o f Osterix and Runx 2 in rat 
osteoblast cells. The quantity o f Osterix in ascorbate group is three times 
higher than that in control group but the quantity o f Runx 2 in ascorbate group 
is similar with that in control group. Also, both o f the quantity o f Osterix and 
Runx 2 in control group is twice higher than that in phosvitine group.
There are significant differences o f Osterix gene expression between control 
group and ascorbate group but there are no significant differences o f Runx 2 
gene expression between control group and ascorbate group. And, there are 
significant differences o f both Osterix and Runx 2 gene expression between 
control group and phosvitin group.
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Figure 13.quantitative RT-PCR of Ibsp
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Figure 13. shows the relative quantity o f qPCR o f Ibsp in rat osteoblast cells.
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Figure 14.quantitative RT-PCR o f T n f l l
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Figure 14. shows the relative quantity o f qPCR o f Tnfl 1 in rat osteoblast cells.
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Histological observations o f the effect o f native phosvitin on osteoclast 
formation and bone resorption induced by PTH in live mouse calvarial bone 
resorption model: - The histological observations o f H & E stained sections o f 
calvarial bones cultured with PTH in the absence and presence o f native 
phosvitin are represented in Figure 1. There was significant osteoclastic 
activity and bone resorption readily observable for those groups treated with 
PTH only, but not for the untreated control and PTH + native phosvitin groups. 
Figure 1 Panel la shows H & E histological section for unstimulated control 
calvaria with no noticeable osteoclastic bone resorbtion. Figure 1 Panel 2a 
shows a histological section o f calvarial bone with PTH showing numerous 
multinucleated osteoclasts and bone resorption. Figure 1 Panel 3 a shows 
histological section o f calvarial bones treated with PTH + native phosvitin with 
minimal osteoclastic bone resorption coupled with formation o f substantial new 
osteiod and bone. This is an unexpected event in our resorption model system, 
as the culture media was devoid o f ascorbate. Under such conditions, it was, at 
best, expected that PTH-induced osteoclastic bone resorption would be 
inhibited however, new osteoid and bone formation should not have occurred. 
This is because new osteoid and bone formation requires ascorbic acid as an 
essential component for the synthesis o f hydroxyprolines and hydroxylysines in 
collagen. Interestingly, our observations for the PTH + native phosvitin group 
are somewhat similar to calvaria treated with PTH + ascorbate, Fig. 1 Panel 4a, 
suggesting that phosvitin has the capacity to mimic functions closely related to
4.13 Histological observation of OC formation and bone formation
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ascorbic acid. It is worth noting that at the end o f the experimental period there 
are obvious variations in the thickness o f the periosteum and the overall bone 
in the histological sections in Fig. 1 Panels la-4a. This is due to culture starting 
conditions and treatments where the original starting calvarial bone thickness 
would be as shown in Figure 1 Panel la and in this control experiment there is 
no significant change in the periosteum or the bone over the culture period. 
However, when the calvaria were cultured in the presence o f different 
stimulatory factors such as PTH, ascorbate and phosvitin, Figure 1 Panels 2a, 
3a, and 4a proliferation and differentiation o f mesenchymal/stem cells 
combined with formation o f new osteoid/bone leads to much thicker bone (old 
bone + new bone) and periosteum cellular layer.
Global visualization o f osteoclast formation by neutral red in cultures 
stimulated with PTH in the absence and presence o f native phosvitin and or 
ascorbate:- In the present work to gain further insights into the biologic events, 
we have globally visualized the osteoclasts by NR and resorption activities 
with silver nitrate. Figure 1 Panels lb, 2b, 3b, and 4b show NR staining o f 
control calvaria, PTH treated only, PTH + native phosvitin treated and PTH + 
ascorbate treated, respectively. Such a global visualization approach showed an 
absence o f observable osteoclasts in the control (untreated) calvaria, Fig. 1 
Panel lb. In contrast, cultures treated with PTH alone showed numerous and 
distinct NR stained multinucleated osteoclasts, Fig. 1 Panel 2b. Importantly, 
the calvaria treated with both PTH + native phosvitin and those treated with 
PTH+ascorbate showed no evidence o f mature multinucleated osteoclasts, Fig.
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1 Panels 3b and 4b. In order to further examine these observations, and reveal 
global osteoclastic resorption activities, or lack thereof, we have counterstained 
the NR stained calvaria with silver nitrate. The negative controls showed no 
resorption areas, Fig. 1 Panel lc, whereas calvaria treated with PTH alone 
showed substantial loss o f bone with large resorption areas becoming 
transparent to light, Fig. 1 Panel 2c. Those calvaria cultured in the presence o f 
PTH + native phosvitin and/or PTH + ascorbate showed minimal or no 
osteoclastic bone resorption and light transparency, Fig. 1 Panels 3c and 4c, 
respectively. These data were consistent with the observations from 
histological sections and NR staining for osteoclasts.
Quantitative analysis o f the changes in media calcium and TRAP activity in 
response to parathyroid hormone (PTH) in the absence and presence o f 
phosvitin and ascorbate in mouse calvarial bone organ cultures:- The total 
change in media calcium was determined over the 10 day culture period for 
groups: (a) unstimulated controls, (b) stimulated by 10 nM PTH to undergo 
resorption, (c) 10 nM PTH + 150 nM native phosvitin, and (d) 10 nM PTH + 1 
mM Na ascorbate. Figure 2A shows total cumulative changes in media calcium 
for the groups (a)-(d) over a 10 day culture period. Unstimulated controls 
showed minimal calcium release whereas those treated with PTH only showed 
substantial release o f calcium. However, this release o f calcium was 
significantly inhibited in the presence o f 150 nM phosvitin by 2.5 fold (~60 %) 
and this was statistically significant p< 0.001. A simultaneous inclusion o f PTH 
with ImM Na ascorbate led to complete inhibition o f calcium release with
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additional calcium uptake from the media despite the presence o f PTH. This 
latter case is similar to what would be observed in our bone formation model in 
the presence o f ascorbate and absence o f PTH. The quantitative TRAP enzyme 
activity, a marker for osteoclasts, was consistent with the above results, Fig. 2B. 
The TRAP activity measurements clearly supported the calcium change 
measurements, where both phosvitin and ascorbate impact significantly PTH- 
induced osteoclast differentiation and bone resorption. The results for both 
calcium and TRAP activity were analyzed by two tailed paired Student s t -test 
to show statistical significance (p values are recorded in the legend o f Fig. 2A 
& 2B). Overall, histological, NR, and silver nitrate observations were 
consistent with the quantitative analysis for calcium and TRAP activity.
Quantitative histomorphometric analysis o f calvarial bones in the resorption 
model system in the absence and presence o f PTH, phosvitin and ascorbate:- 
We have utilized the silver nitrate stained calvaria at 2x magnification to 
determine the quantitative global bone resorption areas. Figure 3A shows 
examples o f the approaches used for global quantitation o f the resorption areas 
whereby NR and counter stained calvarial digital images were transformed to 
“black and white” images with shades o f gray in between directly proportional 
to the degree o f light transparency and extent o f bone loss. For example areas 
with complete resorption through the whole thickness o f the calvaria are 
completely white, those areas where there was no resorption were black or dark 
gray, and those areas that have undergone significant resorption whithout 
penetrating through the whole calvarial thickness were light gray. Figure 3B
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shows quantitative histomorphometric analysis where the results are expressed 
as %  bone resorption with total unit resorption area for samples treated with 
PTH alone fixed as 100% and the results for the other sets calculated relative to 
this. This approach o f global quantitative histomorphometric assessment has 
major advantages over typical histomorphometric analysis using thin 
histological sections. This is because the whole bone can be evaluated for 
resorption areas as well as both areas o f complete resorption/dissolution 
showing holes and those that have been partially resorbed showing changes in 
light transparency. In essence a single total calvarial bone resorption area 
measurement o f the whole silver stained calvaria reflects or equates to 
histomorphometric analysis o f ~ 1000 sections o f 5 pm thickness. The data 
clearly demonstrated that phosvitin inhibits the PTH-induced osteoclastic bone 
resorption, and has the capacity to enable new osteoid and bone formation in 
the absence o f  ascorbate.
In order to distinguish a specific phosvitin function from just a role for 
organic phosphate or phosphate group, a parallel set o f experiments using PTH 
and phosphoamino-acids at concentrations -equivalent to those present in 
phosvitin were carried out. Figure 4A shows quantitative calcium release and 
TRAP activity measurements for these experiments with no significant effect 
that was statistically relevant to PTH-induced calcium release by any o f the 
added phospho-amino acids. TRAP activity measurements however, showed a 
small decrease in the presence o f P-Ser and P-Thr, Figure 4B.
Effect o f phosvitin on osteoblastic bone formation in the absence and
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presence o f ascorbate in live mouse calvarial bone formation model:- The 
surprising results obtained above using our mouse calvarial bone resorption 
model suggested the very important biologic effects o f phosvitin under 
conditions where one would only expect to see PTH-induced osteoclastic bone 
resorption. This led us to further investigate the effects o f phosvitin.
Osteoblasts and bone formation in the absence and presence o f ascorbate 
and native phosvitin observed histologically: - The histological observations o f 
H & E stained sections o f calvarial bones cultured over a 10 day period for 
groups: (a) unstimulated controls, (b) stimulated by ImM ascorbate to undergo 
bone formation, and (c) 1 mM ascorbate + 150 nM native phosvitin are shown 
in Fig. 5. Figure 5a shows unstimulated control cultures where there was no 
clear new osteoblast differentiation or new osteoid formation. In the presence 
o f ascorbate, new bone formation was clearly observable with significant 
osteoblastic activity as evidenced by large amounts o f new osteoid formation, 
Fig. 5b. This was also obvious from the large difference in the actual overall 
bone thickness when comparing Fig. 5a and 5b. In the presence o f phosvitin, 
the relative increase in osteoblast numbers/activity and degree o f new osteoid 
formation were more easily detected, Fig 5c. In the presence o f phosvitin, there 
was a remarkable degree o f osteoblast differentiation to the extent that it can be 
observed, that (i) many osteoblasts just being surrounded by their new osteoid 
(ECM), and (ii) clusters o f differentiated osteoblasts along the whole bone 
surface, Fig. 5d. In the presence o f combined ascorbate + phosvitin such 
occurences were even more enhanced, Figs. 5e and 5f. These data were
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supported by the significant levels o f ALP activity, see below.
Quantitative calcium uptake and alkaline phosphatase acitivity in the 
absence and presence o f ascorbate and phosvitin in calvarial bone organ culture 
formation model: The cumulative change in media calcium was determined 
over a 10 day culture period for groups: (a) unstimulated controls, (b) 1 mM 
ascorbate, (c) 150 nM phosvitin + 1 mM ascorbate, and (d) 150 nM native 
phosvitin. Figure 6A shows total change in media calcium for the groups (a)- 
(d). These data were expressed as pmol calcium per ml media and normalized 
per mg dry weight o f calvarial bones. Unstimulated controls, group (a), showed 
minimal calcium uptake whereas those treated with ascorbate, group (b), 
showed substantial uptake o f calcium indicating enhanced osteoblastic activity 
and new bone formation. Similarly, cultures treated with a combination o f 
ascorbate + phosvitin, group (c), showed calcium uptake similar to that o f 
ascorbate alone. Those calvaria cultured in the presence o f phosvitin alone, 
group (d), showed significant uptake o f calcium, 10 fold above that o f media 
alone, but this was much lower than calvaria cultured in the presence o f 
ascorbate or ascorbate + phosvitin. This is clearly seen in the histological 
sections where the new osteoid stained very “light pink” reflective o f young 
osteoid/bone ECM, Fig. 5c. The ALP activity was consistent with the 
histological observations whereby cultures treated as in (b) - (d) showed 
significantly higher ALP activity compared to the control media alone. Fig. 6B.
Quantitative histomorphometric analysis o f calvarial bones in the formation 
model system in the absence and presence o f phosvitin and ascorbate:-
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Quantitative histomorphometric analysis o f H & E sections for calvaria treated 
as in (a) - (d) above as well as those with PTH + ASC and PTH + phosvitin 
showed clearly the significant new osteoid/bone formation, Fig. 7. Figure 7A 
show examples o f how measurements o f new osteoid/bone formation were 
carried out for quantitative analysis. For this purpose the areas between the 
“dotted lines” which show the new light pink osteoid/bone and early stages o f 
the differentiated osteoblasts surrounded by their synthesized ECM were used. 
The old/original bone at the start o f the experiment can be very easily 
distinguished by its much darker color characteristics. The measured areas o f 
the total new osteoid/bone formed for calvaria cultured in the presence o f 
ascorbate only was set to be 100% and all o f the other experimental groups 
with different treatments were calculated relative to this. Figure 7B.
Stable collagen synthesis, new osteoid and bone formation in the presence 
o f phosvitin:- Analysis o f hydroxylproline and total amino-acid content were 
used to calculate the %  collagen content o f the total protein present within the 
calvarial bone culture groups: (i) media alone, (ii) media + ascorbate, and (iii) 
media + phosvitin. The results indicated that the total organic matrix in calvaria 
cultured in the presence o f ascorbate, group (ii), or phosvitin, group (iii), were 
2-3 x higher than those o f the controls, media alone group (i). The total 
hydroxyproline content o f the groups with ascorbate or phosvitin were also 2- 
3x higher providing a calculated %  collagen content o f total proteins to be 53 ± 
6 %, 57 ± 4 %, 58 ± 5 %  for groups in (i), (ii), and (iii), respectively, consistent 
with the observations using the above multiple chemical, biochemical and
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histological analysis. These data clearly demonstrated that in the presence o f 
ascorbate and or phosvitin the newly synthesized ECM is typical bone matrix 
with appropriate hydroxyproline containing stable collagen synthesis forming 
the new osteoid and bone.
Primary osteoblasts as prolyl-hydroxylase enzyme source and hydroxylation 
o f synthetic collagen peptide analogue in the absence and presence o f ascorbate 
and phosvitin:- We have utilized a designed synthetic collagen peptide 
analogue containing multiple consensus recognition sequence for 3- and 4- 
prolyl hydroxylases for proline hydroxylation and two prolyl- hydroxylase 
enzyme sources were used for test tube hydroxylation experiments. Both o f the 
osteoblast enzyme sources were used in test tube reaction conditions involving
+3negative controls, positive control and test reactions in the presence o f Fe 
and ascorbate or phosvitin. The two osteoblast enzyme sources, total lysate and 
microsomal enriched fractions, provided essentially the same results. The 
complexity o f the total lysate was overcome by use o f only a small amount o f 
the reaction sample for MS/MS analysis by design o f appropriate 
concentrations o f reaction mixture components for clear and easy identification 
o f the synthetic peptide during MS analysis. The MS/MS data search provided 
identification o f the original peptide sequence, GPPGPSGPPGPSGPPGPSGK 
(expected mass o f 1680 Da), with no evidence for hydroxylated proline 
residues in any o f the negative control reactions. Figure 8A shows an example 
o f MS/MS fragmentation sequence data that led to the identification o f the 
unmodified original peptide in the negative controls. The positive control
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reactions in the presence o f Fe provided identification o f multiple 
hydroxylated forms o f the synthetic peptide, GPPGPSGPP*GP*SGPPGPSGK 
(1712 Da, 2x P-OH), GPPGPSGP*PGP*SGPPGPSGK (1712 Da, 2x P-OH), 
GPPGPSGPPGPSGP*PGPSGK (1696 Da, lx  P-OH), and 
GPPGPSGPP*GPSGPPGPSGK (1696 Da, lx  P-OH). The asterisks (*) denotes 
the location o f the hydroxyproline with 16 Da mass addition for each hydroxyl 
group and this applies to all o f the peptides identified below too. Figure 8B 
shows an example o f MS/MS spectra that led to the identification o f the
+2hydroxylated peptides in the positive control with Fe . The test reactions in
the presence o f Fe+^ and Na ascorbate provided identification o f multiple 
hydroxylated forms o f the synthetic peptide, GPPGPSGPPGP*SGPPGPSGK 
(1696 Da, lx  P-OH), GPPGPSGP*PGP*SGPPGPSGK (1712 Da, 2x P-OH) 
GPPGPSGPPGPSGPP*GP*SGK (1712 Da, 2x P-OH), and 
GPPGP*SGPP*GPSGP*PGPSGK (1728 Da, 3x P-OH). An example o f 
MS/MS fragmentation sequence data that led to the identification o f the
+3hydroxylated peptides in the test reaction with Fe and Na ascorbate is
+3 • •depicted in Figure 8C. The test reactions in the presence o f Fe and phosvitin
provided identification o f multiple hydroxylated forms o f the synthetic peptide, 
GPPGPSGPPGP*SGP*PGPSGK (1712 Da, 2x P-OH), 
GPPGP*SGPPGP*SGP*PGPSGK (1728 Da, 3x P-OH) 
GPPGPSGPPGPSGP*P*GPSGK (1712 Da, 2x P-OH), and 
GPPGPSGPPGP*SGPPGPSGK (1696 Da, lx P-OH). An example o f MS/MS
+9
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fragmentation sequence data that led to the identification o f the modified
+3 . . . . .hydroxylated peptides in the test reaction with Fe and Phosvitin is given in
Figure 8D.
Biomineralization o f cultured primary osteoblasts in the absence and presence 
o f ascorbate and phosvitin:- To provide additional evidence for the 
involvement o f phosvitin in the synthesis o f collagen and biomineralization we 
have cultured primary calvarial osteoblast in the absence and presence o f (3- 
glycerolphosphate, ascorbate and phosvitin. Figure 9A shows mineral 
deposition microscopically observed after cell layer o f osteoblast cultures were 
exposed to 2% silver nitrate with essentially no Ca-P deposition in the cultures 
with media alone and p-glycerolphoshate, while presence o f ascorbate or 
phosvitin led to substantial mineral deposition. Quantitative Ca analysis o f such 
cell layers and the culture media provided results consistent with these
+2observations. The control cultures showed minimal Ca levels in the cell
+2layers, whereas those with ascorbate or phosvitin showed substantial Ca 
levels, 4-5 fold, as compared to the controls, Figure 9B. These results were 
consistent with the Ca analysis o f the used media o f such cultures showing 
clear corresponding Ca uptake from the media, Figure 9C. Overall, the data 
obtained from osteoblast cultures were consistent with and supported those o f 
the calvarial bone organ culture studies.
Synthesis o f hydroxyproline containing collagens and critical proteins by 
cultured osteoblasts in the absence and presence of, p-glycerolphosphate,
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ascorbate and phosvitin:- Importantly, the mineralization experiments with 
osteoblasts above also provided a third and ultimate opportunity to define 
under cell culture conditions synthesis o f collagens, proline hydroxylation, and 
early critical proteins in the absence and presence o f ascorbate and phosvitin by 
MS technology. Figure 10 (inset) shows pictorial representation o f the 
insoluble cell layer white pellets o f the cultured osteoblasts after acid extraction 
and bench top centrifugation with clear visible white pellets showing the major 
quantitative ECM differences between the controls versus those in the presence 
o f ascorbate or phosvitin. The media alone and P-glycerolphosphate showed 
similar and very small size insoluble ECM, whereas ascorbate and phosvitin 
treated cultures generated substantially larger insoluble ECM. The ECM and 
insoluble components o f the cell layers were subjected to trypsin digestion 
followed by LC-ESI-MS/MS analysis. This was performed on small enough 
aliquots to minimize complexity and highlight specifically the most abundant 
ECM and acid soluble components. The LC-ESI-MS total base-peak ion 
abundance profiles were consistent and correlated with the white pellet sizes, 
whereby for controls media alone and p-glycerolphosphate the total ion 
intensities were ~5x lower than those o f the corresponding ascorbate and 
phosvitin. The MS/MS sequence data were searched against the rat database 
and the results are summarized in Table 1 with major and significant results 
confirming/augmenting the bone organ culture, synthetic collagen peptide and 
mineralizing osteoblast culture studies. Four distinct collagen chains were 
clearly identified with collagen type I as the major component and these were
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present in both ascorbate and phosvitin treated cultures but were absent in the 
controls. As expected ascorbate treated cultures led to identification o f collagen 
type 1 alpha 2(17 distinct peptides with multiple hydroxyproline sites in each 
peptide), collagen type III alpha 1 (7 distinct peptides with multiple 
hydroxyproline sites in each peptide) and collagen type XII alpha 1 (3 distinct 
peptides with no hydroxyproline sites). Similarly, in samples derived from 
phosvitin treated cultures collagen type I alpha 2 ( 1 1  distinct peptides with 
multiple hydroxyproline sites in each peptide), collagen type I alpha 1 (5 
distinct peptides with multiple hydroxyproline sites in each peptide), collagen 
type III alpha 1 (2 distinct peptides with multiple hydroxyproline sites in each 
peptide were clearly identified). Another interesting major protein that was 
identified only in ascorbate and phosvitin treated cultures was vimentin which 
was not present in the controls. While collagens and fibronectin are well known 
ECM components, vimentin has been defined as intracellular/cell surface 
bound “intermediate filament protein” and our identification o f this protein was 
possibly due to cells being lysed and insoluble components together with the 
ECM was pelleted together. The significance o f identifying this important 
protein in only ascorbate and phosvitin treated samples is the fact that it is a 
marker for “epithelial to mesenchymal transition”. One common protein 
identified in all o f the samples derived from the cultured osteoblasts was 
fibronectin, which is important for osteoblast differentiation and is a survival 
factor for the differentiated osteoblasts. While semi-quantitative, from the 
repeat counts and the number o f distinct peptides identified there are clear
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different levels o f this protein in the four differently treated samples. The 
highest level was observed in phosvitin and ascobate treated samples, 17 
distinct peptides and 11 respectively, whereas only 4-5 peptides were identified 
for the samples derived from media alone and p-glycerolphoshate treated 
samples. It is noteworthy that identification o f the proteins and the peptides 
were through the same search conditions (+16 Da modifications for 
hydroxylation o f P residues) and defined within the same search result list for 
each o f the different treatment samples. Importantly, while fibronectin contains 
multiple proline residues none o f the peptides o f this protein were defined to 
contain hydroxylated proline residue. For example in phosvitin treated cultures 
there were 17 peptides o f fibronectin identified with total o f 18 proline residues 
but no hydroxyprolines were defined, whereas collagen type I alpha 2 in this 
same sample and search identified 11 distinct peptides o f this protein with total 
o f 44 proline residues and 21 o f these were identified as hydroxyprolines. 
Figure 11 shows an example o f the MS/MS fragmentation sequence data with y 
and b ion fragments for one o f the collagen type I alpha 2 peptide with three 
hydroxyproline sites found in ascorbate and phosvitin treated osteoblast 
cultures. The precise proline sites o f hydroxylation were defined by the specific 
y and b ion fragments with 16 Da mass additions on proline residues indicated 
by the red arrows in Figure 11.
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5. DISCUSSION
In the bio-mineralization o f osteoblast cells cultured by p-glycerophosphate, 
ascorbate and phosvitin, we found that there is higher calcium concentration in 
the cell layers o f p-glycerophosphate group, ascorbate group and phosvitin 
group than that in control group in calcium assay. And they corresponded to 
the uptaking calcium concentration from media in each group. Regarding to 
the lower ALP activities in p-glycerophosphate group, ascorbate group and 
phosvitin group, we believe it doesn’t mean there is no osteoblast cells 
differentiation but it’s because phosphorus had an inhibitory effect on ALP 
activities(l 14). So we believe there is bio-mineralization activities among p- 
glycerophosphate group, ascorbate group and phosvitin group.
The expression o f Runx2 is upregulated in immature osteoblasts, but 
downregulated in mature osteoblasts. Runx2 is the first transcription factor 
required for determination o f the osteoblast lineage, while Osterix further direct 
the fate o f mesenchymal cells to osteoblasts, blocking their differentiation into 
chondrocytes. Runx2 induces the differentiation o f multipotent mesenchymal 
cells into immature osteoblasts, directing the formation o f immature bone, but 
Runx2 inhibits osteoblast maturation and mature bone formation. Normally, the 
protein level o f Runx2 in osteoblasts reduces during bone development, and 
osteoblasts acquire mature phenotypes, which are required for mature bone 
formation (115). Osterix regulates osteoblast differentiation and increased in a 
time-dependent manner. However, it is an unstable protein(l 16).
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So after the quantification o f gene expression o f Osterix and Runx 2 in 
osteoblast cells, we found that comparing with control group, the value o f 
Osterix is much higher but the Runx 2 is similar in ascorbate group. On the 
other hand, when comparing with control group, the value o f Osterix and Runx 
2 is lower in phosvitin group. It may suggest that there is osteoblast 
differentiation in ascorbate group due to the high value o f Osterix (115,116). 
Also there is osteoblast differentiation in phosvitin group due to the lower 
value o f Runx 2(115,116). O f course, it will need further investigations for 
more clear view.
Ascorbic acid (vitamin C) is one o f nature’s vital biomolecules serving an 
essential role in a number o f important physiological reactions such as collagen 
synthesis, iron metabolism and immunity (50). As detailed in the introduction it 
is surprising therefore, that many species have lost the capacity to synthesize 
ascorbate. This defect has been estimated to have taken place some 35-55 
million years ago in humans and guinea pigs as a result o f highly mutated 
nonfunctional versions o f GLO gene (64-66) and believed to be a common 
occurrence for many species. It appears that this was a result o f evolutionary 
pressure due to the coupling o f the ability to have placental embryo 
development for reproduction and readily available dietary vitamin C source.
In the case o f mammalian vertebrates such an occurrence was inherently timely 
with no major adverse outcome. However, for those species that retained the 
ex-vivo egg embryo development for reproduction, the consequences and the 
adverse limitations o f this is obvious. For development o f the egg embryo and
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general organogenesis the absence o f an ascorbate source dictates no 
development. Based on our current knowledge, however, despite this the ex- 
vivo embryos o f  birds and fish defiantly continue to grow and eventually hatch. 
Fish, dinosaurs and birds were the early vertebrates to evolve pre-dating 
modem vertebrates and primates between 450 -150 million years. Ironically all 
o f these early vertebrates were egg laying species for reproduction and while 
the dinosaurs are extinct the fish and birds are still in existence and continue to 
use the same biological process for reproduction. A lack o f capacity to 
synthesize ascorbate by passeriform birds and teleost fish suggests that the 
developing embryos o f  these species in ex-vivo eggs may utilize alternative 
biomolecule(s) and mechanism(s) for stable collagen synthesis during 
embryogenesis. The physico-chemical properties o f egg yolk phosvitin suggest 
its plausible candidacy but scientific evidence in support o f this has not been 
possible until the present study. As discussed in the introduction this was 
mainly due to lack o f appropriate experimental model systems. For example, 
the most common animal model is the mouse and interestingly they are one o f 
the few species which evolutionarily retained the capacity to biosynthesize 
ascorbate. Knock-out studies in mice with deficient ascorbate synthesis through 
deletion o f the GLO gene showed that collagen synthesis and the ratio o f 
proline: 4-hydroxyproline appeared not to change significantly (67). The data 
indicated that although there was an undesirable impact on general survival and 
weight gain there was no significant effect on the synthesis o f collagen. It was 
suggested that either there was residual acitive ascorbate in tissues/organs or
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collagen synthesis was independent o f ascorbate and there was perhaps another 
mechanism by which stable collagen synthesis was possible (67). Our studies, 
however, using ex-vivo live neonatal mouse calvarial bone cultures which 
eliminates the natural supply o f ascorbate showed clearly that in the absence o f 
added ascorbate in such cultures there was no new osteoid/bone formation and 
hence no stable collagen synthesis, data presented herein and (57). Inclusion o f 
ascorbate in such cultures on the other hand proceeded with rapid synthesis o f 
collagen and formation o f new osteoid and bone.
Phosvitin is an abundant highly phosphorylated protein component o f egg 
yolk derived from the mid-portion o f a full length protein o f  vitellogenin II 
gene by posttranslational proteolytic cleavage and has been studied for almost 
half a century. Internalization o f the egg yolk phosvitin into the oocyte via 
specific cell receptor binding and subsequent endocytosis suggests several 
important physiological functions for this protein during embryogenesis o f 
birds, reptiles and fish [68]. One unique chemical property o f phosvitin is its 
powerful antioxidant/reducing agent capacity. This knowledge, however, has 
not been linked to the fact that it is reminiscent o f ascorbate which is also an 
antioxidant/reducing agent that is an essential biomolecule during the synthesis 
o f stable collagen and hence, formation and maintenance o f connective tissue, 
organs and skeletal system. In order to test our conceptual developments 
detailed above we have utilized our live neonatal mouse calvarial bone organ 
culture system under dissociative bone resorption and formation conditions to 
reveal the unique and important biological properties o f phosvitin not shared by
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any other ECM phosphoprotein to date. The models we have developed have 
some very critical significance since conditions used dissociates the two 
remodeling stages, e.g., osteoclastic bone resorption and osteoblastic bone 
formation such that studies can be carried out to target effects o f added factors 
and drugs on individual components as well as studies o f cancer-bone 
interactions (39,57). The resorption model was designed to permit PTH- 
induced osteoclast formation/differentiation from the resident progenitor/stem 
cells in the absence o f ascorbate. Under these conditions PTH induces rapid 
osteoclastic bone resorption with complete suppression o f osteoblast 
differentiation. Interestingly, this latter phenomenon is related to the inability 
o f the mesenchymal/stromal cells to differentiate to osteoblasts since in the 
absence o f ascorbate they cannot synthesize stable collagen which leads to lack 
o f ECM formation and hence no osteoblast differentiation. The model we have 
developed and used also “highlight critically important evidence that 
osteoclastogenesis is completely independent o f ascorbate” in ex-vivo live 
bone microenvironment which is highly likely to be the case in in vivo bone 
microenvironment too. This is contrary to the suggestion in the literature that 
ascorbate was essential for “osteoclastogenesis” and induced the formation o f 
osteoclasts in a cooparative fushion with la, 25- dihydrovitamin D3 (or PTH) 
in co-culture system o f bone marrow cells and clonal stromal ST2 (or CIMC-2) 
as mesenchymal support cells, (69,70). As we have recently highlighted in our 
work with cancer-bone interaction studies, (57), there are major advantages o f 
the live bone organ culture models we have developed and that the co-culture
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cell systems often do not provide the conditions that are relevant to the in vivo 
circumstances. Under our resorption conditions, phosvitin inhibited PTH- 
induced osteoclast differentiation and bone resorption. However, there were 
some differences in the tissue’s response towards the PTH + phosvitin and 
PTH + ascorbate treatments. In the presence o f phosvitin the osteoclastic 
activity as well as their numbers were significantly reduced and did not 
develop their typical multinucleated form. In the presence o f ascorbate on the 
other hand there was no significant osteoclastic activity and or release o f 
calcium instead there was uptake o f calcium. The surprising aspect o f  these 
observations was the fact that phosvitin inhibited PTH-induced bone resorption 
with “simultaneous formation o f significant amounts o f new osteoid and bone” 
in the absence o f ascorbate. This latter case clearly provoked a major interest 
within the context o f this study, since our calvarial bone resorption model is 
based on the use o f culture media that is devoid o f ascorbate. Under such 
conditions it would be expected that there will be no new stable collagen 
synthesis, osteoid or bone formation because the synthesis and stability o f the 
collagen molecule is critically dependent upon the presence o f ascorbate for the 
synthesis o f collagen containing hydroxylproline residues. The latter 
posttranslational modifications occur through the action o f prolyl-hydroxylases
whose catalytic activities are completely dependent on the presence o f
+2
ascorbate as an antioxidant/reducing agent to regenerate ferrous (Fe ) ion
+3
which undergoes electronic oxidation to ferric (Fe ) ion during the 
hydroxylation step. These observations led us to further investigate this
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important biologic event using our calvarial “bone formation m odel”. The 
results from this bone formation model augmented the observations in the 
resorption system where chemical and biochemical, histological and 
histomorhometric measurements were consistent with new collagen synthesis 
and osteoid/bone formation. The calcium uptake for phosvitin was lower than 
that o f ascorbate alone however, in the presence o f phosvitin alone there was 
significant amount o f differentiated osteoblasts and new osteoid formation 
similar to that o f ascorbate alone. These data indicated that phosvitin alone is 
capable o f promoting osteoblast differentiation and new osteoid deposition and 
co-inclusion o f phosvitin and ascorbate appears to enhance such occurrence. 
While there was a similar level o f ALP activity and amount o f new osteoid 
formation between ascorbate and phosvitin treated cultures, the extent o f 
calcium uptake or biomineralization appeared to be different. These results 
suggest that the initial formation o f the new organic matrix has a common 
biological process for ascorbate and phosvitin, whereas the biomineralization 
(Ca-P deposition) step that follow this appears to be divergent. This latter case 
is likely to be due to the regulatory effect o f phosvitin on the Ca-P crystal 
nucleation which is a known characteristic o f ECM phosphoproteins during 
biomineralization. These different stages involved in the overall bone 
formation and its mineralization are some o f the reasons how our live 
multicellular bone organ culture system responsive to external stimuli by its 
resident stem cells undergoing differentiation which may give rise to some 
divergence in the observations.
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It has been demonstrated that phosvitin bound to collagen substrate can
+2
promote nucleation o f Ca-P (44), and can bind 127 moles o f Ca /mole o f
+2
phosvitin (71). The possibility o f Ca binding to phosvitin may lead to the
+2
observed uptake o f Ca in our bone organ cultures can be excluded. This is
because the solid phosvitin was first dissolved in the culture media to give
+2
stock solution which will render the phosvitin to be saturated with Ca at this
+2
stage since there is excess supply o f Ca in the culture media. Aliquots o f this 
was further diluted 200x in the working culture media to be used. Furthermore, 
based on the above calcium binding capacity o f phosvitin, our calculations
indicate that even without the above experimental approach the potential
+2
amount o f Ca that could bind to phosvitin can only account for <  10 %  that o f
+2
the total Ca up-take from the media for both bone organ cultures and cultured 
osteoblasts. Importantly, our work with cultured osteoblast clearly supported 
and confirmed the bone organ culture studies with mineralization o f the
osteoblasts in the presence o f ascorbate or phosvitin to the same extent. In this
+2
latter case the quantiative Ca deposition in the mineralizing cell layer was
+2
also determined in conjunction with the Ca uptake from the media. The
+2
results confirmed that the Ca up take from the media were correlative with
+2
the Ca depositions to the newly synthesized ECM. It is interesting to note that 
the role o f phosvitin in egg shell (which is predominantly calcium carbonate) 
formation has not been defined nor its presence in this mineralized
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environment. A number o f other phosphoproteins including those specific to 
egg shell have been proposed for this activity such as ovocleidin-17 and 116, 
and ovocalyxin-32 and 36 (72-75).
Our striking results with bone organ culture systems led us to design and 
synthesize a collagen peptide analogue with multiple prolyl-hydroxylase 
recognition sites to provide additional direct supporting evidence. Use o f this 
peptide under test tube chemistry conditions in the absence and presence o f 
ascorbate or phosvitin together with mass spectroscopic analysis provided 
direct evidence in support o f the unique properties o f phosvitin that can mirror 
those o f ascobate in facilitating hydroxylation o f proline residues. These 
observations were further confirmed by use o f cultured mineralizing calvarial 
osteoblasts for the first time with phosvitin. In this latter cell culture system we 
have established clearly that cultured osteoblasts behaved physiologically and 
biochemically the same manner towards exposure to “ascorbate or phosvitin” 
in terms o f osteoblast differentiation, synthesis o f dominant bone ECM proteins 
such as collagen type I alpha 1 and alpha 2 chains, generation o f critically 
important hydroxyprolines in collagens and general biomineralization. The use 
o f mass spectrometric analytical approaches to analyze with high precision the 
intricate details o f the mineralized osteoblast ECM components provided 
ultimate major confirmatory results that phosvitin stimulates osteoblast 
differentiation, collagen synthesis, hydroxyproline formation and regulation o f 
biomineralization. These studies also led to the identification o f vimentin (an 
important marker for epithelial to mesenchymal transition), and collagen type
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Ill (a fibrillar collagen associated with collagen type I in bone), in both 
ascorbate and phosvitin treated cultures which signify the critical role o f 
phosvitin in connective tissue and bone organogenesis.
It is noteworthy that our live bone organ cultures appear to simulate the 
events that arise from intermittent PTH treatment o f osteoporosis which leads 
to stimulation o f bone formation. In the presence o f ascorbate our bone cultures 
respond to PTH by significant differentiation o f osteoblasts and formation o f 
new osteoid/bone. The same response was also observed when phosvitin and 
PTH was used. These results suggest that inclusion o f factors that stimulate 
osteoblast differentiation in bone organ cultures takes precedence over PTH- 
induced osteoclast differentiation.
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6. Conclusions
Overall, our studies culminated in the discovery o f an important and unique 
bioactivity for phosvitin in the collagen synthesis and formation o f new 
osteoid/bone in the absence o f ascorbate, a biological function that has avoided 
discovery for many decades due to lack o f an appropriate model system until 
now. To the best o f authors’ knowledge there has been no other naturally 
occurring biomolecule to date that has shown to have such a capacity except 
ascorbate. In essence our live neonatal mouse calvarial model systems 
developed with bone remodeling stages dissociated have uniquely positioned 
us to truly decipher biological events and test bioactive molecules in a manner 
that cannot be achieved as easily by in vivo animal or in vitro cell culture 
models. This is particularly significant with regards to bone biology since in 
any animal model studies the circumstances in vivo very frequently preclude 
clear determination o f the outcome o f the designed experimental perturbations. 
For instance, in vivo there is continual “bone turnover” involving resorption 
and formation ongoing simultaneously such that the impact o f altering one or 
the other requires long term study to reveal itself. Interestingly, the ex-vivo live 
mouse calvarial bone models, in addition to several other advantages discussed 
recently in (57), have a major advantage within the context o f the present study 
because although mice can biosynthesize ascorbate, this takes place in the liver 
and hence our cultured bones are devoid o f a natural ascorbate source which 
indirectly reflects a system with specific gene product such as ascorbate is
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knocked-out. Complementing those studies use o f the synthetic collagen 
peptide analogue and cultured calvarial osteoblasts provided results that 
augmented the bone organ culture work and confirmed through multiple direct 
evidence the capacity o f phosvitin to stimulate differentiation o f osteoblasts, 
collagen synthesis, hydroxyproline formation, and biomineralization. The 
implications o f the current findings are very significant and broad. From an 
evolutionary point o f view egg yolk phosvitin has been serving a vital role 
individually or in combination with ascorbate in general embryogenesis during 
the development o f egg embryos since the evolution o f the first vertebrates, 
fish (-450 million years ago) and dinausors and birds (-200 million years ago) 
which all relied on an ex-vivo egg embryo development for reproduction. 
Whereas in those species o f passeriform birds, teleost fish and reptiles in which 
the gene for the enzyme in the last step o f ascorbate synthesis has been 
inactivated, the present work provided first specific evidence for a potential 
biomolecule enabling the connective tissue, organ and skeletal system 
formation during their egg embryo development in the absence o f ascorbate. 
The implication for contemporary times is the discovery o f a naturally 
occurring biomolecule which can stimulate the differentiation o f resident local 
progenitor/stem cells to osteoblastic lineage, stable collagen synthesis and 
hence formation o f connective tissue and new bone. This latter phenomenon 
opens new research avenues with major scientific interest in a wide range o f 
applications in tissue engineering and regenerative medicine/dentistry.
103
7. Bibliography
1. Ingber, D.E. (1993) The riddle of morphogenesis: a question of 
solution chemistry or molecular cell engeneering. Cell 75, 1249- 
1252.
2. Mizuno, M., Imai, T., Fujisawa, R., Tani, H., and Kuboki, Y. (2000) 
Bone sialoprotein (BSP) is a crucial factor for the expression of 
osteoblastic phenotypes of bone marrow cells cultured on type I 
collagen matrix. Calcified Tissue International 66, 388-396.
3. Decup, F., Six, N., Palmier, B., Buch, D., Lasfargues, J.J., Salih,
E., and Goldberg, M. (2000) Bone sialoprotein-induced reparative 
dentinogenesis in the pulp of a rat's molar. Clinical Oral 
Investigation 4, 110-119.
4. Six, N., Decup, F., Lasfargues, J.J., Salih, E., Goldberg, M. (2002) 
Osteogenic proteins, bone sialoprotein an bone morphogenetic 
protein 7 (OP-1), and pulp mineralization. Journal of Material 
Science (Materials in Medicine) 13, 225-232.
5. Wang, J., Zhou, H-Y., Salih, E., Xu, L., Wunderlich, L., Gu, X., 
Hofstaetter, J.G., Torres, M., and Glimcher, M.J. (2006) Site- 
specific in vivo calcification and osteogenesis stimulated by bone 
sialoprotein. Calcified Tissue International 79, 179-189.
6. Gordon, J.A.R., Tye, C.E., Sampaio, A.V., Underhill, T.M., Hunter, 
G.K., and Goldberg, H.A. (2007) Bone sialoprotein expression 
enhances osteoblast differentiation and matrix mineralization in 
vitro. Bone 41,462-473.
7. Hynes, R.O. (1992) Integrins: versatility, modulation, and 
signaling in cell adhesion. Cell 69, 11-25.
8. Albelda, S.M., and Buck, C.A. (1990) Integrins and other cell 
adhesion molecules. Faseb Journal 4, 2868- 1880.
9. Blobel, C.P., and White, J.M. (1992) Structure, function and 
evolutionary relationship of proteins containing a disintegrin 
domain. Current Opinion in Cell Biology 4, 760-765.
10. Fisher, L.W., Whitson, S.W., Avioli, L.V., and Termine, J.D. (1983) 
Matrix sialoprotein of developing bone. Journal of Biological 
Chemistry 258, 12723-12727.
104
11. Franzen, A., and Heinegard, D. (1985) Isolation and 
charachterization of two sialoproteins present only in bone 
calcified matrix. Biochemical Journal 232, 715-724.
12. Salih, E., Ashkar, S., Gerstenfeld, L.C., and Glimcher, M.J. (1996) 
Protein kinases of cultured chicken osteoblasts: Selectivity for 
extracellular matrix proteins of bone and their catalytic 
competence for osteopontin. Journal of Bone and Mineral 
Research 11, 1461-1473.
13. Salih,E.,Zhou,H- 
Y.,andGlimcher,M.J.(1996)Phosphorylationofpurifiedbovinebonesi 
aloprotein and osteopontin by protein kinases. Journal of 
Biological Chemistry 271, 16897-16905.
14. Salih, E., Ashkar, S., Gerstenfeld, L.C., and Glimcher, M.J. (1997) 
Identification of the metabolically phosphorylated sites of secreted
^P-labeled osteopontin from cultured chicken osteoblasts. 
Journal of Biological Chemistry 272, 13966-13973.
15. Salih, E., Wang, J., Mah, J., and Fluckiger, R. (2002) Natural 
variation in the extent of phosphorylation of bone 
phosphoproteins as a function of in vivo new bone formation 
induced by demineralized bone matrix in soft tissue and bony 
environments. Biochemical Journal 364, 465-474.
16. Salih, E., and Fluckiger, R. (2004) Complete topographical 
distribution of both the in vivo and in vitro phosphorylation sites of 
bone sialoprotein and their biological implications. Journal of 
Biological Chemistry 279, 19808-19815.
17. Glimcher, M.J., Kossiva, D., and Rouosse, A. (1979) Identification 
of phosphopeptides and y- carboxyglutamic acid-containing 
peptides in epiphysealgroth plate cartilage. Calcified Tissue 
International 27, 187-191.
18. Boskey, A.L., Doty, S.B., Kudryashov, V., Mayer-Kuckuk, P., Roy, 
R., and Binderman, I. (2008) Modulation of extracellular matrix 
protein phosphorylation alters mineralization in differentiating 
chich limb-bud mesencymal cell micromass cultures. Bone 42, 
1061-1071.
19. Veis, A., Spector, A.R., and Zamonscanyk, H. (1972) Isolation of 
an EDTA-soluble phosphoprotein from mineralizing bovine dentin. 
Biochimica et Biophysica Acta 257, 404-413.
105
20. Veis, A., and George, A. (2008) Phosphorylated proteins an 
control over apatite nucleation, crystal growth and inhibition. 
Chemical Reviews 108(11), 4670-4693.
21. He, G., Ramachandran, A., Dahl, T., George, S., Schultz, D., 
Cookson D. Veis, A., George, A. (2005) Phosphorylation of 
phosphophoryn is crucial for its function as a mediator of 
biomineralization. Journal of Biological Chemistry 280, 33109- 
33114.
22. Jadlowiec, J.A., Zhang, X., Li, J., Campbell, P.G., and Sfeir, C. 
(2006) Extracellular matrix-mediated signaling by dentin 
phosphophoryn involves activation of the smad pathway 
independent of bone morphogenetic protein. Journal of Biological 
Chemistry 281,5341-5348.
23. Endo,A.,andGlimcher,M.J.(1989)Theeffectofcomplexingphosphop 
roteinstodecalcifiedcollaged on in vitro calcification. Connective 
Tissue Research 21, 179-190.
24. Hunter, G.K., and Goldberg, H.A. (1993) Nucleation of 
hydroxyappatite by bone sialoprotein. Proceedings of National 
Academy of Sciences of the United States of America 90, 8562- 
8565.
25. Boskey, A.L., Maresca, M., Ullrich, W., Doty, S.B., Butler, W.T., 
and Prince, C.W. (1993) Osteopontin- hydroxyapitite interactions 
in vitro: inhibition of hydrxyapatite formation and growth in a 
gelatin. Journal of Bone and Mineral Research 22, 147-159.
26. Stubbs, J.T., III, Mintz, K. P., Eanes, E.D., Torchia, D. A., and 
Fisher, L.W. (1997) Characterization of native and recombinant 
bone sialoprotein: delineation of the mineral-binding and cell 
adhesion domains and structural analysis of the RGD domains. 
Journal of Bone and Mineral Research 12, 1210-1222.
27. Denhardt, D.T., and Noda, M. (1998) Osteopontin expression and 
function: role in bone remodeling. Journal of Cellular Biochemistry. 
Supplement 30-31,92-102.
28. Chambers, T.J., Fuller, K., Darby, J.A., Pringle, J.A., and Horton, 
M.A. (1986) Monoclonal antibodies against osteoclasts inhibit 
bone resorption in vitro. Journal of Bone and Mineral Research 1, 
127-135.
106
29. Davies, J., Warwick, J., Totty, N., Philip, R., Helfrich, M., and 
Horton, M.A. (1989) The osteoclast functional antigen, implicated 
in the regulation of bone resorption, is biochemically related to the 
vitronectin receptor. Journal of Cell Biology 109, 1817-1826.
30. Reinholt, F.P., Hultenby, K., Oldberg, A., and Heinegard, D. (1990)
Osteopontin- a possible anchor of osteoclasts to bone. 
Proceedings of National Academy of Sciences of the United 
States of America 87, 4473-4475.
31. Ross, F.P., Chappel, J., Alvarez, J.I., Sander, D., Butler, W.T., 
Farach-Carson, M.C., Mintz, K. A., Robey, P. G., Teitelbaum, S.
L., and Cheresh, D. A. (1993) Interactions between the bone 
matrix proteins osteopontin and bone sialoprotein and the 
osteoclast avP3 integrin potentiate bone resorption. Journal of
Biological Chemistry 268, 9901-9907.
32. Helfrich, M.H., Nesbitt, S.A., Dorey, E.L., and Horton, M.A. (1992) 
Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) 
peptide containing proteins including the bone sialoproteins and 
fibronectin. Journal of Bone and Mineral Research 7, 335-343.
33. Glimcher, M.J. (1989) Mechanism of calcification: role of collagen 
fibrils and collagen-phosphoprotein complexes in vitro and in vivo. 
Anatomical Record 224, 139-153.
34. Ek-Rylander, B., Flores, M., Wendel, M., Heinegard, D., and 
Andersson, G. (1994) Dephosphorylation of osteopontin and bone 
sialoprotein by osteoclast tartrate-resistant acid phosphatase: 
modulation of osteoclast adhesion in vitro. Journal of Biological 
Chemistry 269, 14853-14856.
35. Katayama, Y., House, C.M., Udagawa, N., Kazama, J.J., 
McFarland, R.J., Martin, T.J., and Findlay, D. M. (1998) Casein 
kinase 2 phosphorylation of recombinant rat osteopontin 
enhances adhesion of osteoclasts but not osteoblasts. Journal of 
Cellular Physiology 176, 179-187.
36. Andersson, G., Ek-Rylander, B., Hollberg, K., Ljusberg-Sjolander, 
J., Lang, P., Norgard, M., Wang, Y., and Zhang, S.J. (2003) 
TRACP as an osteopontin phosphatase. Journal of Bone and 
Mineral Research 18, 1912-1915.
37. Zhou, H-Y., Takita, H., Fujisawa, R., Mizuno, M., and Kuboki, Y.
107
(1995) Stimulation by bone sialoprotein of calcification in 
osteoblast-like MC3T3-E1. Calcified Tissue International 56, 403- 
407.
38. Cooper, L.F., Yliheikkila, P.K., Felton, D.A., and Whitson, S.W. 
(1998) Spatiotemporal assessment of fetal bovine osteoblast 
culture differentiation indicates a role for BSP in promoting 
differentiation. Journal of Bone and Mineral Research 13, 620- 
632.
39. Curtin, P., McHugh, K.P., Zhou, H-Y., Fluckiger, R., Goldhaber, P., 
Oppenheim, F.G., and Salih, E. (2009) Modulation of bone 
resorption by phosphorylation state of bone sialoprotein. 
Biochemistry 48, 6876-6886.
40. Allerton, S.E. and Perlmann, G.E. (1965) Chemical 
characterization of the phosphoprotein phosvitin. Journal of 
Biological Chemistry 240, 3892-3898.
41. Van het Schip, F.D., Samallo, J., Broos, J., Ophuis, J., Mojet, M., 
Gruber, M., and Ab, G. (1987) Nucleotide sequence of a chicken 
vitellogenin gene and derived amino acid sequence of the 
encoded yolk precursor protein. Journal of Molecular Biology 196, 
245-260.
42. Grogan, J., and Taborsky, G. (1986) Iron binding by phosvitin: 
variation of rate of iron release as a function of the degree of 
saturation of iron binding sites. Journal of Inorganic Biochemistry 
26, 237-246.
43. Hegenauer, J., Saltman, P., and Nace, G. (1979) Iron(lll)-- 
phosphoprotein chelates: stoichiometric equilibrium constant for 
interation of iron(lll) and phosphorylserine residues of phosvitin 
and casein. Biochemistry 18, 3865-3879.
44. Onuma, K. (2005) Effect of phosvitin on the nucleation and 
growth of calcium phosphates in physiological solutions. Journal 
of Physical Chemistry B. 109, 8257-8262.
45. Ishikawa, S., Yano, Y., Arihara, K., and Itoh, M. (2004) Egg yolk 
phosvitin inhibits hydroxyl radical formation from the fenton 
reaction. Bioscience. Biotechnology. Biochemistry. 68, 1324-1331.
46. Katayama, S., Xu, Y., Fan, M.Z., and Mine, Y. (2006)
Antioxidative stress activity of oligophosphopeptides derived from
108
hen egg yolk phosvitin in Caco-2 cells. Journal of Agricultural and 
Food Chemistry 54, 773-778.
47. Sattar Khan, M.A., Nakamura, S., Ogawa, M., Akita, E., Azakami, 
H., and Kato, A. (2000) Bactericidal action of egg yolk phosvitin 
against Escherichia coliunder thermal stress. Journal of 
Agricultural and Food Chemistry 1503-1506.
48. Taborsky, G. (1963) Interaction between phosvitin and iron and 
its effect on a rearrangement of phosvitin structure. Biochemistry 
2, 260-271.
49. Lu, C.L., and Baker, R.C. (1986) Characteristics of egg yolk 
phosvitin as an antioxidant for inhibiting metal-catalyzed 
phospholipid oxidation. Poultry Science. 65, 2065-2070.
50. Padh,H.(1990)Cellular functions of ascorbic acid. Biochemistry 
and Cell Biology 68,1166-1173.
51. Burns, J.J. (1957) Missing step in man, monkey and guinea pig 
required for the biosynthesis of L- ascorbic acid. Nature 180, 553.
52. Pauling, L. (1970) Evolution and the need for ascorbic acid. 
Proceedings of National Academy of Sciences of the United 
States of America 67, 1643- 1648.
53. Zilva, S.S. (1936) Vitamin C requirements of guinea-pig. 
Biochemical Journal 30, 1419-1429.
54. Dabrowski, K. (1990) Gulonolactone oxidase is misssing in 
teleost fish. The direct spectrometric assay. Biological Chemistry, 
Hoppe Seyler 371,207-214.
55. Birney, E.C., Jenness, R., and Ayar, K.M. (1976) Inability of bats 
to synthesize L-ascobic acid. Nature 260, 626-628.
56. Chaudhuri, C.R., and Chatterjee, I.B. (1969) L-ascorbic acid 
synthesis in birds: phylogenetic trend. Science 164, 435-436.
57. Curtin, P., Youm, H., and Salih, E. (2012) Three-dimensional 
cancer-bone metastasis model using ex vivo co-cultures of live 
calvarial bones and cancer cells. Biomaterials 33, 1065-1078.
58. Sidgui, M., Collin, P., Vitte, C., and Foster, N. (1995) Osteoblast 
adhesion and resorption of isolated osteoclasts on calcium
109
sulphate hemihydrate. Biomaterials 16, 1327-1332.
59. Braidman, I.P., Rothwell, C., Webber, D.M., Crowe, P., and 
Anderson, D.C. (1990) Location of osteoclast precursors in fetal 
rat calvarial cultures on collagen gels. Journal of Bone and 
Mineral Research 5, 287-298.
60. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J.
(1951) Protein measurement with folin phenol reagent. Journal of 
Biological Chemistry 193, 265-275.
61. Yingst, D.R., and Hoffman, J.F. (1983) Intracellular free Ca and 
Mg of human red blood cell ghosts measured with entrapped 
arsenazo III. Analytical Biochemistry 132, 431-448.
62. Vora, S.R., Palamakumbura, A.H., Mitsi, M., Guo, Y., Pischon, N., 
Nugent, M.A., and Trackman, P.C. (2010) Lysyl oxidase 
propeptide inhibits FGF-2-induced signaling and proliferation of 
osteoblasts. Journal of Biological Chemistry 285, 7384-7393.
63. Eng, J., McCornack, A., and Yates, 3rcl J.R. (1994) An approach 
to correlate tandem mass spectral data of peptide with amino acid 
sequences in a database. Journal of the American Society for 
Mass Spectrometry 5, 976-989.
64. Nishikimi, M., Kawai, T., and Yagis, K. (1992) Guinea pigs 
possess a highly mutated gene for L- gulono-gamma-lactone 
oxidase, the key enzyme fo L-ascorbic acid biosynthesis missing 
in this species. Journal of Biological Chemistry 267, 21967-21972.
65. Nishikimi, M., Fukuyama, R., Minoshiman, I., and Yagis, K. (1994) 
Cloning and chromosomal mapping of the human nonfunctional 
gene for L-gulono-gamma-lactone oxidase, the enzyme for L- 
ascorbic acid biosynthesis missing in man. Journal of Biological 
Chemistry 269, 13685-13688.
66. Lachapelle, M.Y., and Drouin, G. (2011) Inactivation dates of the 
human and guinea pig vitamin C genes. Genetica 139, 199-207.
67. Parsons, K.K., Maeda, N., Yamauchi, M., Banes, A.J., and Koller, 
B.H. (2006) Ascorbic acid- independent synthesis of collagen in 
mice. American Journal of Physiology - Endocrinology and 
Metabolism 290, El 131-E39.
68. MacLean, I.M., and Sanders, E.J. (1983) Cationized ferritin and
110
phosvitin uptake by coated vessicles of the early chick embyro. 
Anatomy and Embryology (Berl) 166, 385-397.
69. Otsuka, E., Kato, Y., Hirose, S., Hagiwara, H. (2000) Role of 
ascorbic acid in the osteoclast formation: induction of osteoclast 
differentiation factor with formation of the extracellular collagen 
matrix. Endocrinology 141,3006-3011.
70. Ragab AA, Lavish SA, Banks MA, Goldberg VM, Greenfield EM. 
(1998) Osteoclast differentiation requires ascorbic acid. Journal of 
Bone and Mineral Research 13, 970-977.
71. Grizzuti, K., and Perlmann, G.E. (1973) Binding of magnesium 
and calcium ions to the phosphoglycoprotein phosvitin. 
Biochemistry 12, 4399-4403.
72. Hincke MT, Gautron J, Mann K, Panheleux M, McKee MD, Bain 
M, Solomon SE, Nys Y. (2003) Purification of ovocalyxin-32, a 
novel chicken eggshell matrix protein. Connect Tissue Research 
44,1619.
73. Gautron J, Murayama E, Vignal A, Morisson M, McKee MD, 
Rehault S, Labas V, Belghazi M, Vidal ML, Nys Y, Hincke MT. 
(2007) Cloning of ovocalyxin-36, a novel chicken eggshell protein 
related to lipopolysaccharide-binding proteins, bactericidal 
permeability-increasing proteins, and plunc family proteins.
Journal of Biological Chemistry 282, 5273-5286.
74. Mann K, Hincke MT, Nys Y. (2002) Isolation of ovocleidin-116 
from chicken eggshells, correction of its amino acid sequence and 
identification of disulfide bonds and glycosylated Asn. Matrix 
Biology 21,383- 387.
75. Hincke MT, Tsang CP, Courtney M, Hill V, Narbaitz R. (1995) 
Purification and immunochemistry of a soluble matrix protein of 
the chicken eggshell (ovocleidin 17). Calcified Tissue 
International 56, 578-583.
76. Gorski, J.P., Wang, A., Lovitch, D., Powell, K., Midura, R.J. (2004) 
Extracellular bone acidic glycoprotein-75 condensed 
mesenchyme regions to be mineralized and localized with bone 
sialoprotein during intramembranous bone formation. Journal of 
Biological Chemistry 279, 25455-25461.
77. Goulas, A.; Triplett E.L.; Taborsky, G. (1996)
111
Oligophosphopeptides of varied structural complexity derived 
from the egg phosphoprotein, phosvitin. Journal of Protein 
Chemistry 15(1), 1-9.
78. Hegde, M.N. and Moany A. (2012) Remineralization of enamel 
subsurface lesions with casein phosphopeptide- amorphous 
calcium phosphate: A quantitative energy dispersive X-ray 
analysis using scanning electron microscopy: An in vitro study. 
Journal of Conservative Dentistry 15(1): 61-67.
79. Nishikimi, M., Kawai, T., and Yagis, K. (1992) Guinea pigs 
possess a highly mutated gene for L-gulono-gamma- lactone 
oxidase, the key enzyme fo L-ascorbic acid biosynthesis missing 
in this species. Journal of Biological Chemistry 267, 21967-21972.
80. Nishikimi, M., Fukuyama, R., Minoshiman, I., and Yagis, K. (1994) 
Cloning and chromosomal mapping of the human nonfunctional 
gene for L-gulono-gamma-lactone oxidase, the enzyme for L- 
ascorbic acid biosynthesis missing in man. Journal of Biological 
Chemistry 269, 13685-13688.
81. Paul, S. (2011) Fish bone chemistry and ultrastructure: 
implications for taphonomy and stable isotope analysis. Journal of 
Archaeological Science 38, 3358-3372.
82. Nelson, D.L. and Cox, M.M. (2005) Lehninger’s principles of 
biochemistry, 4th Edition, W.H. Freeman and Co., New York.
83. Brinckman, J., Notbohm, H., and Muller, P.K. (2005) Collagen. 
Topics in Current Chemistry 247, Springer, Berlin.
84. Parsons, K.K., Maeda, N., Yamauchi, M., Banes, A.J., and Koller, 
B.H. (2006) Ascorbic acid-independent synthesis of collagen in 
mice. American Journal of Physiology - Endocrinology and 
Metabolism 290, El 131 -El 139.
85. Wilson, J.X. (1990) Regulation of ascorbic acid concentration in 
embryonic chick brain. Developmental Biology 139, 292-298.
86. Wang J, Mah J, Zhou H.-Y, Glimcher MJ, Salih E. (1998) 
Expression of bone microsomal casein kinasell, bone sialoprotein, 
and osteopontin during the repair of calvarial defects. Bone 
22:621-28.
87. Zhou H-Y, Salih E, Glimcher MJ. (1998) Isolation of a novel
112
glcosylated phosphoprotein with disulphide cross- links to 
osteonectin. Biochemical Journal 330, 1423-31.
88. Zhou, H-Y, Salih, E., Glimcher, M.J. (2010) Isolation and 
characterization of glycosylated phosphoproteins from teleost 
alewife and blueback herring bone. Journal of Biological 
Chemistry 285: 36170-36178.
89. MacLean, I.M., and Sanders, E.J. (1983) Cationized ferritin and 
phosvitin uptake by coated vessicles of the early chick embyro. 
Anatomy and Embryology (Berl). 166 (3), 385-397.
90. Samaraweera,H., Zhang,W.G., Lee,E.J., Ahn,D.U.(2011) Egg 
Yolk Phosvitin and Functional Phosphopeptides—Review. 
Journal of Food Science 76. 7,143-150
91. Romanoff AL, Romanoff AJ.(1949) The avian egg. New-York : 
John Wiley and Sons. 918p.
92. Samuelsen O, Haukland HH, Jenssen H. (2005) Induced 
resistance to the antimicrobial peptide lactoferrincin B in S. 
aureus. FEBS Letter 579:3421-6.
93. McBee LE, Cotterill OJ.(1979) Ion-exchange chromatography and 
electrophoresis of egg yolk proteins. Journal of Food Science 
44:656-60.
94. Burley RW, Cook WH.(1961) Isolation and composition of avian 
egg yolk granules and their constituents a- and p-lipovitellins. 
Canadian Journal of Biochemistry and Cell Biology 39:1295-307.
95. MacKenzie SI, Martin WG.(1967) The macromolecular 
composition of hen's egg yolk at successive stages of maturation. 
Canadian Journal of Biochemistry and Cell Biology 45:591-601.
96. Wallace RA.(1985) Vitellogenesis and oocyte growth in 
nonmammalian vertebrates. In: Browder LW, editor. 
Developmental Biology. Vol 1, New York: Plenum, p 127-77.
97. Mecham DK, Olcott HS.(1949) Phosvitin, the principal 
phosphoprotein of egg yolk. Journal of the American Chemical 
Society 71:3670-9.
113
98. Culbert J, Mclndoe WM.(1971) A comparison of the heterogeneity 
of phosvitin of egg-yolk and blood-plasma of the domestic fowl 
(Gallus domesticus) International Journal of Biochemistry 2 
(12):617-22.
99. Wallace RA, Morgan JP.(1986) Chromatographic resolution of 
chicken phosvitin multiple macromolecular species in a classic 
viteliogenin-derived phosphoprotein. Biochemical Journal 
240:871-8.
100. Abe Y, Itoh T, Adachi S.(1982) Fractionation and characterization 
of hen's egg yolk phosvitin. Journal of Food Science 47(6):1903- 
7.
101. Taborsky G, Mok C.(1967) Phosvitin homogeneity and molecular 
weight. Journal of Biological Chemistry 242:1495-501.
102. Shainkin R, Perlmann GE.(1971) Phosvitin, a 
phosphjoglycoprotein. Journal of Biological Chemistry 240;2278- 
84.
103. Brockbank RL, Vogel HJ.(1990) Structure of the oligosaccharide 
of hen phosvitin as determined by two-dimensional 1H NMR of 
the intact glycoprotein. Biochemistry 12:5574-83.
104. Burley RW, Cook WH.(1961) Isolation and composition of avian 
egg yolk granules and their constituents a- and (3-lipovitellins. 
Canadian Journal of Biochemistry 39:1295-307.
105. RUNX2 runt-related transcription factor 2.RefSeq. Jul.
2008.Web.1 Jun. 2013.
<http://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailV 
iew&T ermT oSearch=860>
106. SP7 Sp7 transcription factor. RefSeq. Jul. 2010.Web.1 Jun. 2013. 
<http://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailVi 
ew&TermToSearch=121340>
107. ACTB actin, beta. RefSeq. Jul. 2008.Web.1 Jun. 
2013.<http://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowD 
etail View&T ermT oSearch=60>
®108. Quick-StartProtocol. RNeasy Mini Kit, Part 
1 .Jan.2011 .Web.1 .Jun.2013.
<http://webcache.googleusercontent.com/search?q=cache:lbKTP
114
uuCTDgJ:www.qiagen.com/resources/Download.aspx%3Fid%3D 
%257B0E32FBB1 -C307-4603-AC81 -
A5E98490ED23%257D%26lang%3Den%26ver%3D1 +&cd=1 &hl 
=en&ct=clnk&gl=us&client=safari>
109. Curtin, P., H. Youm and Salih(2012).’’Three-dimensional cancer- 
bone metastasis model using ex-vivo co-cultures of live calvarial 
bones and cancer cells.” Biomaterials 33(4):1065-1078.
110. Dorogi, P. L. (1984). “Kinetics and mechanism of Ca2+ binding to 
arsenazo III and antipyrylazo III.” Biochimica et Biophysica Acta 
799(1):9-19.
111. Wang, J., M. J. Glimcher, J. Mah, H. Y. Zhou and E. Salih(1998). 
“Expression of bone microsomal casein kinase II, bone 
sialoprotein, and osteopontin during the repair of calvarial defects.” 
Bone 22(6):621-628.
112. Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J.
Randall(1951). “Protein measurement with the Folin phenol 
reagent.” Journal of Biological Chemistry 193(1): 265-275.
113. Ma,H.P.,Ming,L.G.,Ge,B.F.,Zhai,Y.K.,Song,P.,Xian,C.J. and 
Chen,K.M.(2011). “Icariin is more potent than genistein in 
promoting osteoblast differentiation and mineralization in vitro.” 
Journal of Cellular Biochemistry 112:916-923.
114. Xie,C., Lu,R.,Huang,Y.,Wang,Q.,Xu,X.(2010).” Effects of ions and 
phosphates on alkaline phosphatase activity in aerobic activated 
sludge system.” Bioresource Technology 101 (10):3394-3399.
115. Komori,T.(2010).” Regulation of osteoblast differentiation by 
Runx2.”Ave Exp Med Biol.658:43-49.
116. Peng,Y.,Shi,K.,Wang,L.,Lu,J.,Li,H.,Pan,S.,Ma,C.(2013). 
“Characterization of Osterix protein stability and physiological role 
in osteoblast differentiation.” PLoS One.8(2):e56451.
117. RefSeq, Jul 2008
115
8. Appendix
Developmental Biology 381 (2013) 256-275
ELSEVIER
Contents lists available at SoienceDirect
Developmental Biology
jou rn a l h om e p a g e :  w w w .e ls e v ie r . c om / lo c a te / d e v e lo pm en ta lb io lo g y
Evolution of Developmental Control Mechanisms
Novel b ioactiv ity  o f  ph osv itin  in conn ect iv e  tissu e and b on e  (J) Cross Mark
o r ga n o gen e s is  revea led by live calvarial b on e  organ  cu ltu re m od e ls
jess Liub \ Drew Czernickb l, Shih-Chun Linb. Abeer Alasmarib, Dibart Serge b.
Erdjan Salih a bc*-1
■* Laboratory fo r the Study o f  Skeletal Disorders and Rehabilitation. Department o f  Orthopeadu Surgery. Harvard Medical School and Children s Hospital.
Boston 02US. MA. USA
*» Department o f  Penodontology and Oral Biology. Boston University School o f Dental Medicine. Boston 02118. MA. USA 
Department o f  Oral Medicine. Infection and Immunity. Harvard School o f  Dental Medicine. Boston 02115. MA. USA
A R T I C L E  I N F O  A B S T R A C T
Article history:
Received 17 January 2013 
Received in revised form 
29 May 2013 
Accepted 4 June 2013 
Available online 18 June 2013
Keywords
Phosvitin
Calvarial bone organ culture
Osteoclasts
Osteoblasts
Collagen synthesis
Mass spectrometry
Egg yolk embryo organogenesis
Evolution
Egg yolk phosvitin is one of the most highly phosphorylated extracellular matrix proteins known in 
nature with unique physico-chemical properties deemed to be critical during ex-vivo egg embryo 
development. We have utilized our unique live mouse calvarial bone organ culture models under 
conditions which dissociates the two bone remodeling stages, viz., resorption by osteoclasts and 
formation by osteoblasts, to highlight important and to date unknown critical biological functions of 
egg phosvitin. In our resorption model live bone cultures were grown in the absence of ascorbate and 
were stimulated by parathyroid hormone i'PTH) to undergo rapid osteoclast formation/differentiation 
with bone resorption. In this resorption model native phosvitin potently inhibited PTH-induced 
osteoclastic bone resorption with simultaneous new osteoid/bone formation in the absence of ascorbate 
I vitamin C). These surprising and critical observations were extended using the bone formation model in 
the absence of ascorbate and in the presence of phosvitin which supported the above results. The results 
were corroborated by analyses for calcium release or uptake, tartrate-resistant acid phosphatase activity 
;marker for osteoclasts), alkaline phosphatase activity (marker for osteoblasts), collagen and hydroxypro- 
iine composition, and histological and quantitative histomorphometric evaluations. The data revealed 
that the discovered bioactivity of phosvitin mirrors that of ascorbate during collagen synthesis and the 
formation of new osteoid/bone. Complementing those studies use of the synthetic collagen peptide 
analog and cultured calvarial osteoblasts in conjunction with mass spectrometric analysis provided 
results that augmented the bone organ culture work and confirmed the capacity of phosvitin to stimulate 
differentiation of osteoblasts, collagen synthesis, hydroxyproline formation, and biomineralization. There 
are striking implications and interrelationships of this affect that relates to the evolutionary inactivation 
of the gene of an enzyme i-gulono-y-lactone oxidase, which is involved in the final step of ascorbate 
biosynthesis, in many vertebrate species including passeriform birds, reptiles and teleost fish whose egg 
yolk contain phosvitin. These represent examples of how developing ex-v ivo embryos of such species can 
achieve connective tissue and skeletal system formation in the absence of ascorbate
c 2013 Elsevier Inc All rights reserved.
Introduction
In the past two decades there has been an emergence of 
conceptual developments in the area of extracellular matrix
(ECM) component-mediated influence on cellular function and 
behavior. ECM proteins have the capacity to play major roles in 
general tissue morphogenesis by imposing regulatory effects on 
cell growth and differentiation (Ingber, 1993; Mizuno et a!., 2000;
Abbreviations PTH. parathyroid hormone; CK1. casein kinase I. OPN. osteopontm: BSP. bone sialoprotein: ECM. extracellular matrix: Ca-P, calcium phosphate:
P Ser. phosphosertne: P Thr. phosphothreomne: P-Tyr phosphotyrosme; mCKIl. microsomal casein kinase II; RANKI.. receptor activator of nuclear factor Kp ligand; DMEM. 
Dulbeccos modified Eagle medium: ER. endoplasmic reticulum. TRAP, tartrate resistant acid phosphatase: MS. mass spectrometry; LC-ESI-MS/MS. liquid-chromatography
electrospray ionization-tandem mass spectrometry.
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Decup et al., 2000; Six et al., 2002: Wang et al.. 2006; Gordon et al., 
2007). Such biological processes are achieved, in general, through 
what is known as 'outside-in" signaling via interactions between 
ECM proteins and cell surface receptors, in particular the integrins 
(Hynes, 1992; Albelda and Buck, 1990; Blobel and White, 1992). 
One specific field in which the ECM non-collagenous phosphopro- 
teins have been extensively studied is normally mineralizing 
tissues such as bone (Fisher et al.. 1983: Franzen and Heinegard. 
1985; Salih et al.. 1996a. 1996b. 1997. 2002: Salih and Fluckiger. 
2004; Glimcher et al.. 1979: Boskey et al.. 2008) and dentin (Veis 
et al.. 1972; Veis and George, 2008; He et al., 2005: Jadlowiec et al.. 
2006). In addition to their involvement in biomineralization and 
its regulation (Mizuno et al.. 2000: Decup et al., 2000; Six et al.. 
2002; Gordon et al., 2007; Salih et al.. 2002: Boskey et al.. 2008; 
Endo and Glimcher, 1989; Hunter and Goldberg, 1993: Boskey 
et al., 1993), bone ECM phosphoproteins are implicated in mod­
ulating cellular function and behavior of bone cells (Gordon et al., 
2007; Boskey et al., 2008: Stubbs III et al., 1997; Denhardt and 
Noda. 1998: Chambers et al., 1986; Davies et al.. 1989: Reinholt 
et al., 1990: Ross et al.. 1993; Helfrich et al.. 1992) via promoting 
cell adhesion, motility and transmembrane signaling. The cova­
lently-bound phosphate groups on these proteins have been 
shown to play a direct role in the nucleation of Ca-P crystals 
during biomineralization (Salih et al., 2002; Glimcher. 1989) as 
well as in cell attachment (Ek-Rylander et al., 1994: Katayama 
et al.. 1998; Andersson et al., 2003). Other studies demonstrated 
the effects on cellular activity and behavior such as osteoblast 
differentiation and bone formation both in  v it r o and in  v iv o by 
bone sialoprotein (BSP) (Mizuno et al.. 2000: Zhou et al.. 1995; 
Cooper et al.. 1998). The biological functions of ECM phosphopro­
teins continue to evolve with new discoveries such as the 
influence of the covalently-bound phosphates on signal transduc­
tion (outside-in signaling). For instance, we have determined 
selective/differential transmembrane protein tyrosine phosphory­
lation and down-stream differentially expressed genes in response 
to purified BSP and its different phosphorylation states. These 
observations were augmented with studies using our unique live 
mouse neonatal calvarial bone organ cultures stimulated by 
parathyroid hormone (PTH) to undergo osteoclastic bone resorp­
tion which was inhibited by added BSP forms (Curtin et al.. 2009).
ECM phosphoproteins are not restricted only to bone and dentin 
and occur in the egg yolks of birds, reptiles and fish which contain 
an abundant highly phosphorylated protein known as phosvitin 
(Allerton and Perlmann, 1965: Van het Schip et al. 1987). Unlike the 
bone ECM phosphoproteins known to contain -10-15 mol of P-Ser/ 
P-Thr residues/mol of protein (Salih et al., 1996b, 1997, 2002; Salih 
and Fluckiger. 2004). phosvitin possesses extraordinary levels of 
covalently-bound phosphates with an estimated -1 2 0  sites of 
phosphorylation (Allerton and Perlmann. 1965). Phosvitin has been 
shown to have biological functions common with those of bone 
phosphoproteins such as a very strong divalent metal binding 
capacity, particularly iron and calcium (Grogan and Taborsky. 
1986: Hegenauer et al., 1979)), as well as calcium phosphate crystal 
nucleation property (Onuma. 2005). However, there are exceptional 
properties of phosvitin not shared with bone phosphoproteins. 
These include powerful antioxidant/reducing activities, and anti­
bacterial effects (Ishikawa et al„  2004: Katayama et al., 2006: Sattar 
Khan et al., 2000). Phosvitin binds to ferric ion (Fe3*) very strongly, 
whereas it forms weak complexes with the ferrous ion (Fe2*) and is 
capable of converting one oxidation state to another (Taborsky. 
1963). It has been shown that phosvitin can effectively inhibit 
Fe2*- and Cu2*-mediated oxidation of phospholipids (Lu and Baker, 
1986) and inhibits Fe2‘-catalyzed hydroxyl radical (OH) production 
in Fenton reaction system (Ishikawa et al.. 2004). These properties 
suggest that phosvitin has a unique spectrum of biological functions 
during egg yolk embryo development. Furthermore, the above
chemical characteristics of phosvitin overlap with those of ascor­
bate (vitamin C) which as an antioxidant/reducing agent has major 
roles in a number of importance physiological reactions such as 
collagen synthesis/stability. iron metabolism and immunity (Padh. 
1990). Based on the significance of collagen as the most abundant 
protein and its wide distribution throughout vertebrate tissues, 
organs and skeletal system, it is surprising that many species have 
lost the capacity to synthesize ascorbate. These include primates 
(Bums. 1957; Pauling. 1970). guinea pigs (Zilva. 1936), teleost fish 
(Dabrowski. 1990), bats (Birney et al., 1976) and passeriform birds 
(Chaudhuri and Chatterjee. 1969). In these species the lack of 
appropriate ascorbate supplementation in their diet adversely 
impacts multiple metabolic biochemical processes with eventual 
development of scurvy. The inability to synthesize vitamin C is due 
to a deficiency in L-gulono-y-lactone oxidase (CLO) which is the 
enzyme responsible for catalyzing the last step of ascorbate 
biosynthesis (Burns, 1957).
Despite its discovery more than half a century ago. phosvitin 
has not been characterized with respect to its biological functions 
related to connective tissue and bone formation. This is most likely 
due to the lack of an appropriate experimental model that could 
be used which can reveal clearly such bioactivity with interpre­
table data and without major uncertainties or complications that 
the observed effects are solely due to the added biomolecule. For 
example common in  v iv o animal models such as mice would have 
multiple metabolic problems if ascorbate were eliminated from 
the diet but mice have retained the capacity to synthesize 
ascorbate. It is possible to generate knock-out mice lacking the 
capacity to synthesize ascorbate, however, such an approach is 
also associated with the problem that the absence of ascorbate 
leads to major adverse general physiological problems that could 
complicate the clear interpretation of the final observed experi­
mental outcome. One of the unique chemical characteristics of 
phosvitin is its powerful antioxidant/reducing agent capacity 
which mirrors that of ascorbate. Importantly, ascorbate as an 
antioxidant/reducing agent is an essential biomolecule during 
collagen biosynthesis and hence, formation and maintenance of 
connective tissue, organs and skeletal system. This led to our 
postulate that phosvitin should facilitate collagen synthesis and 
bone formation in the absence of ascorbate. We have utilized our 
unique and well established ex-vivo live neonatal mouse calvarial 
bone organ culture model systems in the absence and presence of 
phosvitin to reveal its potential biological activity in connective 
tissue and bone biology. Using conditions that separate the 
different bone remodeling stages, viz., osteoclastic bone resorption 
or osteoblastic bone formation model systems highlighted the 
unique and to date unknown biological properties of phosvitin 
with important scientific and evolutionary implications. We report 
on our findings that give rise to critical unknown physiological 
functions of phosvitin in the synthesis of stable collagen, forma­
tion of new osteoid and general connective tissue and bone 
organogenesis with major scientific and evolutionary impact.
Materials and methods
L ive m o u s e  c a lv a r ia l  b o n e  o r g a n  cu l t u r e s  a n d  e f f e c t  o f  n a t iv e  
p h o s v i t in  o n  b o n e  r em o d e l in g
Calvaria from 5-7 day old neonatal CD-I mice (Charles River 
Laboratories. MA) were dissected under sterile conditions. Calvaria 
were cut in the occipital lobe, and partially in the frontal lobe, to 
produce a trapezoid structure and washed briefly in culture 
medium. The live bone organ culture medium consisted of 
Dulbecco's modified Eagle medium (DMF.M) supplemented with
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bovine serum albumin (BSA), fraction V (5 mg/ml. Sigma Co.), 
100 U/ml penicillin and 100 Mg/ml streptomycin and 250 ng/ml 
amphotericin B (Gibco, Grand Island. NY) with 'no' fetal calf serum 
(FCS) or ascorbate. This approach permits studies to be performed 
with remodeling events dissociated whereby addition of 10 nM 
parathyroid hormone (PTH) the calvarial bone undergoes predo­
minantly osteoclastic bone resorption. For bone formation the 
culture media was supplemented with 1 mM sodium ascorbate 
(Sigma. Co.) instead of PTH. These models were developed and 
used recently in our other studies where detailed methodologies 
were described (Curtin et al., 2009. 2012).
Chicken egg yolk native phosvitin was purchased from (Sigma- 
Aldrich. Co.) and its purity was tested by SDS-PAGE and highly 
sensitive mass spectrometric MS/MS analysis of the trypsin 
digests, (a) 30 Mg of native phosvitin was run using a 12% SDS- 
PAGE however due to its high phosphorylation states phosvitin 
cannot be visualized by Coomasie blue, but can be readily detected 
using 'Stains all" (Salih et al.. 1996b). Native phosvitin stained a 
40 kDa band (-80%) with two other minor bands at 90 kDa (-20%) 
and 140 kDa ( < 2%). In gel trypsin digestion of the excised bands 
corresponding to the above molecular weight bands was followed 
by MS/MS analysis for identification, (b) A second sample of native 
phosvitin 1 mg in 50 mM ammonium bicarbonate was digested 
using 3% (w/w) trypsin x 2 over 24 h followed by repeating this for 
a second time. Overall. 12% trypsin was used during 48 h incuba­
tion at 37 C. which is much higher than that commonly used 
which is 2% (w/w) trypsin once overnight. This is because 
phosvitin is resistant to proteolytic action due to its extensive 
phosphorylation. Aliquots of the digested samples were processed 
for tandem-mass-spectrometric analysis (MS/MS sequence analysis) 
and the collision-induced-dissociation fragmentation sequence data 
was searched against the chicken database using specified dynamic 
mass modification of 80 Da on Ser/Thr residues (for phosphoryla­
tion) to identify both the phosphorylated and non-phosphorylated 
peptides that may belong to phosvitin or any other protein 
unrelated to phosvitin. The global search of the MS/MS sequence 
data against the chicken and bird databases identified more than 76 
phosphopeptides/peptides all belonging to chicken phosvitin with 
no identification of peptides belonging to any other protein within 
these databases. These results clearly indicated that the samples of 
phosvitin used were remarkably pure.
E ffe c t  o f  c h ic k e n  e g g  y o lk  n a t iv e  p h o s v it in  in  b o n e  r e s o r p t i o n  m o d e l
The effect of native phosvitin on osteoclast formation and bone 
resorption was evaluated using mouse calvarial bone organ cul­
tures stimulated by PTH to undergo rapid osteoclastic bone 
resorption in the absence and presence of native phosvitin. Four 
groups. 6 calvaria per group, for a total of 24 calvarium were set up 
as follows: (a) unstimulated controls (negative control): (b) bone 
resorption model, stimulated by 10 nM parathyroid hormone 
(residues 1-34 bovine PTH, positive control) in DMEM-BSA media:
(c) 10 nM PTH+150 nM native phosvitin (5 Mg/ml in DMEM-BSA);
(d) 10 nM PTH+1 mM ascorbate (200 Mg/ml): and (e) 10 nM PTH 
+ 15 mM phospho-amino acids individually P-Ser. or P-Thr or P-Tyr. 
The concentration of the phospho-amino acids was adjusted to be 
15 mM in order to equate to the total number of P-Ser/P-Thi 
residues that may be present per mole of native phosvitin that 
has been reported in the literature, as -100 mol P-Ser/P-Thr/mol of 
protein (Allerton and Perlmann, 1965). The concentration of 
phosvitin used in the present study was based on the normally 
expected physiologically relevant concentrations of bioactive 
molecules in vivo as well as our other studies using ECM bone 
phosphoproteins with the calvarial bone organ culture system 
(Curtin et al.. 2009). The calvaria were placed on stainless steel 
grids such that the bone was elevated and the media formed a thin
film over the periosteal surface and incubated at 37 C with 5% CO  ^
in a tissue culture incubator (NAPCO. Winchester. VA) for 10 days, 
as previously described (Curtin et al., 2009). The media was 
changed every 2 days and the used media was stored at 4 C for 
calcium analyses. At the end of the 10 day culture period, the six 
calvaria from each treated group in (aHd) were bisected along the 
sagittal suture to generate 12 half calvaria per treatment group. 
Four half calvaria from each group (aHd) were fixed in 10% 
formalin, embedded in paraffin, sectioned and stained with 
hematoxylin and eosin (H 8i E) for histological observations. Four 
half calvaria from each group (aHd) were processed for tartrate- 
resistant acid phosphatase (TRAP) activity (see below) and the 
remaining four from each group were used for neutral red (NR) 
staining followed by silver nitrate counter-staining.
N eu tra l r e d  (NR) s ta in in g  t o  v i s u a l iz e  o s t e o c l a s t  a c t iv i t y  a n d  s i lv e r  
n it ra te  s t a in in g  f o r  b o n e  r e s o r p t i o n  in  r e s p o n s e  t o  PTH  in  th e  a b s e n c e  
a n d  p r e s e n c e  o f  p h o s v i t in
NR has been used for staining of osteoclasts (Curtin et al.. 2009, 
2012; Sidgui et al., 1995; Braidman et al.. 1990) as they take up NR 
rapidly and because their large size and multinudeated nature 
provide a clear contrast between themselves and other bone cells 
for microscopic observations. After the 10 day culture period, 
calvaria were incubated for an additional 45 min at 37 C with NR, 
70 Mg/ml (Sigma, Co.). The mature multinudeated osteoclasts were 
evaluated microscopically in the experimental groups (aHd). Fol­
lowing this, NR stained samples were washed in PBS. fixed in 10% 
formalin overnight and counter stained with 2% silver nitrate 
(Sigma-Aldrich. Co.) for 20 min to reveal gross mineral loss and 
bone resorption areas. We have used this similar approach in our 
recent work to develop and study a three-dimensional cancer-bone 
metastasis model using live calvarial bones and tumor cells in a 
roller tube system (Curtin et al.. 2012). Other investigators have 
used NR staining to visualize osteoclasts and quantitate their 
numbers and have showed that the results were closely related to 
those for TRAP staining of osteoclasts (Sidgui et al.. 1995). Further­
more, NR stains and localizes the same osteoclasts as TRAP 
(Braidman et al.. 1990). It should be noted that, within the context 
of our studies, where the NR staining is performed at the end of the 
experiment followed by silver nitrate counter staining, the possible 
undesirable effects of NR on cellular biology does not impact 
our observations. After NR staining the bones are not cultured 
further.
G lo b a l h is t o m o r p h o m e t r i c  a n a ly s is  o f  c a lv a r ia l b o n e s in r e s o r p t i o n  
m o d e l
The calvarial bones in experimental groups (aHd) above 
stained with NR and counter stained with silver nitrate were used 
at low microscopic magnification (2 x ) to measure quantitative 
degree of osteoclastic bone resorption. The digital recorded images 
such as those in for example Fig. 1; Panels lc. 2c. 3c and 4c were 
processed and converted to black and white images such that 
there were gradation between black and white background 
depending on the degree of resorption. This provided shades that 
ranged from 'black and dark gray for no resorption areas" and 
“white for complete resorption of bone with large irregular holes 
and light gray for resorption areas where those regions of calvaria 
became thin". The total areas reflecting the above shades were 
measured and processed for quantitation of the degree of resorp­
tion under different bone organ culture treatments.
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Fig. 1. Bone resorption model using mouse calvarial bone organ cultures stimulated by PTH to undergo bone resorption in the absence and presence of phosvitin and Na 
ascorbate. Panel I. control untreated calvaria: (a) H » E sections of the parietal bone region with no osteoclastic bone resorption: (b) NR stained calvaria showing no 
multinudeated osteoclasts (MNOC): and (c) NR+silver nitrate counter-stained calvaria showing very little light transparency consistent with mineral dense bone and 
reflecting lack of bone resorption. Panel 2. calvaria stimulated with PTH to undergo osteoclastic bone resorption: (a) H & E sections of the parietal bone region showing 
osteoclastic bone resorption regions: (b) NR stained calvaria showing numerous active multinudeated osteoclasts: and (c) NR+silver nitrate counter-stained calvaria showing 
extensive areas with light transparency reflecting substantial bone resorption. Panel 3. calvaria stimulated by PTH to undergo osteoclastic bone resorption in the presence of 
phosvitin: (a) H a E sections of the parietal bone region showing no osteoclastic bone resorption, however, there was substantial amount of new osteoid/bone formation; 
(b) NR stained calvaria showing no active multinudeated osteoclasts (OSC). and (c) NR+silver nitrate counter-stained calvaria showing very little light transparency reflecting 
minimal bone resorption areas (RA). Panel 4. calvaria stimulated by PTH to undergo osteoclastic bone resorption in the presence of Na ascorbate: (a) H a E sections of the 
parietal bone region showing no osteoclastic bone resorption or new bone formation; (b) NR stained calvaria showing no active multinudeated osteoclasts: and (c) NR+silver 
nitrate counter-stained calvaria showing very little light transparency reflecting minimal bone resorption. All magnifications were: H a E 200 *. NR 200 - and silver nitrate 
counter stain 100 x .
T a r tra te  r e s is t a n t  a c id  p h o s p h a t a s e  (TRAP) a c t iv i t y  o f  c a lv a r ia l b o n e  
o r g a n  c u lt u r e s  s t im u la t e d  b y  PTH  in th e absence a n d  p r e s e n c e  o f  
p h o s v i t in
In order to assay for TRAP activity, which is a marker for 
osteoclast numbers and activity, the enzyme was released from 
the cellular layer of the calvaria by treatment with 250 pl/calvar- 
ium lysis buffer, (0.15 M NaCI/30 mM NaHC03, pH 8.0, containing 
0.5% Nonidet P-40), and kept on ice for 1 h with frequent agitation 
followed by centrifugation to remove calvarial bone and debris, 
and cell extracts were used immediately for assay. The TRAP 
enzyme activity was determined by incubation of 50 pi of each 
calvarial cell extract in duplicate with 250 pi of 0.1 M sodium 
acetate buffer, pH 5.0, containing 50 mM tartaric acid. 3 mM ZnCl2 
and 16 mM p-nitrophenylphosphate (pNPP, Sigma Co.) for 30 min 
at 37 C using a 96 well microplate. At the end of the incubation 
time, 10 pi of 2 M NaOH was added to each well and absorbance at 
405 nm was measured. The hydrolysis of the substrate and amount 
of p-nitrophenol (pNP) released was calculated using the extinc­
tion coefficient *-405 nm= 12,500 mol'11 cm' 1 to calculate the con­
centration in mol I'1. This information together with time of 
incubation was used to calculate the rate of substrate hydrolysis 
in terms of pmol I"' min"' and normalized for the protein content
(per mg protein) of the calvarial cell extract. The protein content of 
the cell extracts was determined by a modified method of Lowry's 
micro-protein assay using bicinchoninic acid (Lowry et aL. 1951).
E ffe c t  o f  n a t iv e  p h o s v i t in  in  b o n e  f o r m a t i o n  m o d e l
Effect of phosvitin on osteoblastic bone formation was evalu­
ated using mouse calvarial bone organ cultures stimulated to 
undergo osteoblastic new osteoid and bone formation in the 
absence and presence of ascorbate and native phosvitin. Four 
groups of calvarial bone organ cultures. 6 calvaria per group, for a 
total of 24 calvarium were set up as follows: (a) unstimulated 
controls (negative control): (b) bone formation model by inclusion 
of 1 mM Na ascorbate (positive control, 200pg/ml DMEM-BSA 
media): (c) 150 nM of native phosvitin only (5 pg/ml DMEM-BSA 
media), and (d) 1 mM ascorbate+150 nM native phosvitin. The 
calvaria were cultured on a "grid-system" as described above for 10 
days. The media was changed every 2 days and the used media 
saved for calcium analysis. At the end of the 10 day culture period, 
the 6 calvaria from each group, treated as in (a)-(d). were bisected 
along the sagittal suture. One half of each calvaria was fixed in 10% 
formalin, embedded in paraffin, sectioned and stained with H & E
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for histological observations, and the second half was processed 
for alkaline phosphatase (ALP) activity.
A lk a lin e  p h o s p h a t a s e  (ALP) a c t iv i ty  o f  c a lv a r ia l b o n e  o r g a n  c u ltu r e s  
in  t h e  a b s e n c e  a n d  p r e s e n c e  o f  a s c o r b a t e  a n d  p h o s v i t in
ALP activity, a marker for osteoblast and bone formation, was 
determined by release of the enzyme from the calvarial bone 
cellular layer using the same lysis buffer as for TRAP enzyme 
preparation detailed above. ALP activity was measured by incuba­
tion of 50 pi of cell extract in duplicates with 250 nl of 0.15 M NaCI 
+30 mM NaHCOj. pH 8.0. in the presence of 16 mM p-mtrophe- 
nylphosphate (pNPP. Sigma Co.) for 30 mm at 37 C using a 96 well 
microplate. The absorbance at 405 nm was measured and the rate 
of hydrolysis of the substrate and amount of p-nitrophenol (pNP) 
released was calculated using the extinction coefficient r4os »«= 
12.500 mol' 1 1 cm*' to calculate the concentration in m oll' and 
the rate of hydrolysis using the incubation time in mol I”1 min 
The alkaline phosphatase activity in pmol I' 1 min ' was then 
normalized for the protein concentration as for the TRAP acti­
vity above.
D e te rm in a t i o n  o f  h y d r o x y p r o l in e  a n d  c o l l a g e n  a n a ly s i s  in  th e  
c a lv a r ia l  b o n e  o r g a n  cu ltu r e s
In order to further support the chemical, biochemical and 
histological analysis which demonstrated the synthesis of stable 
collagen, formation of new osteoid and bone we have determined 
collagen and hydroxyproline composition at a quantitative level of 
the cultured calvarial bones. At the end of the culture period each 
group containing 4 calvaria for groups: (i) controls with media 
alone; (ii) media+150 Mg/ml Na ascorbate; and (iii) media+150 nM 
phosvitin, were rinsed in phosphate buffer, vacuum dried and 
hydrolyzed in 0.5 ml of 6 N HC1 at 110 C for 22 h. The hydrolysates 
were then subjected to amino acid analysis and collagen content 
was calculated from the total hydroxylproline and total amino-acid 
content as described previously (Salih et al., 1996b, 2002).
C a lc iu m  a n a ly s is  o f  th e  m e d ia
Media calcium levels were determined by an Arsenazo III 
microplate calcium assay. The assay reagent contained 300 mg/l 
Arsenazo III in a 50 mM sodium acetate buffer pH 4.8 (Yingst and 
Hoffman. 1983). 10 m! from each sample, all time points, were 
assayed in duplicates with the addition of 190 pi of the Arsenazo III 
reagent in a 96 well plate and absorbance measured at 620 nm. 
Calcium contents were calculated from a standard curve from 0 to 
70 nmol [Ca2*|.
H is t o l o g i c a l  a n d  q u a n t i ta t iv e  h i s t o m o r p h o m e t n c  a n a ly s is
Histological sections for the resorption model experiments 
using PTH were obtained from 4 calvaria per treatment group 
with three different regions and two serial sections for each 
region. A total of 20 sections from each of the treatment groups 
were used to obtain representative osteoclastic bone loss. Histo­
logical sections for the bone formation model experiments were 
obtained from 6 calvaria from each of the treatment groups with 
similar sectioning strategy as above A total of 30 sections from 
each group were examined to adequately evaluate the predomi­
nant pattern occurring in each group. Quantitative histomorpho- 
metric analysis for sets of experiments using bone formation 
model were obtained from the above 30 sections. All microscopic 
images were obtained as previously described (Curtin et al., 2009. 
2012).
P r im a r y  o s t e o b la s t s  a s  p r o ly l- h y d r o x y la s e  e n z y m e  s o u r c e  a n d  
h y d r o x y la t io n  o f  s y n th e t i c  c o l l a g e n  p e p t id e  a n a l o g
We have designed and utilized a synthetic collagen peptide 
analog containing 20 amino-acids and consensus sequences with 
multiple potential proline hydroxylation sites. CPPGPSGPPCPS 
GPPGPSGK, (synthesized by Peptide 2 Inc.. Chantilly. VA. USA).
C u ltu r e d  p r im a r y  c a lv a r ia l o s t e o b la s t s  a s  e n z y m e  s o u r c e
The primary 19 day embryonic rat calvarial osteoblasts were 
generated as described previously (Vora et al.. 2010). We have 
cultured the primary osteoblasts in 10 ml of u-MEM supplemented 
with non-essential amino-acids, 10% fetal calf serum and pemcil- 
lin/streptomycin antibiotic in 10 cm culture dishes with initial cell 
density -1 x 106 cells per dish. At confluency (-10 day culture) the 
cells were cultured overnight with u-MEM media containing “no 
fetal calf serum" and the cell layers of four 10 cm culture dishes 
were collected.
(i) T ota l c e l l  ly sa t e  p r e p a r a t io n . The cell layers from two culture 
dishes (total -15x106 cells) were collected using sterile cell 
scraper in the presence of 1 ml lyses buffer. 50 mM NH4HC0,. 
pH 7.8. containing 0.5% Nonidet-P-40, and kept on ice for 1 h. The 
sample was then centrifuged at 10.000 rpm using Eppendorf 
bench top centrifuge to remove cell debris and the supernatant 
was kept as an enzyme source.
(ii) M ic r o s o m a l f r a c t io n  c o n t a in in g  e n d o p la sm i c  r e t i c u lu m  (ER) 
+ C o lg i  p r e p a r a t io n . The cell layers from two culture dishes (total 
-10 x 106 cells) were collected using sterile cell scraper in the 
presence of 1 ml of 50 mM NH4HCO j, pH 7.8, buffer with "no 
Nomdet-P-40. The sample was then centrifuged at 10,000 rpm using 
Eppendorf bench top centrifuge to remove nucleus and cell mem­
brane. The supernatant containing microsomal fractions was then 
subjected high speed centrifugation at lOO.OOOg to collect the ER 
+Golgi fraction. The pellet was then suspended in 200 nl of 50 mM 
NH4HCO* pH 7.8 containing 0.5% Nonidet-P-40 and kept as an ER 
+Colgi enzyme source as described previously. (Salih et al, 1996a). The 
two osteoblast enzyme sources, (i) and (ii), were then used to evaluate 
the prolyl-hydnoxylation of the synthetic collagen peptide analog in 
the absence and presence of ascorbate, phosvitin. Fe'2 and Fe' 1 and 2- 
ketoglutarate. Reaction conditions with total volume of 100 mI 
containing 50 nl of total cell lysate or 20 nl of microsomal fraction 
enzyme source: (a) negative control-1 containing no Fe*2 and Fe*3. 
50 Mg peptide+0.3 mM 2-ketoglutarate+enzyme source (i) or (ii) 
+50 mM NH4HC0,. pH 7.8; (b) negative control-2 containing no 
enzyme source. 50 Mg peptide+0.3 mM 2-ketoglutarate+100 mM 
ferrous chloride (Fe*2}+50mM NH4HCO* pH 7.8; (c) negative con- 
trol-3 with Fe'5. 50Mg peptide+0.3 mM 2-ketoglutarate+100mM 
ferric chloride (Fe' '}+enzyme source (i) or (ii)+50 mM NH4HCO+ 
pH 7.8: (d) positive control with ferrous chloride (Fe*2). 50 Mg peptide 
+0.3 mM 2-ketogluUrate+100 mM ferrous chloride (Fe*2)+enzyme 
source (i) or (ii}+50 mM NH4HCO3. pH 7.8; (e) test reaction with 
ascorbate. 50 Mg peptide+0.3 mM 2-ketoglutarate+100MM feme 
chloride (Fe' J)+enzyme source (i) or (ii)+l mM Na ascorbate+50 
mM NH4HCO5, pH 7.8; (0 test reaction with phosvitia 50 Mg peptide 
+0.3 mM 2-ketoglutarate+100 mM feme chloride (Fe*3)+enzyme 
source (i) or (ii)n—0.4 mM phosvitin+50 mM NH4HCO1. pH 7.8. The 
reactions were allowed to proceed for 1 h at 37 C. followed by 
aliquots of 10 mI from each reaction condition (aHf) subjected to 
LC-MS/MS analysis to define proline hydroxylation and the precise 
site(s) of hydroxylation within the peptide
120
J. Liu et aL ! Developmental Biology 381 (2013) 256-275 261
M a s s  s p e c t r o m e t r i c  a n a ly s is  f o r  th e  p r o ly l- h y d r o x y la t r o n  o f  th e  
s y n th e t i c  c o l l a g e n  p e p t id e  a n a l o g
Nano-flow liquid-chromatography-electrospray-ionization-tadem
mass spectrometnc (UC-ESI-MS/MS) analyses were carried out using 
an ITQ-linear ion trap mass spectrometer (Thermo Electron. San Jose. 
CA). The reaction samples of 10 u! each from (a) to (f) above were 
suspended in 20 pi of 97.4% H20:2.5% CH,CN:0.1% HC02H followed by 
bC-ESI-MS/MS analyses using an on-line auto-sampler (Micro AS, 
Thermo-Finnigan, CA) with auto-injections of 3 pi onto an in-line 
fused silica micro-capillary column. (75 pm * 10 cm), packed in- 
house with C|8 resin (Micron Bio-resource. Inc. Auburn. CA) and 
developed at a flow rate of 250 nl/min. Peptides were separated lay a 
55 min elution comprising of multi-step-linear gradient using solvent 
A. H20/2.5% CH jCN/0.1% HCD2H. and solvent B. CH,CN/0.1% HC02H. 
The gradient steps were from 100% solvent A to 8% solvent B in 5 min, 
to 15% solvent B in 10 min. to 25% solvent R in 10 min, to 50% solvent 
B in 20 min, and to 95% solvent B in 10 mm using a Surveyor MS 
Pump Plus (ThermoFinnigan, CA). The eluted peptides were directly 
nano-electrosprayed and the MS/MS data were generated using data- 
dependent acquisition with a MS survey scan range between 390 and 
2000 m/z. This data-dependent acquisition begins with the 1C separa­
tion which generates a total ion chromatogram in a survey scan 
followed by selection of specific ions for collision induced dissociation 
(C1D. MS/MS) in descending order of signal intensity. Each survey scan 
(MS) was followed by sequential selection of five peptides for C1D. at 
35% normalized collision energy, with dynamic exclusion parameters, 
repeat count 1. repeat duration 30 s and exclusion duration 20 s. This 
process was continuously alternated between MS scan and five 
tandem MS throughout the nano-LC chromatography.
M S/M S d a t a  s e a r c h  f o r  Id e n t if i c a t io n  o f  p r o ly l- h y d r o x y la t io n  a n d  
l o c a t i o n  o f  th e  h y d r o x y la t e d  p r o l in e  r e s id u e  w it h in  th e  s y n th e t ic  
c o l l a g e n  p e p t id e  a n a l o g
Since our designed synthetic collagen peptide has unique sequence 
with repeats of GPP. PPG. GPS. and PSG we have generated a custom 
database containing multiple unrelated proteins and inserted the 
synthetic peptide sequence, GPPGPSCPPCPSCPPCPSGK. into that 
database. This permitted rapid search of the MS/MS data generated 
from the analysis of above reaction aliquots by usual Bioworks 3.3.1 
software and SEQUEST search engine (Eng et al„  1994). The OTA files 
were generated with the following settings: precursor-ion tolerance of 
1.5 amu. fragment ion tolerance of 1.0 amu, and automated calculated 
charged states +1. +2. and +3. The searches were performed with 
parameters: half trypsin since we have only one trypsin recognized 
residue within the peptide, and + 16 Da (mass addition) modifications 
of proline residues which are expected to occur if proline hydroxyla- 
tion occurred. We have also specified up to 5 potential hydroxylations 
on the peptide because there are multiple potential proline residues 
within the peptide that may possibly become hydroxylated.
The database search results were filtered using the criteria: 
ACnsO.l; probabilitysO.l; for and XCorral.8. 2.2. 3.75 for Z= +1. +2. 
and +3. In addition to the search parameters and criteria used, the 
identified peptide sequences assessed manually by examining 
each of the identified peptide MS/MS spectra for the quality and 
the confidence through the y and b ion fragment series. In such 
evaluation the number of y and b ion fragments, their consecutive 
occurrence in a series and representation of "high-intensity" ion- 
fragments were used as bases for acceptance.
B iom in e r a liz a t io n  o f  c u l t u r e d  p r im a r y  o s t e o b l a s t s  in  th e  a b s e n c e  a n d  
p r e s e n c e  o f  a s c o r b a t e  a n d  p h o s v it in
The primary rat osteoblasts were cultured in six well (3.5 cm 
each well) culture plates until confluent as described above. One 
culture plate (six wells, 2 x 106 cells/well) of confluent osteoblasts
was used for each of the following treatments: (a) media alone; 
(b) media+lOmM p-glycerolphosphate. (c) media+10 mM (5-gly- 
cerophosphate-i-20 ug/ml (100 nM) Na ascorbate; and i d) media 
+ 10 mM ft-glycerophosphate+20 jig/ml (0.7 nM) phosvitin. These 
cultures were incubated for 5 days followed by (i) triplicate wells 
of each treatment were used for fixing with 10% formalin over­
night followed by exposure to 2% silver nitrate for 30-60 min to 
visualize Ca-P deposition microscopically, and (ii) triplicate wells 
of each treatment were processed for quantitative calcium analysis 
to determine extent of mineral deposition in the cell layer. For 
quantitative calcium analysis in (ii) the media was removed and 
the cell layer was collected in the presence of 0.5 ml of 50 mM 
NH4HC0, using sterile cell scraper and placed in Eppendorf tubes 
and left on ice for 1 h for cells to burst in this “hypotonic- buffer. 
The insoluble cell debris, nucleus and the mineralized ECM was 
then collected by bench top centrifugation at 10.000 rpm. The 
pellet containing the ECM and insoluble cellular components was 
then suspended in 0.5 ml of 0.1 M HCI and left at 4 C overnight for 
dissolution of the Ca-P mineral. The HCI extracts were then 
partially neutralized by addition of sub-molar equivalent of 1.0 M 
NaOH (40 pi. keeping still the pH < 4) and centrifuged as above to 
pellet the insoluble ECM and cellular components. 10 pi of super­
natant from each triplicate sample treatments (aHd) were assayed 
for calcium levels in duplicates as described above using Arsenazo III 
reagent calcium assay. The media calcium levels of these mineraliz­
ing primary osteoblasts treated as in (aHd) above was also 
determined in order to correlate with calcium deposition levels.
S y n th e s is  o f  h y d r o x y p r o l in e  c o n t a in in g  c o l l a g e n s  a n d  c r i t ic a l p r o t e in s  
in v o lv e d  in  o s t e o b la s t  d if f e r e n t ia t io n  b y  c u l t u r e d  o s t e o b la s t s  in  th e  
a b s e n c e  a n d  p r e s e n c e  o f  / l- g ly c e r o lp h o s p h a t e .  a s c o r b a t e  a n d  
p h o s v i t in
The insoluble ECM and cellular components (the pellet after HCI 
extraction of the mineralized cell layers above) was re-suspended in 
0.1 ml of 50 mM NH4HCO+ pH 7.8, and 10 pi of the HCI soluble extract 
(partially neutralized) was included in this suspension and subjected 
ro trypsin (5 pg) digestion overnight at 37 C. 10 pi of such trypsin 
digested samples derived from each of the culture conditions (aHd) 
above were suspended in 20 pi of 97.4% H20:2.5% CH-jCN:0.1% HCC)2H 
followed by LC-ESI-MS/MS analyses using an on-line auto-sampler 
(Micro AS. Thermo-Finnigan. CA) with auto-injections of 3 pi onto an 
in-line fused silica micro-capillary column. (75 pm x 10 cm) as 
detailed above. The MS/MS data generated from the analysis of 
aliquots from the above samples were searched against the rat- 
specific database, Umprot (Universal Protein Resources, Version 9.0). 
which combines the data from Swiss-Prot (version 51) TreMBL 
(Version 34) and PIR using the Bioworks 33.1 software and SEQUEST 
search engine (Eng et al„  1994). The data were searched with specified 
dynamic modification of 16 Da mass additions for hydroxylation of the 
proline residues and the results documented as described above.
S ta t is t ic s
Data are presented as means - SD The paired Students t-test 
was used to compare groups. The differences between groups 
were considered statistically significant for p < 0.05. It should be 
noted that although there are multiple treatment sets the impor­
tant comparisons are between PTH treatment versus control 
(media alone) showing PTH induced bone resorption, or PTH 
treatment versus ascorbate or phosvitin to indicate effects of these 
added factors on PTH-induced bone resorption. Similarly in the 
bone formation model the comparison needed is negative controls 
versus ascorbate or phosvitin treatment, or positive control 
(+ascorbate) versus +phosvitin. Such analysis require paired 
Students r-test and not an Anova type analysis.
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Results
H is t o l o g i c a l  o b s e r v a t i o n s  o f  th e  e f f e c t  o f  n a t iv e  p h o s v i t in  on  
o s t e o c l a s t  f o r m a t i o n  a n d  b o n e  r e s o r p t i o n  in d u c e d  b y  PTH  
in  l iv e  m o u s e  c a lv a r ia l b o n e  r e s o r p t i o n  m o d e l
The histological observations of H & E stained sections of 
calvarial bones cultured with PTH in the absence and presence 
of native phosvitin are represented in Fig. 1. There was significant 
osteoclastic activity and bone resorption readily observable for 
those groups treated with PTH only, but not for the untreated 
control and PTH+native phosvitin groups. Panel la in Fig. 1 shows 
H & E histological section for unstimulated control calvaria with no 
noticeable osteoclastic bone resorbtion. Panel 2a in Fig. 1 shows a 
histological section of calvarial bone with PTH showing numerous 
multinudeated osteoclasts and bone resorption. Panel 3a in Fig. 1 
shows histological section of calvarial bones treated with PTH 
-t-native phosvitin with minimal osteoclastic bone resorption 
coupled with formation of substantial new osteoid and bone. This 
is an unexpected event in our resorption model system, as the 
culture media was devoid of ascorbate. Interestingly, our observa­
tions for the PTH+native phosvitin group are somewhat similar to 
calvaria treated with PTH+ascorbate (Fig. 1; Panel 4a). suggesting 
that phosvitin has the capacity to mimic functions closely related 
to ascorbic acid. It is worth noting that at the end of the 
experimental period there are obvious variations in the thickness 
of the periosteum and the overall bone in the histological sections 
in Panels la-4a in Fig. 1. This is due to culture starting conditions 
and treatments where the original starting calvarial bone thick­
ness would be as shown in Panel la in Fig. 1 and in this control 
experiment there is no significant change in the periosteum or the 
bone over the culture period. However, when the calvaria were 
cultured in the presence of different stimulatory factors such as 
PTH, ascorbate and phosvitin (Fig. 1; Panels 2a. 3a, and 4a) 
proliferation and differentiation of mesenchymal/stem cells com­
bined with formation of new osteoid/bone leads to much thicker 
bone (old bone+new bone) and periosteum cellular layer.
G lo b a l  v is u a l iz a t io n  o f  o s t e o c l a s t  f o r m a t i o n  b y  n e u tr a l r e d  in  c u ltu r e s  
s t im u la t e d  w ith  PTH in th e  a b s e n c e  a n d  p r e s e n c e  o f  n a t iv e  p h o s v it in  
a n d  o r  a s c o r b a t e
In the present work to gain further insights into the biologic 
events, we have globally visualized the osteoclasts by NR and 
resorption activities with silver nitrate Panels 1 b, 2b. 3b. and 4b in 
Fig. I show NR staining of control calvaria, PTH treated only. PTH 
+native phosvitin treated and PTH+ascorbate treated, respectively. 
Such a global visualization approach showed an absence of 
observable osteoclasts in the control (untreated) calvaria (Fig. I; 
Panel lb). In contrast, cultures treated with PTH alone showed 
numerous and distinct NR stained multinudeated osteoclasts 
(Fig. 1: Panel 2b). Importantly, the calvaria treated with both 
PTH+native phosvitin and those treated with PTH+ascorbate 
showed no evidence of mature multinudeated osteoclasts 
(Fig. 1: Panels 3b and 4b). In order to further examine these 
observations, and reveal global osteoclastic resorption activities, or 
lack thereof, we have counterstained the NR stained calvaria with 
silver nitrate. The negative controls showed no resorption areas 
(Fig. 1: Panel lc). whereas calvaria treated with PTH alone showed 
substantial loss of bone with large resorption areas becoming 
transparent to light (Fig. I; Panel 2c). Those calvaria cultured in the 
presence of PTH+native phosvitin and/or PTH+ascorbate showed 
minimal or no osteoclastic bone resorption and light transparency 
(Fig. 1; Panels 3c and 4c). respectively. These data were consistent 
with the observations from histological sections and NR staining.
Madia pin eTH PhowKin ASC
PTH *
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Phosvitin
Fig. 2. Quantitative calcium release analysis for bone loss and TRAP enzyme 
activity for osteoclast quantification in calvarial bone resorption model. 
(A) Quantitative calcium analysis of media from calvarial cultures: controls (media 
alone). PTH treated only. FTH+phosvttin treated. PTH+Na ascorbate treated, 
phosvitin alone and ascorbate alone. The release of calcium into the media in the 
presence of PTH was substantial compared to the controls. This calcium release was 
significantly reduced (-60%) in the presence of PTH+phosvitin. and even more so in 
calvaria cultured in the presence of PTH+ascorbate. In the latter case there was 
calcium uptake which was also observed with bone cultures treated with phosvitin 
alone and ascorbate alone. The two sample Student's r test indicated that these 
differences in calcium release/bone resorption in response to different treatments 
were statistically significant with p values noted within the figure. (B) Quantitative 
TRAP enzyme activity analysis as a measure of osteoclast numbers in calvaria 
cultured under different conditions as indicated above in (A). The results are 
consistent with the observed calcium levels in the media and the data in Fig. 1. The 
two sample Student's f test indicated that the difference in TRAP activity tn 
response to PTH. PTH+phosvitm. and PTH+Na ascorbate were different and 
statistically significant with p values as noted within the figure
Quantitative a n a ly s is  o f  th e  c h a n g e s  in  m e d ia  c a l c iu m  a n d  TRAP 
a c t iv i t y  in r e s p o n s e  t o  p a r a th y r o id  h o r m o n e  (PTH) in  t h e  a b s e n c e  a n d  
p r e s e n c e  o f  p h o s v i t in  a n d  a s c o r b a t e  in mouse c a lv a r ia l b o n e  o r g a n  
c u lt u r e s
The total change in media calcium was determined over the 10 
day culture period for groups (a) unstimulated controls, 
(b) stimulated by 10 nM PTH to undergo resorption, (c) 10 nM 
PTH+150nM native phosvitin, and (d) 10 nM PTH+1 mM Na 
ascorbate. Fig. 2A shows total cumulative changes in media 
calcium for the groups (aHd) over a 10 day culture period 
Unstimulated controls showed minimal calcium release whereas 
those treated with PTH only showed substantial release of calcium. 
However, this release of calcium was significantly inhibited in the 
presence of 150 nM phosvitin by 2.5 fold (-60%) and this was
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Fjjj 3 Global * osteoclastic bone resorption determined by histomorphometric analyses of the silver stained whole calvarial bones. (A) E«"iples of ^
" e a tm e n ™  s t S  with NR and counter stained with silver n.trate where the d.gital,mages (at 2 * magnification) were transformed to black - d  wh. e ^ages and 
different shades of these depending on the degree of resorption. The arrows show either black or dark gray areas where there were no resorprion. or wh«e,and litfitM  
a™s w h e™ p t io n  occu^ed. t L  digital densities of the white and light gray areas were used to calculate * resorption areas. Panel
PTH alone Panel 3 PTH+phosvit.n and Panel 4 PTHa-ascorbate. (B) The calculated * bone resorption areas relative to PTH-mduced bone resorption show clear and 
substantial reduction in bone resorption as a result of inclusion of either phosvitin or ascorbate in the PTH-treated cultures.-® )* and -90%, respectively. The tv™ «mp 
Student's r test indicated that these differences in bone resorption in response to different treatments were statistically significant with p values noted within the figure.
statistically significant p <  0.001. A simultaneous inclusion of PTH 
with 1 mM Na ascorbate led to complete inhibition of calcium 
release with additional calcium uptake from the media despite the 
presence of PTH. This latter case is similar to what would be 
observed in our bone formation model in the presence of ascor­
bate and absence of PTH. The quantitative TRAP enzyme activity, a 
marker for osteoclasts, was consistent with the above results 
(Fig. 2B). The TRAP activity measurements clearly supported the 
calcium change measurements, where both phosvitin and ascor­
bate impact significantly PTH-induced osteoclast differentiation 
and bone resorption. The results for both calcium and TRAP 
activity were analyzed by two tailed paired Students f-test to 
show statistical significance (p values are recorded in the legend of 
Fig. 2A and B). Overall, histological, NR. and silver nitrate observa­
tions were consistent with the quantitative analysis for calcium 
and TRAP activity.
Quantitative h is t o m o r p h om e t r i c  analysis o f  c a lv a r ia l b o n e s  in th e  
r e s o r p t i o n  m o d e l  s y s t e m  in  th e  a b s e n c e  a n d  p r e s e n c e  o f  PTH, 
p h o s v i t in  a n d  a s c o r b a t e
We have utilized the silver nitrate stained calvaria at 2* 
magnification to determine the quantitative global bone resorp­
tion areas. Fig. 3A shows examples of the approaches used for 
global quantitation of the resorption areas whereby NR and 
counter stained calvarial digital images were transformed to "black 
and white' images with shades of gray in between directly 
proportional to the degree of light transparency and extent of 
bone loss. For example areas with complete resorption through
the whole thickness of the calvaria are completely white, those 
areas where there was no resorption were black or dark gray, and 
those areas that have undergone significant resorption without 
penetrating through the whole calvarial thickness were light gray. 
Fig. 3B shows quantitative histomorphometric analysis where the 
results are expressed as % bone resorption with total unit resorp­
tion area for samples treated with PTH alone fixed as 100% and the 
results for the other sets calculated relative to this. The data clearly 
demonstrated that phosvitin inhibits the PTH-induced osteoclastic 
bone resorption, and has the capacity to enable new osteoid and 
bone formation in the absence of ascorbate.
In order to distinguish a specific phosvitin function from just a 
role for organic phosphate or phosphate group, a parallel set of 
experiments using PTH and phosphoamino-acids at concentra­
tions -equivalent to those present in phosvitin were carried out. 
Fig. 4A shows quantitative calcium release and TRAP activity 
measurements for these experiments with no significant effect 
that was statistically relevant to PTH-induced calcium release by 
any of the added phospho-amino acids. TRAP activity measure­
ments however, showed a small decrease in the presence of P-Ser 
and P-Thr (Fig. 4B).
O s t e o b la s t s  a n d  b o n e  f o r m a t i o n  in  th e  a b s e n c e  a n d  p r e s e n c e  o f  
a s c o r b a t e  a n d  n a t iv e  p h o s v i t in  o b s e r v e d  h is t o l o g i c a l ly  in  c a lv a r ia l 
b o n e  o r g a n  c u lt u r e  f o r m a t i o n  m o d e l
The histological observations of H & E stained sections of 
calvarial bones cultured over a 10 day period for groups 
(a) unstimulated controls, (b) stimulated by 1 mM ascorbate to
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alone
Fig- 4. Quantitative calcium release analysis for bone loss and TRAP enzyme 
activity for osteoclast quantification in the presence of phospho-amino-acids using 
bone resorption model. (A) Quantitative calcium analysis of media from calvarial 
cultures: controls. PTH treated only: PTH+P Ser treated: PTH+PThr and PTH+P-Tyr 
treated. The release of calcium into the media in the presence of FTH was 
substantial compared to the control media alone. In the presence of PTH+phos- 
pho-amino acids there was no significant difference statistically from the PTH alone 
in calcium release. (8) Quantitative TRAP enzyme activity analysis as a measure of 
osteoclast numbers and activity in calvaria cultured under different conditions as 
indicated above in (A).
undergo bone formation, and (c) 1 mM ascorbate+150 nM native 
phosvitin are shown in Fig. 5. Fig. 5a shows unstimulated control 
cultures where there was no clear new osteoblast differentiation 
or new osteoid formation. In the presence of ascorbate, new bone 
formation was clearly observable with significant osteoblastic 
activity as evidenced by large amounts of new osteoid formation 
(Fig. 5b). This was also obvious from the large difference in the 
actual overall bone thickness when comparing Fig. 5a and b. In the 
presence of phosvitin, the relative increase in osteoblast numbers/ 
activity and degree of new osteoid formation were more easily 
detected (Fig. 5c). In the presence of phosvitin, there was a 
remarkable degree of osteoblast differentiation to the extent that 
it can be observed that (i) many osteoblasts just being surrounded 
by their new osteoid (ECM), and (ii) clusters of differentiated 
osteoblasts along the whole bone surface (Fig. 5d). In the presence 
of combined ascorbate+phosvitin such occurences were even 
more enhanced (Fig. 5e and f). These data were supported by 
the significant levels of ALP activity, see below.
Q u a n t i t a t iv e  c a l c iu m  u p ta k e  a n d  a lk a l in e  p h o s p h a t a s e  a d t iv i t y  in th e  
a b s e n c e  a n d  p r e s e n c e  o f  a s c o r b a t e  a n d  p h o s v i t in  in c a lv a r ia l b o n e  
o r g a n  c u lt u r e  f o r m a t i o n  m o d e l
The cumulative change in media calcium was determined over 
a 10 day culture period for groups (a) unstimulated controls, 
(b) 1 mM ascorbate, (c) 150 nM phosvitin+1 mM ascorbate, and 
(d) 150 nM native phosvitin. Fig. 6A shows total change in media 
calcium for the groups (aHd). These data were expressed as nmol 
calcium per ml media and normalized per mg dry weight of 
calvarial bones. Unstimulated controls, group (a), showed minimal 
calcium uptake whereas those treated with ascorbate, group (b), 
showed substantial uptake of calcium indicating enhanced osteo­
blastic activity and new bone formation. Similarly, cultures treated 
with a combination of ascorbate+phosvitin. group (c). showed 
calcium uptake similar to that of ascorbate alone. Those calvaria 
cultured in the presence of phosvitin alone, group (d). showed 
significant uptake of calcium. 10-fold above that of media alone, 
but this was much lower than calvaria cultured in the presence of 
ascorbate or ascorbate+phosvitin. This is clearly seen in the 
histological sections where the new osteoid stained very “light 
pink" reflective of young osteoid/bone ECM (Fig. 5c). The ALP 
activity was consistent with the histological observations whereby 
cultures treated as in (bHd) showed significantly higher ALP 
activity compared to the control media alone (Fig. 6B).
Q u a n t i t a t iv e  h is t o m o r p h om e t r i c  a n a ly s is  o f  c a lv a r ia l b o n e s  in th e  
f o r m a t io n  m o d e l  s y s t e m  in  th e  a b s e n c e  a n d  p r e s e n c e  o f  p h o s v i t in  a n d  
a s c o r b a t e
Quantitative histomorphometric analysis of H & E sections for 
calvaria treated as in (aHd) above as well as those with PTH+ASC 
and PTH+phosvitin showed clearly the significant new osteoid/ 
bone formation (Fig. 7). Fig. 7A shows examples of how measure­
ments of new osteoid/bone formation were carried out for 
quantitative analysis. For this purpose the areas between the 
•dotted l in e s" which show the new light pink osteoid/bone and 
early stages of the differentiated osteoblasts surrounded by their 
synthesized ECM were used. The old/original bone at the start of 
the experiment can be very easily distinguished by its much 
darker color characteristics. The measured areas of the total new 
osteoid/bone formed for calvaria cultured in the presence ot 
ascorbate only was set to be 100% and all of the other experi­
mental groups with different treatments were calculated relative 
to this (Fig. 7B).
S ta b le  c o l l a g e n  sy n th e s is , new o s t e o i d  a n d  b o n e  f o r m a t i o n  in  th e 
p r e s e n c e  o f  phosvitin
Analysis of hydroxylproline and total amino-actd content were 
used to calculate the % collagen content of the total protein present 
within the calvarial bone culture groups (i) media alone, (ii) media 
+ascorbate. and (iii) media+phosvitin. The results indicated that 
the total organic matrix in calvaria cultured in the presence of 
ascorbate, group (ii). or phosvitin. group (iii), were 2-3 * higher 
than those of the controls, media alone group (i). The total 
hydroxyproline content of the groups with ascorbate or phosvitin 
were also 2-3 x higher providing a calculated % collagen content 
of total proteins to be 53 ± 6%. 57 + 4%. 58 ± 5% for groups in (i). 
(ii), and (iii), respectively, consistent with the observations using 
the above multiple chemical, biochemical and histological analysis. 
These data clearly demonstrated that in the presence of ascorbate 
and or phosvitin the newly synthesized ECM is typical bone matrix 
with appropriate hydroxyproline containing stable collagen synth­
esis forming the new osteoid and bone.
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Media alone Ascorbate alone
Phosvitin alone
Ascorbate + Phosvitin
Fig. 5. Bone formation model using mouse calvarial bone organ cultures in the absence and presence of phosvitin and Na ascorbate, (a] H & E sections of the parietal bone 
region of calvaria cultured in media alone with no osteoblastic new formation, (b) H & F. sections of the parietal bone region of calvaria cultured in the presence of Na 
ascorbate showing new osteoblastic bone formation, (c) H a E sections of the parietal bone region of calvaria cultured in the presence of phosvitin alone showing significant 
amounts of new osteoid and differentiated osteoblasts, (d) Higher magnification of the H a E section in (c). (el H a E sections of the parietal bone region of calvana cultured 
in the presence of Na ascorbate+phosvitin showing significant amounts of new osteoid and differentiated osteoblasts. (f) Higher magnification of the H a E section in (e). The 
new bone formation in (b). (c) and (d) as compared to the control (a) is clearly visible from the thickness of the overall bone and the new light pink osteoid surrounding the 
differentiated osteoblasts. All the magnifications were at 200 x except those higher magnifications; 400 *, for (d) and (e).
P r im a r y  o s t e o b l a s t s  a s  p r o ly l- h y d r o x y la s e  e n z y m e  s o u r c e  a n d  
h y d r o x y la t io n  o f  s y n th e t ic  c o l la g e n  p e p t id e  a n a l o g  in th e  a b s e n c e  a n d  
p r e s e n c e  o f  a s c o r b a t e  a n d  p h o s v i t in
We have utilized a designed synthetic collagen peptide analog 
containing multiple consensus recognition sequences for 3- and 
4-prolyl hydroxylases for proline hydroxylation and two prolyl- 
hydroxylase enzyme sources were used for test tube hydroxylation 
experiments. Both of the osteoblast enzyme sources were used in
test tube reaction conditions involving negative controls, positive 
control and test reactions in the presence of Fe'3 and ascorbate or 
phosvitin. The two osteoblast enzyme sources, total lysate and 
microsomal enriched fractions, provided essentially the same 
results. The complexity of the total lysate was overcome by use 
of only a small amount of the reaction sample for MS/MS analysis 
by design of appropriate concentrations of reaction mixture 
components for clear and easy identification of the synthetic 
peptide during MS analysis. The MS/MS data search provided
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Fig. 6. Quantitative calcium uptake analysis for new bone formation and ALP 
enzyme activity for osteoblast quantification in calvarial bone formation model. 
(A) Quantitative calcium analysis of media from calvarial cultures: controls; 
phosvitin treated only: phosvitin-*-ascorbate treated; and Na ascorbate treated 
only. The uptake of calcium from the media in the presence of ascorbate and 
ascorbate+phosvitin was significant and much higher than that of cultures in the 
presence of phosvitin. However, the calcium uptake in the presence of phosvitin 
was -10 * higher than those of controls with media alone The two sample 
Student s t test indicated that these differences in calcium uptake/bone formation 
in response to different treatments were statistically significant with p values noted 
within the figure. (B) Quantitative ALP enzyme activity analysis as a measure of 
osteoblast numbers in calvaria cultured under different conditions as indicated 
above in (A). The results are consistent with the observed calcium uptake levels in 
(A) above and the histological data in Fig. 5 The two sample Students t test 
indicated that the difference in ALP enzyme activity in response to different 
treatments were statistically significant with p values noted within the figure.
identification of the original peptide sequence. GPPCPSGPPGP- 
SGPPGPSGK (expected mass of 1680 Da), with no evidence for 
hydroxylated proline residues in any of the negative control 
reactions. Fig. 8A shows an example of MS/MS fragmentation 
sequence data that led to the identification of the unmodified 
original peptide in the negative controls. The positive control 
reactions in the presence of Fe"2 provided identification of multi­
ple hydroxylated forms of the peptide. GPPGPSGPP'GP'SGPPG 
PSGK (1712 Da. 2 x P-OH). GPPCPSGP*PGP*SGPPGPSGK (1712 Da. 
2 x P-OH). GPPGPSGPPGPSGP'PGPSGK (1696 Da. 1 x P-OH). and 
CPPGPSGPP*CPSGPPGPSGK (1696 Da. I x P-OH). The asterisks (*) 
denotes the location of the hydroxyproline with 16 Da mass 
addition for each hydroxyl group and this applies to all of the 
peptides identified below too. Fig. 8B shows an example of MS/MS 
spectra that led to the identification of the hydroxylated peptides 
in the positive control with Fe*2. The test reactions in the presence 
of Fe’’ and ascorbate provided identification of multiple hydro­
xylated forms of the peptide. GPPGPSGPPGP*SGPPCPSGK (1696 
Da. 1 x P-OH). GPPGPSGP*PCrSGPPGPSGK (1712 Da, 2 x P-OH) 
GPPGPSGPPGPSGPP*GP"SGK (1712 Da. 2 x P-OH). and GPPGP'SGP
P’GPSGP"PGPSGK (1728 Da, 3x P-OH). An example of MS/MS 
fragmentation sequence data that led to the identification of the 
hydroxylated peptides in the test reaction with Fe‘1 and ascorbate 
is depicted in Fig. 8C. The test reactions in the presence of Fe’’ and 
phosvitin provided identification of multiple hydroxylated forms 
of the peptide, GPPGPSGPPCP*SGP*PCPSGK (1712 Da. 2 * P-OH). 
GPPGP’SGPPGP'SGP'PGPSGK (1728 Da. 3x P-OH) GPPGPSGPPG 
PSCP'P'GPSGK (1712 Da. 2 x P-OH). and GPPGPSGPPCP'SGPPGP 
SGK (1696 Da. 1 x P-OH). An example of MS/MS fragmentation 
sequence data that led to the identification of the modified 
hydroxylated peptides in the test reaction with Fe"3 and phosvitin 
is given in Fig. 8D.
B iom in e ra li z a t io n  o f  c u lt u r e d  p r im a r y  o s t e o b la s t s  in  th e  a b s e n c e  a n d  
p r e s e n c e  o f  a s c o r b a t e  a n d  p h o s v i t in
To provide additional evidence for the involvement of phosvitin 
in the synthesis of collagen and biomineralization we have 
cultured primary calvarial osteoblast in the absence and presence 
of p-glycerolphosphate. ascorbate and phosvitin. Fig. 9A shows 
mineral deposition microscopically observed after cell layer of 
osteoblast cultures were exposed to 2% silver nitrate with essen­
tially no Ca-P deposition in the cultures with media alone and p- 
glycerolphosphate. while presence of ascorbate or phosvitin led to 
substantial mineral deposition. Quantitative Ca analysis of such 
cell layers and the culture media provided results consistent with 
these observations. The control cultures showed minimal Ca"2 
levels in the cell layers, whereas those with ascorbate or phosvitin 
showed substantial Ca"2 levels. 4-5-fold, as compared to the 
controls (Fig. 9B). These results were consistent with the Ca 
analysis of the used media of such cultures showing clear 
corresponding Ca uptake from the media (Fig. 9C). Overall, the 
data obtained from osteoblast cultures were consistent with and 
supported those of the calvarial bone organ culture studies.
Synthesis o f  h y d r o x y p r o l in e  c o n ta in in g  c o l l a g e n s  a n d  c r i t ic a l p r o te in s  
b y  c u ltu r e d  o s t e o b la s t s in the a b s e n c e  a n d  p r e s e n c e  o f  
p - g ly c e r o lp h o s p h a t e ,  a s c o r b a t e  a n d  p h o s v i t in
Importantly, the mineralization experiments with osteoblasts 
above also provided a third and ultimate opportunity to define 
under cell culture conditions synthesis of collagens, proline 
hydroxylation, and early critical proteins in the absence and 
presence of ascorbate and phosvitin by MS technology Inset of 
Fig. 10 shows pictorial representation of the insoluble cell layer 
white pellets of the cultured osteoblasts after acid extraction and 
bench top centrifugation with clear visible white pellets showing 
the major quantitative ECM differences between the controls 
versus those in the presence of ascorbate or phosvitin. The media 
alone and p-glycerolphosphate showed similar and very small size 
insoluble ECM, whereas ascorbate and phosvitin treated cultures 
generated substantially larger insoluble ECM. The ECM and inso­
luble components of the cell layers were subjected to trypsin 
digestion followed by IC-ES1-MS/MS analysis. This was performed 
on small enough aliquots to minimize complexity and highlight 
specifically the most abundant ECM and acid soluble components. 
The LC-ESI-MS total base-peak ion abundance profiles were 
consistent and correlated with the white pellet sizes, whereby 
for controls media alone and p-glycerolphosphate the total ion 
intensities were -5 x lower than those of the corresponding 
ascorbate and phosvitin. The MS/MS sequence data were searched 
against the rat database and the results are summarized in Table 1 
with major and significant results confirming/augmenting the 
bone organ culture, synthetic collagen peptide and mineralizing 
osteoblast culture studies. Four distinct collagen chains were 
clearly identified with collagen type I as the major component
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and these were present in both ascorbate and phosvitin treated 
cultures but were absent in the controls. As expected ascorbate 
treated cultures led to identification of collagen type 1 alpha 2 
(17 distinct peptides with multiple hydroxyproline sites in each 
peptide), collagen type I alpha 1 (3 distinct peptides with multiple 
hydroxyproline sites in each peptide), collagen type III alpha 1 
(7 distinct peptides with multiple hydroxyproline sites in each 
pept.de) and collagen type XII alpha 1 (3 distinct peptides with no 
hydroxyproline sites). Similarly, in samples derived from phosvitin 
treated cultures collagen type I alpha 2 (11 distinct peptides with 
multiple hydroxyproline sites in each peptide), collagen type 
alpha t (5 distinct peptides with multiple hydroxyproline sites in 
each peptide), collagen type III alpha 1 (2 distinct peptides with 
multiple hydroxyproline sites in each peptide) were clearly iden­
tified Another interesting major protein that was identified only 
in ascorbate and phosvitin treated cultures was vimentin which 
was not present in the controls. While collagens and fibronectin 
are well known ECM components, vimentin has been defined as 
intracellular/cell surface bound 'intermediate filament protein 
and our identification of this protein was possibly due to cells 
being lysed and insoluble components together with the ECM was 
pelleted together. The significance of identifying this important 
protein in only ascorbate and phosvitin treated samples is the fact 
that it is a marker for “epithelial to mesenchymal transition One 
common protein identified in all of the samples derived from the
cultured osteoblasts was fibronectin. which is important for 
osteoblast differentiation and is a survival factor for the differ­
entiated osteoblasts. While semi-quantitative, from the repeat 
counts and the number of distinct peptides identified there are 
clear different levels of this protein in the four differently treated 
samples. The highest level was observed in phosvitin and ascor­
bate treated samples, 17 distinct peptides and 11 respectively 
whereas only 4-5 peptides were identified for the samples derived 
from media alone and p-glycerolphosphate treated samples. It is 
noteworthy that identification of the proteins and the peptides 
were through the same search conditions (+16 Da modifications 
for hydroxylation of P residues) and defined within the same 
search result list for each of the different treatment samples. 
Importantly, while fibronectin contains multiple proline residues 
none of the peptides of this protein were defined to contain 
hydroxylated proline residue. For example in phosvitin treated 
cultures there were 17 peptides of fibronectin identified with total 
of 18 proline residues but no hydroxyprolines were defined 
whereas collagen type 1 alpha 2 in this same sample and search 
identified 11 distinct peptides of this protein with total of 44 
proline residues and 21 of these were identified as hydroxypro­
lines Fig. 11 shows an example of the MS/MS fragmentation 
sequence data with y and b ion fragments for one of the collagen 
type I alpha 2 peptide with three hydroxyproline sites found in 
ascorbate and phosvitin treated osteoblast cultures. The precise
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Fig. 8. LC-ESI-MS/MS sequence analyses of synthetic collagen peptide analog incubated with prolyl-hydroxylase source in the absence and presence of Fe"3. Fe'ascorbate 
and phosvitin. MS/MS spectrum of the synthetic peptide incubated under different reaction conditions. (A) A negative control conditions containing no ft-' - and Fe**, 50 ng 
peptide-*-0.3 mM 2-ketoglutarate+enzyme sources50 mM NH4HCO,. pH 7.8. the senes of y and b fragment ions provide the full peptide sequence CPPGPSCPPGPSGPPGPSCK 
containing no hydroxyproline residue. (B) A positive control conditions containing ferrous chloride (Fe*'3), 50 pg peptidesO.3 mM 2-ketoglutarates 100 i*M ferrous chloride 
(Fe*3i*-enzyme source*-50 mM NH.HCO,. pH 7 8. the senes of y and b fragment ions reflect the full peptide sequence CPPCPSGPPCPSCP'PCPSCK with a single 
hydroxyproline residue. (C) A test reaction with ascorbate. 50 pg peptide*-0.3 mM 2-kefogIutaratesl00 pM ferric chloride Fe'! -enzyme source -! mM Na ascorbate 
s50 mM NHpHCOs. pH 7.8, the series of y and b fragment ions reflect the full peptide sequence CPPCPSCPPCPSCPP'GPSGK with a single hydroxyproline residue. (D) A test 
reaction with phosvitin. 50 pg peptidet-OJ mM 2-ketoglutarate+100 pM ferric chloride (Fe* !)-*-enzyme source+-0 4 pM phosvitin*-50 mM NH*HCO,. pH 7.8. the series of y 
and b fragment ions reflect the full peptide sequence GPPCPSGPPCP*SCPPGPSCK with a single hydroxyproline residue indicated by a loss of mass equivalent to P*16Da 
(-113 Da) between y* and y!0 fragment ions, red arrow. In all cases the precise sites of hydroxyproline are denoted by an asterisk (*).
proline sites of hydroxylation were defined by the specific y and b 
ion fragments with 16 Da mass additions on proline residues 
indicated by the red arrows in Fig. 11.
Discussion
Ascorbic acid (vitamin C) is one of the natures vital biomole- 
cules serving an essential role in a number of important physio­
logical reactions such as collagen synthesis, iron metabolism and 
immunity (Padh. 1990). As detailed in the introduction it is 
surprising therefore, that many species have lost the capacity to 
synthesize ascorbate. This defect has been estimated to have taken 
place some 35-55 million years ago in humans and guinea pigs as 
a result of highly mutated nonfunctional versions of GLO gene 
(Nishikimi et aL. 1992. 1994; Lachapelle and Droum. 2011) and 
believed to be a common occurrence for many species. It appears 
that this was a result of evolutionary pressure due to the coupling 
of the ability to have placental embryo development for reproduc­
tion and readily available dietary vitamin C source. In the case of 
mammalian vertebrates such an occurrence was inherently timely
with no major adverse outcome. However, for those species that 
retained the ex-vivo egg embryo development for reproduction, 
the consequences and the adverse limitations of this is obvious. 
For development of the egg embryo and general organogenesis the 
absence of an ascorbate source dictates no development. Based on 
our current knowledge, however, despite this the ex-vivo embryos 
of birds and fish defiantly continue to grow and eventually hatch. 
Fish, dinosaurs and birds were the early vertebrates to evolve pre­
dating modern vertebrates and primates between 450 and 150 
million years. Ironically all of these early vertebrates were egg 
laying species for reproduction and while the dinosaurs are extinct 
the fish and birds are still in existence and continue to use the 
same biological process for reproduction. A lack of capacity to 
synthesize ascorbate by passeriform birds and teleost fish suggests 
that the developing embryos of these species in ex-vivo eggs may 
utilize alternative biomolecule(s) and mechanism(s) for stable 
collagen synthesis during embryogenesis. The physico-chemical 
properties of egg yolk phosvitin suggest its plausible candidacy 
but scientific evidence in support of this has not been possible 
until the present study. As discussed in the introduction this was 
mainly due to lack of appropriate experimental model systems.
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Tig. 9. Biomineralization of the primary embryonic calvarial osteoblasts in the absence and presence of p-glycerolphosphate. ascorbate and phosvitin. (A) Microscopic 
observation of confluent osteoblasts cultured for 5 days in media alone, p-glycerolphosphate, p-glycerolphosphate+ascorbate, and p-glycerolphosphate+phosvitin followed 
by exposure to 2% silver nitrate for 30 min. The significant density of black nodules of mineral deposits were clearly visible in cultures treated with ascorbate and phosvitin. 
All magnifications were 100 * . (B) Quantitative calcium levels in HCI extracts of the mineralizing osteoblast cell layers demonstrating the substantial mineral deposition in 
the presence of ascorbate and phosvitin. The two sample Student's r test indicated that the differences in the levels of calcium deposition in controls (media alone or p- 
glycerolphosphate) versus those cultures in the presence of p-glycerolphosphate+ascorbate or phosvitin were statistically significant with p values noted within the figure. 
The calcium deposition for ascorbate versus phosvitin were, however, at similar levels and not statistically different. (C) Quantitative calcium uptake from the media of 
cultures in media alone, p-glycerolphosphate. p-glycerolphosphate+ascorbate. and p-glycero!phosphate+phosvitin reflecting significant level of calcium uptake from the 
media by osteoblast cell layer for cultures in the presence of ascorbate or phosvitin consistent with the calcium deposition levels in (B) above. The two sample Student's r test 
indicated differences to be statistically different with p values noted within the figure.
For example, the most common animal model is the mouse and 
interestingly they are one of the few species which evolutionarily 
retained the capacity to biosynthesize ascorbate. Knock-out stu­
dies in mice with deficient ascorbate synthesis through deletion of 
the GLO gene showed that collagen synthesis and the ratio of 
proline:4-hydroxyproline appeared not to change significantly 
(Parsons et al., 2006). The data indicated that although there 
was an undesirable impact on general survival and weight gain 
there was no significant effect on the synthesis of collagen. It was 
suggested that either there was residual active ascorbate in 
tissues/organs or collagen synthesis was independent of ascorbate 
and there was perhaps another mechanism by which stable 
collagen synthesis was possible (Parsons et al„  2006). Our studies, 
however, using e x - v iv o live neonatal mouse calvarial bone cultures 
which eliminates the natural supply of ascorbate showed clearly 
that in the absence of added ascorbate in such cultures there was 
no new osteoid/bone formation and hence no stable collagen 
synthesis (data presented herein; Curtin et al„  2012). Inclusion 
of ascorbate in such cultures on the other hand proceeded with 
rapid synthesis of collagen and formation of new osteoid 
and bone.
Phosvitin is an abundant highly phosphorylated protein com­
ponent of egg yolk derived from the mid-portion of a full length
protein of vitellogenin II gene by post-translational proteolytic 
cleavage and has been studied for almost half a century. Our most 
recent studies on the topographical distribution of phosphoryla­
tion sites of phosvitins also led to the discovery of a second 
phosvitin derived from vitellogenin I gene (Czemick et al.. 2013). 
Internalization of the egg yolk phosvitin into the oocyte via 
specific cell receptor binding and subsequent endocytosis suggests 
several important physiological functions for this protein during 
embryogenesis of birds, reptiles and fish (MacLean and Sanders, 
1983). One unique chemical property of phosvitin is its powerful 
antioxidant/reducing agent capacity. This knowledge, however, 
has not been linked to the fact that it is reminiscent of ascorbate 
which is also an antioxidant/reducing agent that is an essential 
biomolecule during the synthesis of stable collagen and hence, 
formation and maintenance of connective tissue, organs and 
skeletal system. In order to test our conceptual developments 
detailed above we have utilized our live neonatal mouse calvarial 
bone organ culture system under dissociative bone resorption and 
formation conditions to reveal the unique and important biologi­
cal properties of phosvitin not shared by any other ECM phospho- 
protein to date. The models we have developed have some very 
critical significance since conditions used dissociates the two 
remodeling stages, e.g., osteoclastic bone resorption and
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Fig. 10. LC-ESI-MS total base-peak ion abundance of the trypsin digested ECM and 
insoluble mineralizing osteoblast cell layers generated in the absence and presence 
of ascorbate or phosvitin. (Inset) pictorial representation of the acid insoluble cell 
layers with clear visible white pellets showing the major quantitative ECM 
differences between the controls versus those in the presence of ascorbate or 
phosvitin. red circled areas. (A) An example of LC-ESI-MS total base peak ion 
abundance profile of trypsin digested osteoblast ECM for samples derived from 
media alone or p-glycerolphosphate cultures (B) LC-ESI-MS total base peak ion 
abundance profile of trypsin digested osteoblast ECM for sample derived from 0- 
glycerolphosphate+ascorbate cultures 1C) LC-ESI-MS total base peak ion abun­
dance profile of trypsin digested osteoblast ECM for sample derived from p- 
glycerolphosphatea-phosvitin cultures. The total ion intensities of controls -5 - 
lower than those derived from cultured in the presence of ascorbate or phosvitin 
correlating with the ECM pellet sizes indicated in the (inset).
osteoblastic bone formation such that studies can be carried out to 
target effects of added factors and drugs on individual components 
as well as studies of cancer-bone interactions (Curtin et aL 2009. 
2012). The resorption model was designed to permit PTH-induced 
osteoclast differentiation from the resident progenitor/stem cells 
in the absence of ascorbate. Under these conditions PTH induces 
rapid osteoclastic bone resorption with complete suppression of 
osteoblast differentiation. Interestingly, this latter phenomenon is 
related to the inability of the mesenchymal/stromal cells to 
differentiate to osteoblasts since in the absence of ascorbate they 
cannot synthesize stable collagen which leads to lack of ECM 
formation and hence no osteoblast differentiation. The models
used also "highlight critically important evidence that osteoclas- 
togenesis is completely independent of ascorbate" in ex-vivo live 
bone micro­
environment which is highly likely to be the case in in vivo bone 
microenvironment too. This is contrary to the suggestion in the 
literature that ascorbate was essential for “osteoclastogenesis" and 
induced the formation of osteoclasts in a cooperative fusion with 
lu.25-dihydrovitamin D-, (or PTH) in co-culture system of bone 
marrow cells and clonal stromal ST2 (or CIMC-2) as mesenchymal 
support cells (Otsuka et aL 2000; Ragab et aL 1998). As we have 
recently highlighted in our work with cancer-bone interaction 
studies (Curtin et aL 2012). there are major advantages of the live 
bone organ culture models we have developed and that the co­
culture cell systems often do not provide the conditions that are 
relevant to the in vivo circumstances. Under resorption conditions, 
phosvitin inhibited PTH-induced osteoclast differentiation and 
bone resorption as revealed by NR staining and global quantitative 
histomorphometric analysis of silver stained whole calvaria which 
has major advantages over typical histomorphometric analysis 
using thin histological sections. There were however, some differ­
ences in the tissue's response toward the PTH+phosvitin and PTH 
♦ascorbate treatments. In the presence of phosvitin the osteoclas­
tic activity as well as their numbers were significantly reduced and 
did not develop their typical multinucleated form. In the presence 
of ascorbate on the other hand there was no significant osteoclas­
tic activity and or release of calcium instead there was uptake of 
calcium. The surprising aspect of these observations was the fact 
that phosvitin inhibited PTH-induced bone resorption with "simul­
taneous formation of significant amounts of new osteoid and 
bone" in the absence of ascorbate. This latter case clearly provoked 
a major interest within the context of this study, since our calvarial 
bone resorption model is based on the use of culture media that is 
devoid of ascorbate. Under such conditions it would be expected 
that there will be no new stable collagen synthesis, osteoid or 
bone formation because the synthesis and stability of the collagen 
molecule is critically dependent upon the presence of ascorbate 
for the synthesis of collagen containing hydroxylproline residues. 
Such post-translational modifications occur through the action of 
prolyl-hydroxylases whose catalytic activities are completely 
dependent on the presence of ascorbate as an antioxidant/redu- 
cing agent to regenerate ferrous (Fe"2) ion which undergoes 
electronic oxidation to ferric (Fe-3) ion during the hydroxylation 
step. These observations led us to further investigate this impor­
tant biologic event using our calvarial “bone formation model". The 
results from this bone formation model augmented the observa­
tions in the resorption system where chemical and biochemical, 
histological and histomorphometric measurements were consis­
tent with new collagen synthesis and osteoid/bone formation. The 
calcium uptake for phosvitin was lower than that of the ascorbate 
alone however, in the presence of phosvitin alone there was 
significant amount of differentiated osteoblasts and new osteoid 
formation simitar to that of ascorbate alone. These data indicated 
that phosvitin alone is capable of promoting osteoblast differen­
tiation and new osteoid deposition and co-inclusion of phosvitin 
and ascorbate appears to enhance such occurrence. While there 
was a similar level of ALP activity and amount of new osteoid 
formation between ascorbate and phosvitin treated cultures, the 
extent of calcium uptake or biomineralization appeared to be 
different. These results suggest that the initial formation of the 
new organic matrix has a common biological process for ascorbate 
and phosvitin. whereas the biomineralization (Ca-P deposition) 
step that follow this appears to be divergent. This latter case is 
likely to be due to the regulatory effect of phosvitin on the Ca-P 
crystal nucleation which is a known characteristic of ECM phos- 
phoproteins during biomineralization. These different stages 
involved in the overall bone formation and its mineralization are
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some of the reasons how our live multicellular bone organ culture 
system responsive to external stimuli by its resident stem cells 
undergoing differentiation which may give rise to some diver­
gence in the observations in Fig. 6 as compared to Fig. 7B 
Interestingly, our live bone cultures appear to simulate the events 
that arise from intermittent PTH treatment of osteoporosis which 
leads to stimulation of bone formation. In the presence of 
ascorbate or phosvitin bone cultures respond to PTH by significant 
differentiation of osteoblasts and formation of new osteoid/bone. 
These results suggest that inclusion of factors that stimulate 
osteoblast differentiation in bone organ cultures takes precedence 
over PTH-induced osteoclast differentiation.
It has been demonstrated that phosvitin bound to collagen 
substrate can promote nudeation of Ca-P (Onuma, 2005). and can 
bind 127 mol of Ca*2/mol of phosvitin (Grizzuti and Perlmann. 
1973). The possibility of Ca*2 binding to phosvitin may lead to the 
observed uptake of Ca*2 in our bone organ cultures can be 
excluded. This is because the solid phosvitin was first dissolved 
in the culture media to give stock solution which will render the 
phosvitin to be saturated with Ca*2 at this stage since there is 
excess supply of Ca*2 in the culture media. Aliquots of this was 
further diluted 200 x in the working culture media to be used. In 
addition, based on the above calcium binding capacity of phosvi­
tin. our calculations indicate that even without the above experi­
mental approach the potential amount of Ca*2 that could bind to 
phosvitin can only account for < 10% that of the total Ca*2 up-take 
from the media for both bone organ cultures and cultured 
osteoblasts. Importantly, our work with cultured osteoblasts 
clearly supported and confirmed the bone organ culture studies 
with mineralization of the osteoblasts in the presence of ascorbate 
or phosvitin to the same extent. In this latter case the quantitative 
Ca*2 deposition in the mineralizing cell layer was also determined 
in conjunction with the Ca*2 uptake from the media. The results 
confirmed that the Ca*2 up-take from the media were correlative 
with the Ca*2 depositions to the newly synthesized ECM. It is 
interesting to note that neither the role of phosvitin in egg shell 
(predominantly calcium carbonate) formation has not been 
defined nor its presence in this mineralized environment. Other 
phosphoproteins including those specific to egg shell have been 
proposed for this activity such as ovocleidin-17 and -116. and 
ovocalyxin-32 and -36 (Hincke et al„  2003, 1995; Gautron et al., 
2007; Mann et al.. 2002).
Our striking results with bone organ culture systems led us to 
design and synthesize a collagen peptide analog with multiple 
prolyl-hydroxylase recognition sites to provide additional direct 
supporting evidence. Use of this peptide under test tube chemistry 
conditions in the absence and presence of ascorbate or phosvitin 
together with mass spectroscopic analysis provided direct evi­
dence in support of the unique properties of phosvitin that can 
mirror those of ascorbate in facilitating hydroxylation of proline 
residues. These observations were further confirmed by use of 
cultured mineralizing calvarial osteoblasts for the first time with 
phosvitin. In this latter cell culture system we have established 
clearly that cultured osteoblasts behaved physiologically and 
biochemically the same manner toward exposure to ‘a s c o r b a t e  o r  
p h o s v i t in ' in terms of osteoblast differentiation, synthesis of 
dominant bone ECM proteins such as collagen type I alpha I 
and alpha 2 chains, generation of critically important hydroxypro- 
lines in collagens and general biomineralization. The use of mass 
spectrometric analytical approaches to analyze with high precision 
the details of the mineralized osteoblast ECM components 
provided ultimate confirmatory results that phosvitin stimu­
lates osteoblast differentiation, collagen synthesis, hydroxyproline 
formation and regulation of biomineralization These studies also 
led to the identification of vimentin (an important marker for 
epithelial to mesenchymal transition), and collagen type III
J
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Fig. II. LC-ESI-MS/MS sequence analyses of the collagen type I alpha 2 chain derived from trypsin digested ECM of mineralizing osteoblast cell layers cultured in the 
presence of ascorbate or phosvitin. (MS/MS spectrum of collagen type I alpha 2 chain peptide identified in trypsin digested acid insoluble ECM of mineralizing osteoblasts 
cultured in the presence of (A; ascorbate and (B) phosvitin. The series or b and y fragmentation ions are labeled and the hydroxyproline residues succinctly delined by the 
loss of mass 113 Da (-P-OH) between y„  and y7. yw and y,, and b„  and b,2. The peptide sequence. GATGLP’GVAGAP’GLP'GPR. contained three hydroxyproline residues 
indicated by the asterisks (*) was identified in ECM of mineralizing osteoblasts cultured in the presence of ascorbate or phosvitin.
(a fibrillar collagen associated with collagen type I in bone), in 
both ascorbate and phosvitin treated cultures which signify the 
critical role of phosvitin in connective tissue and bone organo­
genesis.
Conclusions
Overall, our studies culminated in the discovery of an impor­
tant and unique bioactivity for phosvitin in the collagen synthesis 
and formation of new osteoid/bone in the absence of ascorbate, a 
biological function that has avoided discovery for many decades 
due to lack of an appropriate model system until now. To the best 
of author s knowledge there has been no other naturally occurring 
biomolecule to date that has shown to have such a capacity except
ascorbate. In essence our live neonatal mouse calvarial model 
systems developed with bone remodeling stages dissociated have 
uniquely positioned us to truly decipher biological events and test 
bioactive molecules in a manner that cannot be achieved as easily 
by in vivo animal or in  v it r o cell culture models. This is particularly 
significant with regards to bone biology since in any animal model 
studies the circumstances in vivo very frequently preclude clear 
determination of the outcome of the designed experimental 
perturbations. For instance, in vivo there is continual “bone turn­
over" involving resorption and formation ongoing simultaneously 
such that the impact of altering one or the other requires long 
term study to reveal itself. Interestingly, the ex-vivo live mouse 
calvarial bone models, in addition to several other advantages 
discussed recently by Curtin et ai. (2012), have a major advantage 
within the context of the present study because although mice can
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biosynthesize ascorbate, this takes place in the liver and hence our 
cultured bones are devoid of a natural ascorbate source which 
indirectly reflects a system with specific gene product such as 
ascorbate is knocked-out. Complementing those studies use of the 
synthetic collagen peptide analog and cultured calvarial osteo­
blasts provided results that augmented the bone organ culture 
work and confirmed through multiple direct evidence the capacity 
of phosvitin to stimulate differentiation of osteoblasts, collagen 
synthesis, hydroxyproline formation, and biomineralization. The 
implications of the current findings are very significant and broad. 
From an evolutionary point of view egg yolk phosvitin has been 
serving a vital role individually or in combination with ascorbate 
in general embryogenesis during the development of egg embryos 
since the evolution of the first vertebrates, fish (-450 million years 
ago) and dinosaurs and birds (-200 million years ago) which all 
relied on an ex-vivo egg embryo development for reproduction. 
Whereas in those species of passeriform birds, teleost fish and 
reptiles in which the gene for the enzyme in the last step of 
ascorbate synthesis has been inactivated, the present work pro­
vided first specific evidence for a potential biomolecule enabling 
the connective tissue, organ and skeletal system formation during 
their egg embryo development in the absence of ascorbate. The 
implication for contemporary times is the discovery of a naturally 
occurring biomolecule which can stimulate the differentiation of 
resident local progenitor/stem cells to osteoblastic lineage, stable 
collagen synthesis and hence formation of connective tissue and 
new bone. This latter phenomenon opens new research avenues 
with major scientific interest in a wide range of applications in 
tissue engineering and regenerative medicine/dentistry.
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